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Abstract
Lipins are a family of highly conserved proteins found from yeasts to humans. Lipins have dual
functions, serving as phosphatidate phosphatase enzymes (PAP) in the synthesis of neutral fats
(triacylglycerols, TAG) and as transcriptional co-regulators that affect the expression of genes
involved in lipid and fatty acid metabolism. Thus, they play central roles in metabolic control.
Disruption of Lipin function has been implicated in lipodystrophy, obesity and insulin resistance.
Using dLipin, the Drosophila homolog of Lipin, as a model, I aimed to elucidate the relationship
between the two biochemical functions of Lipin and metabolic homeostasis. I discovered there is
a strong interconnection between TAG synthesis and insulin pathway activity. Reduced activity
of dLipin and other enzymes involved in TAG synthesis disrupted insulin pathway activity by
interfereing with phosphatidylinositol (3,4,5)-trisphosphate (PIP3) synthesis. Mosaic analysis
revealed that cell-autonomous loss of dLipin activity in fat the body negatively affects cell
growth. Genetic interaction experiments indicated that dLipin and the insulin pathway regulate
adipogenesis in an interdependent fashion. Furthermore, I found that the nutrient sensing
complex TORC1 regulates dLipin activity in lipid metabolism by controlling dLipin’s
subcellular localization. Hence, the insulin pathway as well as the TORC1 pathway each appears
to be a central regulator of dLipin activity and its functions in lipid metabolism. Nuclear
functions of dLipin did not seem to have an effect on insulin pathway activity. Thus, metabolic
disturbances observed after dLipin knockdown seem to be primarily caused by reduced PAP
activity provided by dLipin. Taken together, the results position dLipin as a central target to
further study the link between TAG synthesis and insulin and TORC1 pathway activity.
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I. Introduction
With obesity constituting a rising epidemic in the USA and worldwide, research into fat
metabolism has become a hot topic. As of 2013, more than 2/3 of the adult population in the
USA were overweight (Body Mass Index (BMI) > 25) and of these, about 1/3 were obese (BMI>
30). Being overweight or obese poses numerous health hazards and current healthcare costs
attributed to obesity are estimated to be 254 billion US$ (Go et al., 2013). Health risks associated
with obesity include the metabolic syndrome, hypertension, coronary artery disease and stroke,
respiratory defects, cancers, infertility and impotence, osteoarthritis, liver and gall bladder
disease and diabetes (Kopelman; 2007). 90 Ninety % per cent of people with type 2 diabetes
have a BMI> 23 suggesting that even being only slightly overweight puts individuals at an
immediate risk of developing type 2 diabetes (Kopelman, 2007). Prevalence of childhood obesity
and associated type 2 diabetes is rising steadily (Deckelbaum and Williams, 2001). As of 2012,
9.3% of the US population has diabetes and 33% of the adult population over the age of 20
shows signs of prediabetes (National Diabetes Statistics Report, 2014). With obesity and diabetes
representing the 2nd and 7th leading cause of death in the USA research into how fat metabolism
and insulin sensitivity are connected and controlled is more important than ever.
1. Characterization of Lipin
During times of excess nutrient uptake energy can be stored either as triacylglycerol
(TAG) or glycogen and saved for times of nutrient deprivation. In animals, TAG is stored in lipid
droplets within adipocytes, specialized fat storage cells, but virtually all cells have the capacity to
synthesize and store TAG in lipid droplets. Lipid droplets consist of a core of neutral lipids
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(TAGs), which is enclosed by a layer of phospholipids and associated proteins (Thiele and
Spandl, 2008).
A mutant mouse strain, the fatty liver dystrophy mouse (fld), displays significant loss of
fat tissue (lipodystrophy) in concert with ectopic fat accumulation in the liver and other
imbalances in lipid metabolism (Langner et al., 1991). The fld mouse was later shown to carry a
mutation in a novel gene, named lipin1. Two additional mouse lipin genes were identified by
sequence similarity, lipin2 and lipin3 (Peterfy et al., 2001). Homologs of mouse lipin genes were
also discovered in Homo sapiens and many genetic model organisms like Saccaromcyes
cerevisae, Arabidopsis thaliana, Caenorhabditis elegans, Drosophila melanogaster as well as
Shizosaccharomyces pombe, Plasmodium falsiparum and Trypanosoma brucei, indicating that
the lipin gene family is evolutionary conserved (Pelletier et al., 2013; Peterfy et al., 2001).
Inadequate adipose tissue in the fld mice was associated with glucose intolerance and increased
atherosclerosis (Reue et al., 2000). Studies with mammalian lipin1 revealed that lipin1 is not
only a lipodystrophy gene, but also an obesity gene, as overexpression of lipin1 in adipose tissue
and skeletal muscle of transgenic mice caused excess fat accumulation (Phan and Reue, 2005).
All three Lipins were identified as Mg2+-dependent phosphatidate phosphatase enzymes (PAP)
(Donkor et al., 2007). PAP activity is required for the conversion of phosphatidic acid (PA) into
diacylglycerol (DAG), an important step of the glycerol-3-phosphate pathway pictured below
(Fig. 1).
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Fig. 1. The glycerol phosphate pathway for glycerolipid synthesis

Fig. 1:
Canonical
glycerol-3-phosphate
that leads(DAG),
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which isGycerol-3-phosphate
the penultimate step in triacylglycerol
(TAG)
and
zwitterionic
phospholipid
(G-3-P) is converted into lysophosphatidic acid (LPA) by glycerol-3synthesisphosphate
via the glycerol
phosphate pathway.(GPAT).
The acyltransferase
enzymes in this pathwayO-acyltransferase (AGPAT)
2-O-acyltransferase
1-acylglycerol-3-phosphate
reside within
the
ER
membrane,
but
lipin
proteins
can
transit
from
the cytosol
the ER
subsequently transforms LPA into phosphatidic acid
(PA).toLipin
then catalyzes the conversion of
membrane to catalyze their enzymatic reaction; lipin proteins may also localize to the
PA into diacylglycerol (DAG), followed by the conversion of DAG into triacylglycerol (TAG)
nucleus. GPAT, glycerol-3-phosphate acyltransferase; AGPAT, acylglycerol-3-phosphate
by diglyceride
acyltransferase
(DGAT). The
final product,
acyltransferase;
DGAT, acyl
coenzyme-A:diacylglycerol
acyltransferase;
LPA,TAG, is then stored in fat droplets.
Figure modified
from Csaki et al, 2013.
lysophosphatidic
acid.

In their role as essential glycerolipd synthesis enzymes, Lipins emerged as attractive
targets for research that aims to elucidate the correlation between fat and glucose metabolism.
1.2. lipin gene family
As mentioned above, lipin genes are present in organisms ranging from Homo sapiens to
yeast. I will shortly summarize the major findings concerning molecular Lipin function(s). Lipin
proteins possess dual cellular roles, serving as PAP enzymes for TAG and phospholipid
synthesis and as transcriptional co-regulators in the regulation of lipid metabolism and
Prog	
   Lipid Res. Author manuscript; available in PMC 2014 July 01.
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adipogenesis genes (Finck et al., 2006; Reue and Zhang, 2008). All mammalian lipin homologs
possess PAP activity (Donkor et al., 2007).
Reue and Zhang
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Fig. 2. Dual cellular functions of lipin proteins
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Lipin-1, proteins
-2, and -3 all exhibit
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in
Fig. 2: Lipin
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dual
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as PAP
enzymes
and transcriptional cotriglyceride and phospholipid biosynthesis. Lipin-1 has also been shown to act as a
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directly
interacting
with nuclearin
receptors
as
regulators.
Lipincoactivator
functions
a PAP
enzyme
the such
glycerolipid
synthesis pathway, thus
PPARα and the coactivator PGC-1α.
contributing to TAG and phospholipid production. Lipin can also participate in the control of fat
metabolism by altering gene transcription in concert with nuclear receptors and other
transcription factors. Image modified from Reue and Zhang, 2008.

1.2.1. Mammalian Lipins
Mammalian Lipin functions have so far been most extensively studied and this is
especially true
lipin1,
the
gene
in the fld mouse. Disruption of lipin1 results in
FEBSfor
Lett. Author
manuscript;
available
in PMCdisrupted
2010 April 3.
lipodystrophy accompanied by insulin resistance, neuropathy, atherosclerosis, abnormal
triglyceride levels and neonatal fatty liver in mice (Langner et al., 1989; Peterfy et al., 2001;
Reue et al., 2000).
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Lipin1 accounts for virtually all PAP activity in white and brown adipose tissue and in
skeletal muscle, and for most of of the PAP activity in liver and brain (Donkor et al., 2007).
Overexpression of lipin1 in adipose tissue led to increased fat accumulation, as did
overexpression of lipin1 in muscle (Phan and Reue, 2005). Hence, Lipin1 is required for cellular
lipid accumulation through its role as a PAP enzyme. Furthermore, secretion of very low density
lipoproteins (VLDL) was negatively affected after loss of Lipin1 activity, which implicates
Lipin1 in processes involved in VLDL sequestration (Khalil et al., 2009).
Lipin1 was also identified as a transcriptional co-regulator that influences expression of
genes involved in fatty acid oxidation (Finck et al., 2006). Fatty acid oxidation takes place in
hepatic mitochondria and represents a catabolic pathway that produces energy.
During times of starvation, hepatic fatty acid oxidation is upregulated. Peroxisome
proliferator-activated receptor (PPAR) α is a gene encoding a nuclear receptor that regulates
numerous genes involved in fatty acid oxidation. Accordingly, PPARα expression is induced
upon starvation. It was shown that starvation-induced PPARα expression is dependent on Lipin1
activity and mediated in concert by Lipin1 and peroxisome proliferator activated receptor γ
coactivator-1 α (PGC-1α). To regulate gene expression, Lipin1 and PGC-1α interact directly
(Finck et al., 2006). The nuclear receptor hepatocyte nuclear factor 4 α (HNF4α) was identified
as an interaction partner of nuclear Lipin1. The interaction between HNF4a and Lipin1 positively
regulates expression of genes involved in fatty acid catabolism (Chen et al., 2012). Thus, Lipin1
affects transcription of genes involved in hepatic fatty acid oxidation via modulation of PPARα
expression and interaction with HNF4a.
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Lipin1 also influences adipogenic gene expression by regulating transcriptional activity
of peroxisome proliferator-activated receptor γ (PPARγ) and CAAT/enhancer binding protein α
(C/EBPα) in preadipocytes (Peterfy et al., 2005; Phan et al., 2004). During the process of
adipogenesis cells differentiate from preadipocytes to adipocytes and final cell number of
adipose tissue is determined. PPARγ and C/EBPα are master regulator genes of adipogenesis and
together, control the terminal differentiation process (Farmer, 2006). It was later shown that
Lipin1’s PAP activity is required for PPARγ transcriptional activity and it was furthermore
suggested that Lipin1 affects PPARγ activity by adjusting PA levels (Zhang et al., 2012). New
data points to the possibility that Lipin1 might also directly bind to PPARγ and thereby induce a
conformational change in PPARγ. This conformational change in PPARγ is proposed to cause a
release of co-repressors and in turn enhance recruitment of PPARγ co-activators (Kim et al.,
2013). This would then allow PPARγ to activate gene expression. Lipin1 is thus involved in
controlling transcriptional activity of PPARγ and C/EBPα by mechanisms that require further
investigation, but that might rely on Lipin1’s PAP activity.
Lipin1 also controls lipogenic and cholesterogenic gene expression in hepatocytes by
directly affecting sterol regulatory element binding protein (SREBP) protein levels (Peterson et
al., 2011). SREBPs are transcription factors that control biosynthesis of cholesterol and fatty
acids. In the presence of low cellular sterol levels, SREBPs are activated and partake in
transcription of lipogenesis and cholesterogenesis genes. Peterson et al. (2011) identified Lipin1
as a negative regulator of nuclear SREBP function.
In addition, Lipin1 negatively regulates transcriptional activity of the nuclear factor of
activated T cells c4 (NFATc4) in adipocytes. NFATc4 activity is repressed by direct protein	
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protein interaction with Lipin1. These data suggest a possible role for Lipin1 in mediating
inflammatory response in adipose tissue (Kim et al., 2010).
In summary, Lipin1 functions as a PAP enzyme and a transcriptional co-regulator.
Lipin1’s PAP activity is indispensable for TAG synthesis and is possibly also involved in the
control of adipogenic gene expression. Lipin1’s transcriptional co-regulator activity contributes
to fatty acid metabolism by directly controlling PPARα expression and HNF4a activity and
influences inflammatory gene transcription via interaction with NFATc4. SREBP-mediated lipid
biogenesis is also affected by Lipin1 activity but the exact mechanisms underlying this
interaction remain elusive.
Lipin2 and Lipin3 were identified based on amino acid similarity to Lipin1 (Peterfy et al.,
2001). Lipin2 and 3 also exhibit PAP activity, but so far these two members of the lipin family
have been much less well characterized. lipin1, lipin2 and lipin3 display distinct tissue
expression levels, suggesting that the different lipin genes have independent physiological roles
(Donkor et al., 2007). lipin2 is predominantly expressed in liver, kidney and brain (Donkor et al.,
2007). A possible involvement of Lipin2 in adipogenesis has been postulated (Donkor et al.,
2009; Grimsey et al., 2008). Even less is known about Lipin3. lipin3 is expressed in the
gastrointestinal tract and, to a much smaller degree, in the liver (Donkor et al., 2007).
The three human Lipins display 44-48% amino acid identity to the corresponding mouse
paralogs. The human Lipin proteins are encoded by LPIN1, LPIN2 and LPIN3. Human lipin
homologs are less well studied than their mouse counterparts. In contrast to studies in mouse,
LPIN1 expression in human adipose tissue is not always positively correlated with adiposity
(Chang et al., 2010, Miranda et al., 2007; Mlinar et al., 2008). Expression levels of PPARγ in
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adipose tissue were positively correlated with LPIN1 expression, as were ADIPOQ (adiponectin)
expression levels. This suggests that higher LPIN1 levels promote maturation of adipocytes with
increased TAG content (Chang et al., 2010). LPIN1 expression in adipose tissue is furthermore
positively correlated with insulin sensitivity and with expression of genes involved in fatty acid
oxidation and lipolysis. An especially strong correlation was found between LPIN1 expression
and PPARα. Thus, LPIN1 might play a critical role in human fatty acid oxidation comparable to
mouse lipin1 (Donkor et al., 2008). Glucose transporter 4 (GLUT4) gene expression was also
positively correlated with LPIN1 mRNA levels (van Harmelen et al., 2007). Thus, LPIN1
expression correlates positively with insulin sensitivity and increased fatty oxidation in humans.
Studies of human populations found that certain LPIN1 and LPIN2 polymorphisms are
associated with type 2 diabetes and other metabolic traits (Aulchenko et al., 2007; Chang et al.,
2010).
Deficiency in LPIN1 has been implicated in recurrent acute myoglobinuria during
childhood and statin-induced myopathy (Zeharia et al., 2008). LPIN2 deficiency can lead to
Majeed Syndrome (Ferguson et al., 2005) and psoriasis (Milhavet et al., 2008).
It thus appears that human LPIN genes overall seem to affect metabolic processes involved in
glucose and lipid homeostasis in a similar way as mouse lipin homologs.
1.2.2. Lipin homologs in yeast, C. elegans and A. thaliana
In 2009 the C. elegans lipin1 homolog was identified (Golden et al., 2009; Gorjanacz and
Mattaj, 2009), lpin-1. Loss of LPIN-1 activity in C. elegans resulted in defects in fat storage, ER
organization and nuclear membrane breakdown, irregular nuclear morphology and abnormal
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chromosome segregation. Worms with lpin-1 knockdown were reduced in size (Golden et al.,
2009).
Mutations of PAH1, the lipin homolog in S. cerevisae resulted in lower TAG content in
mutant cells along with elevated PA levels (Han et al., 2006). PAH1 function was also required
for fat droplet formation (Adeyo et al., 2011). PAH1 was further implicated in the transcriptional
control of phospholipid biosynthesis genes (Santos-Rosa et al., 2005). Cells with PAH1
deficiency exhibited excess nuclear expansion, possibly caused by transcriptional changes of
phospholipid synthesis genes induced by elevated PA levels (Han et al., 2007). Thus, PAH1 may
influence phospholipid synthesis directly as a transcriptional co-regulator by repressing
expression of phospholipid synthesis genes and additionally by modulating PA levels via its PAP
activity (Siniossoglou, 2009). The lipin homolog of the fission yeast (ned1+) affects
chromosomal segregation and ER expansion (Tange et al., 2002). Thus, both PAH1 and C.
elegans lpin-1 appear to contribute to nuclear envelope dynamics.
lipin homologs in A. thaliana (AtPAH1 and AtPAH2) contribute to galactolipid synthesis
and phosphate starvation resistance (Nakamura et al., 2009).
1.2.3. Lipin homolog in D. melanogaster
Mutations in the Drosophila lipin homolog dLipin resulted in animals with decreased
TAG content, which suggests that dLipin also functions as a PAP enzyme (Ugrankar et al., 2011;
Valente et al., 2010). Expression of dLipin was found to be strongest in the fat body, ring gland,
ovaries, Malphigian tubules, midgut and ceca. dLipin showed both cytoplasmic and nuclear
staining, which indicates that dLipin might also possess nuclear function in Drosophila
(Ugrankar et al., 2011). Like mice deficient in lipin1, Drosophila larvae deficient for dLipin
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displayed severe lipodystrophy. Lipodystrophy was accompanied by changes in fat body cell
shape and size and a reduction in fat droplet size (Ugrankar et al., 2011). Cells were rounded in
appearance and exhibited a wide variability in cell size. Ketone body formation was increased in
animals deficient for dLipin. Thus, it appears that fatty acid metabolism was altered. Larval
development was delayed, larval lethality increased, and the few animals reaching the pupal
stage died as pharate adults. This suggests that dLipin is required for the formation of energy
stores in developing larvae. Ultrastructure analysis showed that dLipin is required for proper
assembly and function of mitochondria, autophagosomes and cell nuclei. It was also shown that
dLipin is required for starvation resistance (Ugrankar et al., 2011). These data on dLipin indicate
that Lipin’s function in TAG synthesis is conserved between mammalian species and
Drosophila, as defects observed in flies lacking dLipin resemble the mammalian lipin phenotype.
2. Lipin protein structure
Lipin PAP activity depends on a short amino acid motif that is conserved among species
(DXDXT motif) and a conserved serine (S734) residue (Donkor et al., 2009). The PAP motif is
located in the conserved CLIP domain of the protein and it is present in Lipin homologs from
mammals to protists (Donkor et al., 2006, Pelletier et al., 2013) (Fig. 3). In addition to the PAP
motif, Lipin homologs of mammals and Drosophila contain a co-regulator motif (LXXIL motif)
that is evolutionarily conserved and also located in the CLIP domain (Finck et al., 2006; Peterfy
et al., 2001). The LXXIL motif is required for Lipin’s transcriptional co-regulator activity (Finck
et al., 2006). Mutations in the PAP motif have no effect on transcriptional activity, whereas
changes in the co-regulator motif not only reduce transcriptional, but also PAP activity (Reue
and Brindley, 2008). In addition to the PAP and co-regulator motifs, Lipin also has a nuclear
localization signal (NLS). The NLS is required for nuclear localization, but might also affect
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membrane association and physiological functions of Lipin (Khalil et al., 2009). The
conservation of CLIP and NLIP domains is summarized in Fig. 3.
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In 2008, it was found that lipin1 expression is positively regulated by glucocorticoids and
cAMP. The stimulatory effect of glucocorticoids was antagonized by insulin (Manmontri et al.,
2008; Zhang et al., 2008). A glucocorticoid-response element was identified in the promoter
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region of lipin1. Increased glucocorticoid levels during adipogenesis induced expression of
lipin1 in preadipocytes and thus promoted cell differentiation (Zhang et al., 2008).
Glucocorticoid levels are also elevated during times of physiological stress, like starvation,
diabetes, hypoxia and obesity (Manmontri et al., 2008).
In addition, SREBP-1 activates LPIN1 expression (Ishimoto et al., 2009). SREBPs are
transcription factors that control biosynthesis of cholesterol and fatty acids. In the presence of
low cellular sterol levels, SREBPs are activated and partake in transcription of lipogenesis and
cholesterogenesis genes. Thus, cellular sterol levels also regulate LPIN1 expression.
In adipose tissue, lipin1 expression is also triggered by thiazolidinediones and harmine;
both of which promote insulin sensitivity (Park et al., 2010; Yao-Borengasser et al., 2006). lipin1
expression is further influenced by estrogen levels, as high estrogen levels negatively correlate
with lipin1 expression in the uterus and liver (Gowri et al., 2007). Cytokines, tumor necrosis
factor α and interleukin-1 negatively regulate Lipin1 expression, which leads to an increase in
lipolysis in adipose tissue and hence a reduction in fat stores during infection (Reue and
Brindley, 2008).
In addition to control at the transcriptional level, Lipin1 activity can be modulated at the
protein level. It was shown that PAP activity is primarily cytosolic and translocates to the ER in
response to fatty acids (Gomez-Munoz et al., 1992). The ER represents the major site of TAG
biosynthesis and fat droplet formation (Wilfling et al., 2013). Thus, subcellular localization of
Lipin corresponds with molecular Lipin function. The change in Lipin1’s subcellular localization
has been attributed to a change in Lipin’s phosphorylation status (Gomez-Munoz et al., 1992;
Harris et al., 2007; Huffmann et al., 2002). High cellular concentrations of fatty acids, as well as
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the presence of epinephrine and oleic acid, induce dephosphorylation of Lipin1 and recruitment
of Lipin1 to the ER (Harris et al., 2007). Multiple rapamycin-sensitive phosphorylation sites
have been identified in Lipin1 (Harris et al., 2007; Peterson et al., 2011). Rapamycin-sensitivity
of the phosphorylation sites indicates that phosphorylation at these residues is dependent on the
Ser/Thr kinase target of rapamycin (TOR). Rapamycin acts as an inhibitor of TOR action. TOR
is part of a nutrient sensing protein complex (TOR complex 1, TORC1) and integrates both
nutrient and growth factor/insulin signaling (Dibble and Manning, 2013). Mammalian TORC1mediated (mTORC1) phosphorylation of Lipin1 promotes cytoplasmic Lipin1 retention and loss
of mTORC1 activity has been shown to promote nuclear translocation of Lipin1 (Peterson et al.,
2011). Thus, dephosphorylation of Lipin1 seems to be required for nuclear translocation and ER
association of Lipin1.
Insulin signaling promotes cytoplasmic retention of Lipin1 by stimulating an interaction
between Lipin1 and 14-3-3 proteins (Peterfy et al., 2009). Furthermore, Lipin1’s serine106
residue has been identified as being specifically phosphorylated upon insulin signaling in a
rapamycin-sensitive manner (Harris et al., 2007), which indicates that TOR and insulin pathway
might control Lipin localization in concert. The PAP activity of Lipin1 itself was not modified
by phosphorylation events, suggesting that Lipin1’s phosphorylation status does not affect its
enzymatic activity (Harris et al., 2007), but rather that TOR and insulin influence Lipin1’s
activity by modulating its subcellular localization.
Lipin1’s serine106 residue was later identified to be the target site for the phosphatase
Dullard (Wu et al., 2011). This is consistent with the observation that yeast PAH1 is
dephosphorylated by Nem1, the yeast homolog of Dullard (Santos-Rosa et al., 2005). In neuronal
cells, it was found that sumoylation of Lipin1 resulted in its nuclear localization (Liu and Gerace,
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2009). Furthermore, recent work by Eaton et al. (2013) suggests that Lipin1’s membrane
association, and hence its catalytic activity, may be regulated by pH levels and membrane
phospholipid composition (Eaton et al., 2013).
In summary, Lipin activity is regulated on a transcriptional level by glucocorticoids and
metabolic status as well as on a posttranslational level via phosphorylation and sumoylation.
Intracellular pH and membrane composition may also influence Lipin activity. The effects of
posttranslational modifications on Lipin activity still require more investigation and are not well
understood at this point. It also appears that Lipin activity is closely associated with TOR and
insulin pathway activity. In the next section, I will outline general aspects of TOR and insulin
pathway activity and the influence of TOR and insulin pathway activity on lipid metabolism.
4. Roles of TOR and insulin signaling in metabolic homeostasis
Animals need to balance nutritional status with growth while maintaining overall energy
homeostasis. Thus, pathways evolved that coordinate metabolic demands with dietary input.
From yeast to mammals, favorable nutritional conditions promote cell growth by activation of
the TOR pathway (Dann and Thomas, 2006). TOR is an effector of cell growth by integrating
signals from growth factors/insulin and nutrients, especially amino acids and cellular energy
status (AMP/ATP ratio). TOR activity is reduced in response to certain physiological cues.
These cues include hypoxia, reducing conditions, DNA damage and starvation (Wullschleger et
al., 2006). TOR functions in two distinct complexes, TOR Complex 1 (TORC1) and TOR
Complex 2 (TORC2). Mammalian TORC1 (mTORC1) consists of mTOR, raptor and mLST8.
mTORC2 is made up of mTOR, rictor, SIN1, mLST8 and Protor.
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4.1. General functions of mTORC1
mTORC1 is activated by nutrients and by growth factor signaling/insulin signaling.
Insulin pathway input is communicated to mTORC1 via protein kinase B (AKT). AKT
phosphorylates the mTORC1 inhibitor complex tuberous sclerosis complex 1/2 (Tsc1/2) and thus
allows ras homolog enriched in brain (Rheb), an mTORC1 activator, to phosphorylate mTORC1
(Manning and Cantley, 2003). AKT also phosphorylates and thus inhibits proline-rich AKT
substrate 40 (PRAS-40), which is an mTORC1 inhibitor (Sancak et al., 2007).
How exactly amino acids activate mTORC1 is still subject to research, but it is proposed,
that the ragulator-rag complex recruits mTORC1 to lysomes, the site of Rheb activity (Dibble
and Manning, 2013; Sancak et al., 2010). Activated mTORC1 then phosphorylates downstream
targets, S6 kinase (S6K) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1), and
consequently promotes cell growth (Magnuson et al., 2012). S6K positively regulates protein
synthesis in numerous ways, including translation initiation, translational elongation and mRNA
processing, and thus promotes cell growth (Magnuson et al., 2012). S6K activation also increases
nucleotide synthesis required for DNA and RNA synthesis (Ben-Sahra et al., 2013). 4EBP1 is an
inhibitor of cap-dependent translation as it binds to the eukaryotic translation initiation factor 4F
(eIF4F) (Gingras et al., 1999). mTORC1-mediated phosphorylation of 4EBP1 releases eIF4F
from 4EBP1 and in turn activates translation (Gingras et al., 1999). Furthermore, ribosome
biogenesis is also mediated by mTORC1 (Iadevaia et al., 2014).
Autophagic processes are negatively regulated by mTORC1 as mTORC1 was identified
to directly phosphorylate and consequently inactivate Unc-51-like autophagy activating kinase-1
(ULK1) and death-associated protein 1 (DAP1) (Kim et al, 2011; Koren et al., 2010). Thus,

	
  

15

mTORC1 mediates cell growth by coordinating protein synthesis, nucleotide synthesis and
autophagy (Betz and Hall, 2013).
4.2. General functions of mTORC2
The mechanisms leading to mTORC2 activation are still unknown, but believed to be
initiated by growth factors (Kim and Guan, 2011). Once activated, mTORC2 affects AKT
activity by phosphorylation of the hydrophobic motif in AKT (serine473) (Sarbassov et al.,
2005). mTORC2 also phosphorylates and activates protein kinase C ζ (PKCζ) and, thus,
regulates cell migration and cytoskeleton formation (Li and Gao, 2014). mTORC2-mediated
phosphorylation of serum- and glucocorticoid-induced protein kinase 1 (SGK1) implicates
mTORC2 activity in the mediation of cell proliferation/survival (Garcia-Martinez and Alessi,
2008). SGK1 is a kinase that positively influences cell proliferation and inhibits apoptosis (Lang
et al., 2006). A possible negative feedback loop exists between mTORC1 and mTORC2 activity
that is speculated to lead to changes in mTORC2 protein interactions (Treins et al., 2010). In
summary, mTORC2 mediates cell growth by coordinating cytoskeleton formation, cell migration
and cell proliferation.
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Fig. 3: Overview of mTORC1 and mTORC2 signaling pathways. These images summarize
the mTORC1 (A) and TORC2 (B) pathways. For further explanation, please refer to main text.
Image modified from Kim and Guan, 2011.

4.3. Functions of mTORC1 and mTORC2 in lipid metabolism
The above figure displays effects of mTORC1/mTORC2 activity on general metabolism,
cell survival and cytoskeleton dynamics (Fig. 3). TOR-induced cell growth has been mostly
studied by measuring protein synthesis as a biological output but it is becoming clear that other
anabolic pathways are also affected by TOR activity, likely also lipid synthesis (Birse et al.,
2010; Laplante and Sabatini, 2009 and 2012). Research shows that mTORC1 and mTORC2
directly affect lipid biogenesis.
Adipogenesis is promoted by both mTORC1 and mTORC2 activity. Inhibition of 4EBP1
by TORC1 is believed to allow for PPARγ translation and thus activates adipogenic gene
expression (Zhang et al., 2009). Activation of S6K is also implicated in adipogensis, as S6K
knock out mice show a lack of fat accumulation due to a defect in adipocyte formation
(Carnevalli et al., 2010). Recently it has been discovered that mTORC2 plays a role in
adipogenesis as well. It was demonstrated that mTORC2 positively affects adipogenesis by
phosphorylation of AKT (Yao et al., 2013).
In addition to adipogenesis, mTORC1 also has a role in hepatic lipid biogenesis.
mTORC1 appears to modulate hepatic lipogenesis mainly by regulation of SREBP activity. The
regulation of SREBP might be mediated by mTORC1 activation of S6K (Duevel et al., 2010).
Additionally, SREBP regulation by mTORC1 may be communicated through Lipin1 (Peterson et
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al., 2011). As mentioned previously, Lipin1 is a target of mTORC1-dependent phosphorylation,
which in turn affects Lipin1’s subcellular localization. Upon loss of mTORC1 activity,
dephosphorylated Lipin1 enters the nucleus and represses SREBP activity and thus lipid
biogenesis (Peterson et al., 2011). Hence, mTORC1 regulates lipid biogenesis via S6K and
Lipin1, although the exact molecular mechanisms still remain elusive.
mTORC2 also influences lipogenesis, although substrates and pathways involved remain
largely unknown. It has been proposed that part of the influence of mTORC2 on lipogenesis
results from its effects on SGK1 and AKT activity (Laplante and Sabatini, 2012). mTORC2 was
identified as a suppressor of lipolysis in adipose tissue (Kumar et al., 2010). In addition, hepatic
lipogenesis appears to be subject to mTORC2 regulation as mice with a reduction in mTORC2
activity display reduced expression of key lipid synthesis genes in the liver (Yuan et al., 2012).
These data implicate both mTOR complexes as central regulators of lipid metabolism and
also suggest that aspects of mTOR-mediated regulation of lipid homeostasis might be brought
about by changes in Lipin1 activity.
4.4. General functions of the insulin pathway
As mentioned previously, Lipin activity appears to be regulated by the insulin pathway.
The insulin pathway integrates growth factor/insulin signaling with anabolic cellular processes.
In mammals, circulating insulin-like growth factors (IGFs) promote cell and tissue growth, and
circulating insulin regulates carbohydrate and lipid metabolism (Siddle, 2012). Dimerization of
insulin or insulin-like growth factor receptors (IR/IGRF) triggers autophosphorylation of the
receptors, which in turn promotes recruitment and phosphorylation of insulin receptor substrate 1
and 2 (IRS1, IRS2) proteins (Manning and Cantley, 2007). IRS1/2 phosphorylation activates
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phosphatidylinositol-4,5-bisphosphate 3-kinase	
  (PI3K) (Hemmings and Restuccia, 2012). PI3K
consists of a regulatory p85 subunit and a catalytic p110 subunit (Vogt et al., 2010). The
catalytic p110 subunit phosphorylates phosphatidylinositol (4,5) bisphosphate (PIP2) to produce
phosphatidylinositol (3,4,5) trisphosphate (PIP3) (Vogt et al., 2010). This phosphorylation step is
antagonized by phosphatidylinositol 3, 4, 5 trisphosphate 3-phosphatase (PTEN) (Kishimoto et
al., 2003). PIP3 at the plasmamembrane recruits phosphoinositide-dependent kinase-1 (PDK1)
and AKT. At the plasma membrane, PDK1 activates AKT through phosphorylation. In addition,
mTORC2-mediated phosphorylation of AKT is required for maximal AKT activation
(Hemmings and Restuccia, 2012). AKT then phosphorylates many downstream substrates and
promotes cell survival by blocking proapoptotic proteins and processes (Manning and Cantley,
2007). Forkhead box protein O (FOXO) transcription factors are phosphorylated by AKT, which
leads to FOXO’s removal from the nucleus. By removing FOXO transcription factors from the
nucleus, AKT inhibits expression of proapoptotic and cell cycle arrest genes (Burgering and
Kops, 2002). AKT positively affects cell growth by activation of mTORC1 via Tsc1/2 and
PRAS-40 phosphorylation (Manning and Cantley, 2007). Metabolic processes are also targeted
by AKT. AKT promotes glucose transporter 4 (GLUT4) membrane translocation and thus
promotes glucose uptake (Cong et al., 1997). In addition, glycogen synthesis is stimulated by
AKT through inhibition of glycogen synthase kinase 3 (GSK3) (Manning and Cantley, 2007).
Cell proliferation is regulated by AKT in part by interfering with p27 function (Manning and
Cantley, 2007; Taguchi and White, 2008). Thus, insulin pathway activity is involved in
upregulation of many cellular anabolic pathways.
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Also, ectopic lipid accumulation is a common side effect of reduced insulin sensitivity (Frayn et
al., 2001).
	
  

Cell. Author manuscript; available in PMC 2009 October 5.

21

In adipocytes, insulin signaling enhances TAG production and downregulates lipolysis
(Czech et al., 2013). Two lipolytic pathways exist; one mediated by protein kinase A (PKA) and
the other by protein kinase G (PKG) (Czech et al., 2013; Miyoshi et al., 2007; Sengenes et al.,
2003). Insulin signaling reduces activity of both lipolysis pathways (Czech et al., 2013). AKT
also inhibits hydrolysis of TAG through upregulation of mTORC1 activity, which results in a
reduction of adipose triglyceride lipase (ATGL) mRNA (Chakrabarti et al., 2010). Therefore,
adipocyte lipolysis is attenuated in response to insulin pathway activation. At the same time,
lipogenic mechanisms in adipocytes are upregulated; in particular fatty acid uptake and de-novo
fatty acid synthesis (Czech et al., 2013; Stahl et al., 2002).
In the liver, insulin pathway activity increases de-novo fatty acid synthesis via activation
of acetyl-CoA carboxylase (ACC), a key enzyme in fatty acid synthesis (Berggreen et al., 2009).
In addition, insulin pathway activity also modifies lipogenic gene transcription
(Assimacopoulos-Jeannet et al., 1995; Sul et al., 2000). In hepatocytes, this is mediated by
insulin/mTOR-stimulated processing of SREBPs (Ferre and Foufelle, 2007; Shimomura et al.,
1998). The exact mechanism of how SREBP control is communicated remains elusive, but as
mentioned before, Lipin1 activity appears to play an important role as a negative regulator of
nuclear SREBP activity (Peterson et al., 2011).
In conclusion, both the TOR and the insulin pathway contribute to lipid metabolism
control, in some instances in concert. Lipin activity appears to be targeted by both pathways with
regard to SREBP control. Thus, Lipin could represent an important mediator between
TOR/insulin pathway and lipid homeostasis. The exact mechanisms of the TOR/insulin pathwayinduced and Lipin-communicated effects on lipid metabolism still warrant further investigation.
Drosophila melanogaster has been used as a model system to investigate fat metabolism as well
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as TOR/Insulin signaling (Baker and Thummel, 2007; Grewal, 2008; Teleman, 2009).
Drosophila only has one lipin homolog, dLipin, which simplifies genetic studies. In the next
section, I will summarize insulin and TOR pathways of the fly and point to shared and distinct
characteristics between mammalian and Drosophila insulin/TOR signaling. I will summarize the
most important aspects of lipid and glucose metabolism in the fly.
5. Lipid and glucose metabolism in D. melanogaster
Drosophila shares most of the basic metabolic functions found in mammals. Flies have a
gastrointestinal tract that is similarly functionally segregated as the mammalian counterpart, fat
body that functions as mammalian liver and white adipose tissue, oenocytes that perform basic
hepatocyte-like functions in lipid-processing and specific neurosecretory cells in the brain that
maintain insect metabolic homoeostasis in a way comparable to mammalian pancreatic β cells
(Canavoso et al., 2001; Gutierrez et al, 2007; Rulifson et al., 2002). Organismal growth in
Drosophila is restricted to the larval stages. After metamorphosis the adult fly no longer
increases in size. Like mammals, Drosophila stores energy as TAG and glycogen. Lipid stores
are the primary energy source for insects during diapause, embryonic development and
prolonged flight (Arrese and Soulages, 2010). Both TAG and glycogen are stored in the fat body,
though TAG represents the major energy reserve. TAG is synthesized via the glycerol-3
phosphate pathway involving dLipin and stored in intracellular lipid droplets. Mobilization of
TAG reserves is mediated by triglyceride lipases. In Drosophila the Brummer gene encodes a
lipid droplet associated TAG lipase homologous to the mammalian adipocyte triglyceride lipase
(ATGL) (Groenke et al., 2005). Glycogen is mobilized mostly in the form of the dissacharide
trehalose (Thompson, 2003). TAG and glycogen stores can be mobilized by adipokinetic
hormone (AKH) released from the corpora cardiaca (Arrese and Soulages, 2010). TAG and
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glycogen from fat body stores are mobilized during times of energy depletion like starvation,
flight and during embryogenesis.
Both, the insulin and TOR pathways can activate TAG production in the fat body of
Drosophila (Birse et al., 2010; DiAngelo and Birnbaum, 2009, Teleman et al., 2005). This
suggests that in Drosophila, lipid metabolism is regulated by the insulin and TOR pathways,
similarly compared to mammalian systems.
6. Functions of TOR in D. melanogaster
The Drosophila homolog of mammalian TOR, dTOR functions in many ways
comparable to mammalian TOR in processes controlling cell growth and metabolism (Oldham et
al., 2000). Amino acid input is the major trigger for dTOR-induced cell growth, and cellular
amino acid status is most likely communicated to dTOR via the amino acid transporter, slimfast
(Colombani et al., 2003). dTOR activates metabolic gene expression in an amino acid sensitive
fashion and controls cell cycle progression (Li et al, 2010; Patel et al., 2003). Furthermore,
dTOR is known to coordinate endocytotic and nutrient uptake processes to control cell growth in
the fat body (Hennig et al., 2006). Cell growth was strongly targeted by dTOR in endoreplicative
tissue (Britton and Edgar, 1998). dTOR, like mammalian TOR, inhibits autophagy (Scott et al.,
2004).
dTOR also influences lipid metabolism (Birse et al., 2010; Teleman et al., 2005). Birse et
al. (2010) demonstrated that systemic reduction of TOR activity resulted in decreased overall
TAG stores in animals fed a high-fat or normal diet. This was caused by a decrease in
lipogenesis in combination with increased lipolysis (Birse et al., 2010). Teleman et al. (2005)
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observed that animals with reduced TOR activity displayed significantly reduced fat stores.
Thus, it appears that dTOR is an important regulator of systemic lipid metabolism.
Drosophila has two TOR complexes, TORC1 and TORC2. As in mammalian systems,
Drosophila TORC2 phosphorylates AKT at the hydrophobic motif while the rapamycin-sensitive
TORC1 is believed to primarily control cell growth and overall metabolism of the fly (Sarbassov
et al., 2005, Teleman, 2009). The signaling pathway leading to TORC1 activation in Drosophila
is basically identical to the pathway in mammalian systems, and is summarized in Fig. 5. Like its
mammalian counterpart, dTOR appears to be involved in the insulin pathway cascade. However,
the crosstalk between the dTOR and insulin pathways seems to be complicated and dTOR and
insulin pathway activity are not always directly connected but can also be uncoupled (Colombani
et al., 2003; Oldham et al., 2000; Pallares-Cartes et al., 2012).
7. Functions of the insulin pathway in D. melanogaster
The insulin pathway in Drosophila strongly resembles the mammalian insulin signaling
systems. Not only are molecular components of the pathway conserved, but also physiological
output. Drosophila has eight insulin-like peptides (dILPs), which are homologous to mammalian
insulin in action and protein sequence (Kannan and Fridell, 2013). Each dILP has a distinct
expression pattern, which implies that each dILP possesses a unique physiological function.
dILPs 1, 2, 3 and 5 are expressed in neurosecretory brain cells, whereas dILPs 4 and 5 are
expressed in the midgut. dILP 6 is mainly produced in the fat body, dILP 7 in the ventral nerve
cord of the brain and the newly discovered dILP 8 in imaginal discs (Kannan and Fridell, 2013).
Larval ablation of the neurosecretory cells that are responsible for releasing dILPs 2, 3 and 5
resulted in a phenotype that mirrors the physiological effects of insulin resistance in mammals
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(Rulifson et al., 2002; Broughton et al., 2005). dILP binding activates the Drosophila homolog
of the mammalian insulin receptor, InR. Two insulin receptor substrate proteins exist in
Drosophila, namely Chico and Lnk. As in the mammalian insulin pathway, phosphorylation of
IRS recruits PI3K (p60 and p110 subunits) to the plasma membrane where it catalyzes the
generation of PIP3. PIP3 accumulation activates PDK1 and AKT. These protein interactions are
all highly conserved between flies and mammals (Teleman, 2009). The interaction between AKT
and FOXO has been especially well studied in flies (Teleman, 2009). It was found that
overexpression of FOXO led to growth arrest and food avoidance as well as reduced cell size,
cell number and reduced lipid stores (Kramer et al., 2003; Puig et al., 2003; Teleman et al.,
2005). By modulating FOXO activity, AKT affects growth, cell proliferation and metabolism in
Drosophila. As is the case in mammals, lipid metabolism might be controlled by dTOR and
insulin pathway through SREBP regulation in Drosophila (Porstmann et al., 2008).
Thus, the insulin pathway output of Drosophila is comparable to that in mammals, with
effects on overall metabolism and growth; although the exact mechanisms involved still require
further elucidation. Overall, the high degree of functional conservation of TOR/insulin signaling
and the physiological similarities regarding lipid and glucose metabolism between mammals and
flies predispose Drosophila as a prime candidate to elucidate the interconnection and crosstalk
amongst TOR/insulin pathway activity and lipid/glucose homeostasis. Figure 5 summarizes the
TOR/insulin pathway in Drosophila.
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Fig. 5: TOR/insulin pathway in Drosophila. dILPs are secreted by insulin-producing cells
throughout the body and bind to the insulin receptor homolog, InR. This leads to dimerization
and subsequent autophosphorylation of InR, followed by binding of the fly IRSs, Chico and Lnk.
Phosphorylation of the IRSs recruits PI3K to the plasma membrane where it catalyzes the
generation of PIP3. PIP3 located at the plasma membrane triggers the activation of PDK1 and
AKT. Thereby PDK1 phosphorylates and thus activates AKT. AKT is further phosphorylated by
TORC2. Activated AKT then targets downstream components to adjust metabolic and growth
related cellular responses. Amongst the targets are TORC1, FOXO and GSK3β. Image modified
from Teleman, 2009.

There are also differences in insulin pathway dynamics between Drosophila and
mammals. One important difference is that in Drosophila glucocorticoids do not play a role in
insulin signaling because flies do not synthesize glucocorticoids (Teleman, 2009). Another
difference is that in Drosophila the complexity of the insulin cascade is reduced. Drosophila
possesses homologs for all components of the insulin pathway present in mammals, but a single
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fly homolog often represents multiple mammalian signaling components. This means that
mutations in fly insulin signaling cascade components may give more direct and clear effects,
but it also implies that direct comparisons of fly and mammalian protein function is sometimes
not straightforward, as mammalian proteins might exhibit specialized functions (Teleman, 2009).
8. Goals of PhD research
Drosophila represents an ideal model for genetic manipulation and interaction
experiments. As described earlier, the insulin and TOR pathways are highly conserved on both
the physiological and molecular level between flies and mammals. In addition, Lipin function
appears to be conserved between flies and mammals. Thus, I conducted experiments aimed to
further elucidate the relationship between dLipin’s dual activity in fat metabolism and
TOR/insulin signaling using Drosophila as a model system. With the fat body representing the
major site for TAG and glycogen storage, I focused my research on the fly fat body. In my
research I addressed the following questions:
1. How are dLipin and insulin pathway activities linked in Drosophila? I investigated the
relationship between dLipin and insulin signaling by exploring the effects of dLipin activity on
cell growth and by measuring insulin pathway activity in flies with reduced dLipin expression.
Genetic interaction studies were carried out to shed light on the epistatic relationship between
dLipin and the insulin cascade and to investigate the effects of insulin pathway activity on dLipin
function. To investigate the role of insulin pathway activity in dLipin regulation, I examined the
effect(s) of insulin pathway modifications on dLipin localization.
2. How is insulin resistance induced in animals that lack Lipin activity? As previously
mentioned, lipin1 deficiency results in insulin resistance but it is not known whether the lack of
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PAP or transcriptional co-regulator activity is responsible for this effect. Therefore, I aimed to
address how the loss of either of these activities affects insulin pathway activity in Drosophila.
To this end, I expressed dLipin lacking the PAP motif and dLipin lacking its NLS in animals
with RNAi-mediated dLipin knockdown and examined insulin pathway activity in the larval fat
body.
3. How are Lipin and TOR activities linked in Drosophila? To address the question of
whether dLipin activity is also subject to regulation by TOR in Drosophila, I examined cellular
localization and abundance of dLipin in the larval fat body upon reducing TOR activity. The
epistatic relationship between TOR and dLipin was investigated with genetic interaction
experiments.
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II. Materials and Methods
1. Fly stocks
Simplified genotype

Genotype

Description

Source

w1118

w1118

white mutant used as a

Bloomington

recipient strain for P

Drosophila Stock

element

Center (BDSC)

transformations and as
control fly line for
experiments.
dLipin
dLipinRNAi

Df7095

w1118;

Gal4-driven

Vienna Drosophila

P{GD14004}v36007

expression of double-

Research Center

stranded dLipin RNA.

(VDRC) #36007

w1118;

Deficiency removing

BDSC #7860

Df(2R)Exel7095/CyO

chromosomal regions
44B3-44C2, including
the entire dLipin gene
at 44B4-44B5.

dLipine00680

w1118;

dLipin containing

Harvard Exelixis

PBac{RB}CG8709e00

piggyBac element in

Collection #e00680

680/CyO

5’ UTR of the dLipin
gene.

LipinWT6M

w1118; UASdLipinWT

GAL4 driven

Lehmann Laboratory

expression of wildtype
dLipin.
lipin1

w1118; UASlipin1

Gal4 driven

Sandra Schmitt

expression of homo
sapiens lipin1.
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lipin2

w1118; UASlipin2

Gal4 driven

Sandra Schmitt

expression of homo
sapiens lipin2.
lipin3

w1118; UASlipin3

Gal4 driven

Sandra Schmitt

expression of homo
sapiens lipin3.
WTdLipin

w1118; UASWTdLipin

GAL4 driven

Sandra Schmitt

expression of
WTdLipin.

ΔNLSdLipin

w1118;

GAL4 driven

Sandra Schmitt

UASΔNLSdLipin

expression of dLipin

Peter Du

lacking the nuclear
localization signal
(NLS).

ΔPAPdLipin

w1118;

GAL4 driven

Sandra Schmitt

UASΔPAPdLipin

expression of dLipin

Peter Du

with mutation in the
PAP catalytic site.
TOR signaling
pathway
raptorRNAi

rictorRNAi

Tsc1RNAi

y1 sc* v1;

Gal4-driven

P{TRiP.HMS00124}at

expression of double-

tP2

stranded raptor RNA.

y1 sc* v1;

Gal4-driven

P{TRiP.HMS01588}at

expression of double-

tP2

stranded rictor RNA.

y1 sc* v1;

Gal4-driven

BDSC #41912

BDSC #36699

BDSC #35144

P{TRiP.GL00012}attP expression of doubleTsc2RNAi

	
  

2

stranded Tsc1 RNA.

y[1] sc[*] v[1];

Gal4-driven

P{y[+t7.7]

expression of double-

BDSC #35401
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v[+t1.8]=TRiP.GL003 stranded Tsc2 RNA.
21}attP2
TORRNAi

Rheb

y1 sc* v1;

Gal4-driven

P{TRiP.HMS00904}at

expression of double-

tP2

stranded TOR RNA.

w[*];

Activation of TOR

Lehmann Laboratory

y[1] w[1118];

GAL4 driven

BDSC #8287

P{w[+mC]=UAS-

expression of wild

Pi3K92E.Exel}3

type PI3K92E.

y[1] w[1118];

GAL4 driven

P{w[+mC]=UAS-

expression of a

Pi3K92E.A2860C}1

dominant negative

BDSC #33951

P{w[+mC]=UASRheb.Pa}3
Insulin signaling
pathway
PI3K92EWT

PI3K92Edomneg

BDSC #8288

version on PI3K92E.
PI3K21BHA

y[1] w[*];

GAL4 driven

P{w[+mC]=UAS-

expression of

Pi3K21B.HA}2

dominant negative

BDSC #25899

version of PI3K21B.
Dp110CAAX

P{Dp110-CAAX}1, y1

Gal4 driven

w*

expression of

BDSC #25908

constitutively active
Pi3K92E.
InRWT

y[1] w[1118];P{w[+

GAL4 driven

BDSC #8262

mC]=UAS-InR.Exel}2 expression of wildtype InR.
InRconst.active

	
  

y[1] w[1118];

GAL4 driven

P{w[+mC]=UAS-

expression of a

InR.del}2

constitutive active

BDSC #8248
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version of InR.
InRDN

y1 w1118;P{UAS-

Gal4 driven

InR.K1409A}3

expression of a

BDRC #8253

dominant negative
version of InR.
AKTmyr

GAL4 driven

Lehmann Laboratory

expression of
myristoylated, active
form of Akt.
AKTmyrlacZ

GAL4 driven

Lehmann Laboratory

expression of
myristoylated, active
form of Akt.
chico

UASchico

Gal4 driven

Saitoe laboratory,

expression of chico.

Tokyo Metropolitan
Institute of Medical
Science

Reporter lines
ubiPLC

tGPH

P{Ubi-PH-PLCδ-

Ubiquitous expression

Pichaud Laboratory,

GFP}

of GFP fused to PIP2

University College

specific PH domain.

London

Ubiquitous expression

BDSC #8164

w1118; P{tGPH}4

of GFP fused to PIP3
specific PH domain.
DcgGFP

Gal4Dcg; DcgGFP

Fat body GFP marker.

Graff Laboratory,
UT Southwestern
Medical Center

Gal4 driver lines
TubGAL4

y1 w*; P{tubP-

Ubiquitous expression
1

GAL4}LL7/TM3, Sb

	
  

BDSC #5138

of GAL4.
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FB(cg)

w1118; P{CgGAL4.A}2

Expression of GAL4

BDSC #7011

in fat body, hemocytes
and lymph gland.
FB(r4)

DJ761

y[1] w[*];

Expression of Gal4 in

P{w[+mC]=r4-

fat body and salivary

GAL4}3

glands.

w[1118];

GAL4 expression in

P{w[+mW.hs]=GawB

all larval tissues

}DJ761

except CNS and

BDSC #33832

BDSC #8185

imaginal discs.
hsGAL4

w; P(GAL4-hsp70)

Heat-shock induced

Lehmann Laboratory

GAL4 expression.
daGal4
TubCD2GAL4

w[1118];

Weak, ubiquitous

P{daGAL4.w[-]}3

Gal4 expression.

TubCD2GAL4

Inducible driver used

Campbell	
  

in FLIP-out technique

Laboratory,

to generate mosaic

University of

animals.

Pittsburgh

Expression of heat

Campbell	
  

shock induced Flip

Laboratory,

recombinase and Gal4

University of

driven GFP.

Pittsburgh

w1118;

GAL4 driven

VDRC #48593

P{GD16262}v48593

expression of double

hsflp; UASGFP/CyO hsflp;UASGFP/CyO

BDSC #8641

Fat synthesis
enzymes
AGPAT3RNAi

stranded AGPAT3
RNA.
DGAT2RNAi

w1118;

GAL4 driven

P{GD16204}v48584

expression of double

VDRC #48584

stranded DGAT2
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RNA.
GPAT4RNAi

w1118;

GAL4 driven

P{GD3566}v10281/T

expression of double

M3

stranded GPAT4

VDRC #10281

RNA.
Experimental
animals
dLipin knockdown
Df7095/ dLipine00680

Df(2R)Exel7095/

Transheterozygous for

PBac{RB}CG8709e00

dLipin hypomorphic

680

allele and Df7095.

dLipinRNAi/TubGA

P{GD14004}v36007/

Ubiquitous

L4

P{tubP-Gal4}LL7

knockdown of dLipin.

Sandra Schmitt

Sandra Schmitt

/TM3, Sb1
dLipinRNAi/Fb(cg)

P{GD14004}v36007/

Knockdown of dLipin

P{Cg-GAL4.A}2

in fat body cells.

hsflp;

Sandra Schmitt

Mosaic animals

Sandra Schmitt

Test genetic

Sandra Schmitt

dLipinRNAi/UASGF
;TubCD2GAL4
Insulin pathway
and dLipin
interaction
Dp110CAAX;

P{Dp110-CAAX}1, y1

dLipinRNAi/FB(cg);

w*;P{GD14004}v3600 interaction between

tGPH

7/ P{Cg-GAL4.A}2;

PI3K92E and dLipin

P{tGPH}4

with regard to PIP3
levels.

	
  

dLipinRNAi/FB(cg);

P{GD14004}v36007/

Localize PIP3 fat body Sandra Schmitt

tGPH

P{Cg-GAL4.A}2;

cells with active

P{tGPH}4

dLipin knockdown.
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Df7095/ dLipine00680; Df(2R)Exel7095/

PIP3 labelled in

tGPH

PBac{RB}CG8709e00

transheterozygous

680; P{tGPH}4

animals.

dLipinRNAi/FB(cg);

P{GD14004}v36007/

Fat body labelled with

InRDN/DcgGFP

P{CgGAL4.A}2;P{UA

GFP in animals

S-InR.K1409A}3/

carrying dLipin and

DcgGFP

InRDN transgenes.

dLipinRNAi/FB(cg);

P{GD14004}v36007/

Test genetic

InRDN

P{CgGAL4.A}2;P{UA

interaction between

S-InR.K1409A}3

dLipin and InRDN in

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt

fat body cells.
dLipinRNAi/FB(cg);

P{GD14004}v36007/

PIP3 labelled in cells

tGPH/WTdLipin

P{Cg-GAL4.A}2;

with dLipin

P{tGPH}4/

knockdown and

UASdLipinWT

WTdLipin expression.

dLipinRNAi/FB(cg);

P{GD14004}v36007/

PIP3 labelled in cells

tGPH/ΔNLS dLipin

P{Cg-GAL4.A}2;

with dLipin

P{tGPH}4/

knockdown and

UASdLipinΔNLS

ΔNLSdLipin

Sandra Schmitt

Sandra Schmitt

expression.
dLipinRNAi/FB(cg);

P{GD14004}v36007/

PIP3 labelled in cells

tGPH /ΔPAP dLipin

P{Cg-GAL4.A}2;

with dLipin

P{tGPH}4/

knockdown and

UASdLipinΔPAP

ΔPAPdLipin

Sandra Schmitt

expression.
TOR pathway and
dLipin interaction
FB(cg); TORRNAi
FB(cg); raptorRNAi

	
  

P{CgGAL4.A}2;P{TRi

Knockdown of TOR in

P.HMS00904}attP2

fat body cells.

P{Cg-GAL4.A}2;

Knockdown of raptor

Sandra Schmitt
Sandra Schmitt
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P{TRiP.HMS00124}at

in fat body cells.

tP2
FB(cg); rictorRNAi

P{Cg-GAL4.A}2;

Knockdown of rictor

P{TRiP.HMS01588}at

in fat body cells.

Sandra Schmitt

tP2
FB(cg);

P{Cg-GAL4.A}2;

Knockdown of Tsc1 in

Tsc1RNAi

P{TRiP.GL00012}attP fat body cells.

Sandra Schmitt

2
FB(cg); Tsc2RNAi

P{Cg-GAL4.A}2;

Knockdown of Tsc2 in

Sandra Schmitt

v[+t1.8]=TRiP.GL003 fat body cells.
21}attP2
dLipinRNAi/FB(cg);

P{GD14004}v36007/

PIP3 localization after

raptorRNAi/tGPH

P{Cg-GAL4.A}2;

dLipin and raptor

P{TRiP.HMS00124}at

knockdown.

Sandra Schmitt

tP/P{tGPH}4
dLipinRNAi/FB(cg);

P{GD14004}v36007/

Concomitant dLipin

raptorRNAi/

P{Cg-GAL4.A}2;

and raptor knockdown

WTdLipin

P{TRiP.HMS00124}at

in the fat body with

tP/UASdLipinWT

simultaneous

Sandra Schmitt

expression of
WTdLipin.
dLipinRNAi/FB(cg);

P{GD14004}v36007/

Concomitant dLipin

raptorRNAi/

P{Cg-GAL4.A}2;

and raptor knockdown

ΔNLSdLipin

P{TRiP.HMS00124}at

in the fat body with

tP/UASdLipinΔNLS

simultaneous

Sandra Schmitt

expression of

ΔNLSdLipin.
dLipinRNAi/FB(cg);

P{GD14004}v36007/

Concomitant dLipin

raptorRNAi/

P{Cg-GAL4.A}2;

and raptor knockdown

ΔPAPdLipin

P{TRiP.HMS00124}at

in the fat body with

Sandra Schmitt

simultaneous
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tP/UASdLipinΔPAP

expression of

ΔPAPdLipin.
dLipin
chromosome
staining
hsGal4;

w; P(GAL4-hsp70);

Expression of dLipin

dLipinWT6M

P{GD14004}v36007

in salivary gland for

Sandra Schmitt

chromosome staining.
FB(cg); TORRNAi

P{Cg-GAL4.A}2;

TOR knockdown in fat

P{TRiP.HMS00904}at

body tissue.

Sandra Schmitt

tP2
Rescue experiments
Df7095/ dLipine00680; Df(2R)Exel7095/

Expression of

WT dLipin/FBr4

WTdLipin in fat body

PBac{RB}CG8709e00

Sandra Schmitt

680;UASWTdLipin/r4- of dLipin mutants.
GAL4
Df7095/ dLipine00680; Df(2R)Exel7095/

ΔNLSdLipin /FBr4

PBac{RB}CG8709e00

lacking NLS in fat

680;UASΔNLSdLipin/

body of dLipin

r4-GAL4

mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

ΔPAPdLipin/FBr4

Expression of dLipin

PBac{RB}CG8709e00

lacking PAP motif in

680;UASΔPAPdLipin/

fat body of dLipin

r4-GAL4

mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

	
  

Expression of dLipin

Strong ubiquitous

ΔPAP

PBac{RB}CG8709e00

expression of dLipin

dLipin/TubGal4

680;UASΔPAPdLipin/

lacking PAP motif in

tubP-Gal4

dLipin mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

Strong ubiquitous

lipin1/ TubGal4

expression of human

PBac{RB}CG8709e00

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt
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lipin1 in dLipin

Gal4

mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

Strong ubiquitous

lipin2/ TubGal4

PBac{RB}CG8709e00

expression of human

680;UASlipin2/tubP-

lipin2 in dLipin

Gal4

mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

Strong ubiquitous

lipin3/ TubGal4

PBac{RB}CG8709e00

expression of human

680;UASlipin3/tubP-

lipin3 in dLipin

Gal4

mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

Expression of human

lipin1/ FBr4

PBac{RB}CG8709e00

lipin1 in fat body of

680; lipin1/r4-GAL4

dLipin mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

Expression of human

lipin2/ FBr4

PBac{RB}CG8709e00

lipin2 in fat body of

680; lipin2/r4-GAL4

dLipin mutants.

Df7095/ dLipin
lipin3/ FBr4

	
  

680;UASlipin1/tubP-

e00680

; Df(2R)Exel7095/

Expression of human

PBac{RB}CG8709e00

lipin3 in fat body of

680; lipin3/r4-GAL4

dLipin mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

Expression of human

lipin1/ DJ761

PBac{RB}CG8709e00

lipin1 in nearly all

680; lipin1/

larval tissues of dLipin

GawB}DJ761

mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

Expression of human

lipin2/ DJ761

PBac{RB}CG8709e00

lipin2 in nearly all

680; lipin2/

larval tissues of dLipin

GawB}DJ761

mutants.

Df7095/ dLipine00680; Df(2R)Exel7095/

Expression of human

lipin3/ DJ761

PBac{RB}CG8709e00

lipin3 in nearly all

680; lipin3/

larval tissues of dLipin

GawB}DJ761

mutants.

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt

Sandra Schmitt
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ΔNLSdLipin/TubGal

UASΔNLSdLipin/

Strong ubiquitous

4

tubP-Gal4

expression of

Sandra Schmitt

ΔNLSdLipin for
ecdysone rescue
experiment.
Table 1: List of all fly lines used in experiments described in this thesis. Fly lines are listed
with genotype, a short description of the experiment(s) they were used in and the source they
were obtained from.

2. Plasmids
Name

Description

Source

pUASTattB

Fly transformation vector

Basler Laboratory, University of Zurich

containing attB site.
pBluescriptKSII Cloning vector

Stratagene

pCMV-

Vector containing human

Mammalian Gene Collection

SPORT6 lipin1

lipin1 cDNA

pENTR223.1-

Vector containing human

Sfi lipin2

lipin2 cDNA

pCR-XI-TOPO

Vector containing human

lipin3

lipin3 cDNA

GH19076

dLipin cDNA in POT2 vector

Mammalian Gene Collection

Mammalian Gene Collection

Berkley Drosophila Genome Project
(BDGP)

pTV2

pTarget

	
  

Fly transfomation vector;

Sekelsky Laboratory, University of North

Ends-in-Mutagenesis

Carolina

Fly transformation vector;

Sekelsky Laboratory, University of North

Ends-in-Mutagenesis

Carolina
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Table 2: List of all plasmids used. A short description of each plasmid is given and the source
of the plasmid listed.

3. Antibodies
Primary Antibodies
Name

Host

Dilution

Source

anti-dLipin

rabbit

Western Blot: 1:1000

Lehmann Laboratory

Immunohistochemistry:
1:400
Chomosome staining:
1:200 to 1:2000
anti-

rabbit

Western Blot: 1:1000

Cell Signaling Technology #4060

anti-panAKT

rabbit

Western Blot: 1:1000

Cell Signaling Technology #2125

anti-4EBP1

rabbit

Western Blot: 1:2000

Nahum Sonenberg Laboratory,

phosphoAKT

Goodman Cancer Center
anti-phospho

rabbit

Western Blot: 1:1000

4EBP1

Cell Signaling
Technology #2855

anti-actin

rabbit

Western Blot: 1:500

Sigma Aldrich #A2066

anti-tubulin

rabbit

Western Blot: 1:1000

Cell Signaling Technology #2125

anti-p110

goat

Immunohistochemistry: Santa Cruz Biotechnology
1:400 to 1:50

#sc-7248

Secondary Antibodies

	
  

Name

Conjugate

Host

Source

anti-rabbit

Alexa Fluor 647

Goat

Life Technologies
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anti-rabbit

Rhodamine

Donkey

Jackson ImmunoResearch

anti-rabbit

Alkaline Phosphatase

Donkey

Jackson ImmunoResearch

anti-goat

Alexa Fluor 647

Donkey

Jackson ImmunoResearch

Table 3: List of all primary and secondary antibodies used. For primary antibodies host
species and dilution as well as source are listed. For secondary antibodies host species, conjugate
and source are listed.

4. Primers
Name

Sequence

Description

NLSmutafwd 5’GGTGTCCAAGAGCAAAACCTCGC Site-directed mutagenesis:
AAATGAAGAAGA3’

Introduced deletion of nuclear
localization signal (NLS) into
dLipin cDNA.

G-Cmutafwd

5’GGTGGTGATCTCGGAGATTGACG

Site-directed mutagenesis:

GCACCATCA3’

Introduced point mutation
changing GAC codon into GAG
within phosphatidic phosphatase
catalytic motif.

nonmutarev
lipinfwdnew

5’GCCATTCAGCCGTACGACTAGGT

Site-directed mutagenesis: non-

TAGGC3’

mutagenic reverse primer.

5’GCTGCGGCCGCGTTGCTATGGCT

Site-directed mutagenesis: Used to

GTGGCCAC3’

amplify 6kb of dLipin gene.
Introduced NotI restriction site at
5’ end.

NLSREV

5’GACTGGGTACCCACCAGCGCCGT

Site-directed mutagenesis: Used to

CTCCAGCTC3’

amplify 6kb of dLipin gene.
Introduced KpnI restriction site at
3’ end.
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GCISceIrevn

5’CATCGAACCAGGTATTACCCAGT

Site-directed mutagenesis:

ew

TATCCCTAGGCGGTCGAACTCCTC

Introduction of ISceI site and

GTCCGAGGGTGGT3’

SexA1 restriction site.

5’CTTCAAACGAAGCTGAGACGA3’

Site-directed mutagenesis:

NLSseqfwd

Verification of NLS deletion after
site directed mutagenesis.
GCseqfwd

5’GCACCAATGCAAGCTTCAATGC3’ Site-directed mutagenesis:
Verification of base exchange after
site directed mutagenesis.

ISceseqfwd

5’CCCAGGTGCAGCAAAGCGAGC3’

Site-directed mutagenesis:
Verification of presence of ISceI
site.

lipin2fwdNot 5’GTCAGGCGGCCGCCCGTCAAGGC Amplification of human Lipin2
CCACCATGAAT3’

cDNA. Introduces NotI cutting
site.

lipin2Kpnrev

5’CTGAGGTAGCGCCCTAAGACAG

Amplification of human Lipin2

GTCATCCA3’

cDNA. Introduces KpnI cutting
site.

lipin3fwd

5’GACTGCGGCCGCAGCACCAGCC

Amplification of human Lipin3

ATGAACTACGT3’

cDNA. Introduces NotI cutting
site.

lipin3rev

5’CTGATCTAGAGGCTGGTTCAGTC

Amplification of human Lipin3

CAGGGTATC3’

cDNA. Introduces XbaI cutting
site.

rp49rev

5’ GCGCTTGTTCGATCCGTA 3’

Amplification of rp49 transcript
for qRT PCR analysis.

rp49fwd

5’ CGGATCGATATGCTAAGCTGT 3’

Amplification of rp49 transcript
for qRT PCR

Fruit Fly

Sequence not published; Qiagen RT2

Amplification of Dp110 transcript

PI3k92E

qPCR primer set for amplification of

for qRT PCR analysis.

PI3K92E fragment (#330001)
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Table 4: List of all primers used in experiments. Primer name, sequence as well as a short
description of how they were used in given.

5. Fly maintenance
Flies were grown and maintained on standard fly food prepared with 1.8% yeast, 6.1%
cornmeal, 1.3% corn syrup, 1.1% agar and 8.2% malt extract in tap water. The food contained
0.75% propionic acid and 1% tegosept to suppress bacterial and fungal growth. Flies were kept
at 25 °C.
6. Molasses agar plates
500ml of distilled H2O containing 3.5% agar and 14% molasses. The mixture was
autoclaved for 20minutes at 15 psi on liquid cycle, and then after cooling to about 60°C, poured
into small petri dishes. The molasses plates were stored at 4°C.
7. Media
Liquid Broth (LB) was used to grow bacterial cultures. For 1 liter of LB 950ml distilled
H2O was mixed with 10g tryptone, 5g yeast extract and 10g NaCl. The pH was adjusted to 7.0
with 10N NaOH. The volume was then adjusted to 1Liter with distilled H2O. The medium was
sterilized by autoclaving for 20 minutes at 15 psi on liquid cycle. For LB media plates, 15g/L of
Bacto Agar was added to the medium before autoclaving. Antibiotics were added to media at the
following concentrations: Ampicillin (50mg/ml): 150µg/ml; Chloramphenicol (34mg/ml):
170µg/ml; Kanamycin (10mg/ml): 50µg/ml.
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8. Preparation of competent E.coli cells
5ml of LB were inoculated with a single colony of Escherichia coli (E. coli). The
bacterial culture was grown overnight at 37°C with constant shaking. 1ml of the overnight
culture was transferred into 100ml of preheated (37°C) LB and grown at 37°C and 240 rpm for 2
hours or until final OD600 of 0.3-0.6. The cells were then placed on ice, divided into two prechilled 50 ml polypropylene tubes and pelleted by centrifugation in a tabletop centrifuge at 1,600
x g and 4°C for 7 minutes. The supernatant was discarded and the bacterial pellet re-suspended
in 10 ml ice cold 0.1M CaCl2 followed by centrifugation at 1,100 x g and 4°C for 5 minutes. The
cells were kept overnight at 4°C. The next day, 480µl 80% glycerol was added to the cells.
Aliquots of 100µl were pipetted into pre chilled Eppendorf tubes and immediately stored at 80°C.
9. Transformation of competent cells
Competent cells were defrosted on ice and 100µl 0.1M CaCl2 added. DNA was added to
the cells in a volume not exceeding 5% of the volume of the competent cells. Contents of the
tube were gently mixed followed by a 30 minute incubation period on ice. Cells were heat
shocked at 42°C for 2 minutes in a water bath, and immediately transferred back to ice. 800µl of
LB broth were added and the cells grown at 37°C and 220 rpm for 90 minutes. Cells were plated
onto LB media plates, containing a selective antibiotic if needed.
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10. Ligation
All ligations were carried out using T4 DNA Ligase (New England BioLabs # M0202S)
according to the manufacturer’s recommendations. The ligation reactions were kept at 16°C in a
water bath overnight and transformed into competent E. coli cells the following day.
11. Generation of pUASTattBlipin1, pUASTattBlipin2 and pUASTattBlipin3 constructs
The human genome encodes three lipin paralogs. To test whether Lipin function is
conserved between Drosophila melanogaster and Homo sapiens, and in order to determine
whether any human lipin paralog can replace the single Drosophila melanogaster lipin gene
(dLipin), UAS responder lines for all three human lipin paralogs were created. These responder
lines were then expressed in dLipin mutant animals (Df7095/ dLipine00680). To this end, each
human lipin paralog was cloned into the Drosophila pUASTaTTB transformation vector.
The plasmid pCMV-SPORT6 lipin1 (Table 2) was grown in LB media containing ampicillin
overnight at 37°C with shaking. Plasmid DNA was prepared from the overnight culture using the
GenScript QuickCleanII Plasmid Miniprep Kit (# L004320). lipin1 cDNA was cut from the
vector backbone using KpnI and AvrII and the lipin1 fragment separated from the plasmid DNA
by agarose gel electrophoresis. The lipin1 fragment was cut out from the gel, and the DNA
purified using the QuickCleanII Gel Extraction Kit from Genscript (# L00418). The final
destination vector, pUASTattB, was prepared by cutting with KpnI and and XbaI (XbaI and AvrII
have compatible ends for ligation), and a ligation reaction with both components was set up.
pENTR223.1-Sfi lipin2 plasmid (Table 2) was grown in LB overnight at 37°C with
shaking and chloramphenicol added as the selective antibiotic. Plasmid DNA was isolated the

	
  

46

following day using the GenScript QuickCleanII Plasmid Miniprep Kit (# L004320). lipin2
cDNA was amplified using PCR (forward primer: lipin2fwdNot; reverse primer: lipin2Kpnrev;
Table 4). Phusion High-Fidelity DNA Polymerase (New England BioLabs #F-S30S) was used to
amplify the fragment. The lipin2 fragment was then digested with NotI and KpnI as was the
destination vector pUASTattB. A ligation reaction with both components was set up.
pCR-XI-TOPO lipin3 plasmid (Table 2) was grown in LB overnight at 37°C with shaking
and kanamycin added as the selective antibiotic. Plasmid DNA was purified the following day
using the GenScript QuickCleanII Plasmid Miniprep Kit (# L004320). lipin3 cDNA was
amplified in a PCR reaction (forward primer: lipin3fwd; reverse primer: lipin3rev; Table 4).
Phusion High-Fidelity DNA Polymerase (New England BioLabs #F-S30S) was used to amplify
the fragment according to manufacturer’s recommendations. lipin3 cDNA and the destination
vector pUASTattB were cut with NotI and XbaI, and ligated.
All three ligation reactions were transformed into E.coli cells and plated on LB plates
with ampicillin as the selective antibiotic. Colonies were picked the next day and DNA prepared
using GenScript QuickCleanII Plasmid Miniprep Kit (# L004320). Analytical restriction
digestions were conducted to verify the presence of lipin inserts in the clones picked. . To screen
for presence of lipin1 fragment the construct was digested with KpnI and XmaI, lipin2 presence
was detected by cutting with NotI and KpnI whereas lipin3 presence was verified by restriction
digest with NotI and XbaI. Positive clones were grown up in 50ml ampicillin containing LB
medium overnight at 37°C with shaking and plasmid was DNA purified using Qiagen HiSpeed
Plasmid Midi Kit (# 12643). The DNA was sent off to BestGene Inc for injection into fly
embryos. For the sake of simplicity, these constructs are being referred to as lipin1, lipin2 and
lipin3 in the remainder of the text.
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12. Site-directed mutagenesis and generation of pUASTattBWTdLipin, pUASTattBΔPAPdLipin
and pUASTattBΔNLSdLipin constructs
dLipin cDNA (plasmid GH19076) was used to create three different UAS responder
lines. WTdLipin is a construct used to express wild type dLipin. ΔPAPdLipin encodes dLipin
with a point mutation at position 2886 of the nucleotide sequence. This point mutation leads to
an encoded protein with a glutamate (Glu or E) residue at position 812 of the protein instead of
an aspartate (Asp or D) residue (D812E). This change in the amino acid sequence results in a
loss of phosphatidic acid phosphatase activity (PAP activity) (Finck et al.; 2006). ΔNLSdLipin
encodes a mutant dLipin lacking the nuclear localization signal (NLS; amino acid positions 276281), thus this protein is not able to translocate to the nucleus and affect gene regulation. I
targeted the NLS instead of the co-regulator motif because previous research showed that
deletion of the co-regulator motif not only affects nuclear activity, but also PAP activity of
Lipin1 (Reue and Brindley; 2008). To identify the putative NLS in dLipin I used the openly
accessible PredictNLS software from the Rost laboratory
(https://rostlab.org/owiki/index.php/PredictNLS).
MNSLARVFSNFRDFYNDINAATLTGAIDVIVVEQRDGEFQCSPFHVRFGKLGVLRSREK
VVDIEINGVPVDIQMKLGDSGEAFFVEECLEDEDEELPANLATSPIPNSFLASRDKANDT
MEDISGVVTDKNASEELLLPLPLPRRNSIDFSKEEPKEAVVEGSKFENQVSDYTQRRHTD
NTLERRNLSEKLKEFTTQKIRQEWAEHEELFQGEKKPADSDSLDNQSKASNEAETEKAIP
AVIEDTEKEKDQIKPDVNLTTVTTSEATKEVSKSKTKKRRKKSQMKKNAQRKNSSSSSL
GSAGGGDLPSAETPSLGVSNIDEGDAPISSATNNNNTSSSNDEQLSAPLVTARTGDDSPLS
EIPHTPTSNPRLDLDIHFFSDTEITTPVGGGGAGSGRAAGGRPSTPIQSDSELETTMRDNR
HVVTEESTASWKWGELPTPEQAKNEAMSAAQVQQSEHQSMLSNMFSFMKRANRLRKE
KGVGEVGDIYLSDLDAGSMDPEMAALYFPSPLSKAASPPEEDGESGNGTSLPHSPSSLEE
GQKSIDSDFDETKQQRDNNRYLDFVAMSMCGMSEQGAPPSDEEFDRHLVNYPDVCKSP
SIFSSPNLVVRLNGKYYTWMAACPIVMTMITFQKPLTHDAIEQLMSQTVDGKCLPGDEK
QEAVAQADNGGQTKRYWWSWRRSQDAAPNHLNNTHGMPLGKDEKDGDQAAVATQT
SRPTSPDITDPTLSKSDSLVNAENTSALVDNLEELTMASNKSDEPKERYKKSLRLSSAAIK
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KLNLKEGMNEIEFSVTTAYQGTTRCKCYLFRWKHNDKVVISDIDGTITKSDVLGHILPM
VGKDWAQLGVAQLFSKIEQNGYKLLYLSARAIGQSRVTREYLRSIRQGNVMLPDGPLLL
NPTSLISAFHREVIEKKPEQFKIACLSDIRDLFPDKEPFYAGYGNRINDVWAYRAVGIPIM
RIFTINTKGELKHELTQTFQSSGYINQSLEVDEYFPLLTNQDEFDYRTDIFDDEESEEELQF
SDDYDVDVEHGSSEESSGDEDDDEALYNDDFANDDNGIQAVVASGDERTADVGLIMRV
RRVSTKNEVIMASPPKWINS
Putative NLS; PAP active site; Co-activator motif
Fig 6: Protein (CG8709-PA) sequence of dLipin isoform A with nuclear localization signal
(NLS), PAP active site and co-activator motive. The NLS is deleted in ΔNLSdLipin construct
and the PAP site changed from DIDGT to EIDGT in the ΔPAPdLipin construct via site-directed
mutagenesis.

Plasmid GH19076 was grown in LB with chloramphenicol acting as the selective
antibiotic. Site-directed mutagenesis was carried out using the Change-IT Multiple Mutation Site
Directed Mutagenesis Kit by USB (# 78480) to create ΔPAPdLipin cDNA (forward primer: GCmutafwd; reverse primer: nonmutarev; Table 4) and ΔNLSdLipin (forward primer:
NLSmutafwd; reverse primer: monmutarev; Table 4). Successful mutagenesis was confirmed by
sequencing (primers: GCseqfwd and NLSseqfwd; Table 4). The mutated and wild- type dLipin
cDNAs were isolated from the pOT2 vector using XhoI and EcoICRI and the cDNA fragment
separated from the vector backbone by agarose gel electrophoresis. The cDNA fragments were
cut out from the gel and the DNA was purified using the QuickCleanII Gel Extraction Kit from
Genscript (# L00418). pUASTattB served as the final transformation vector. The vector was cut
with XbaI and the 5’ overhang filled in with Klenow enzyme. This was followed by digestion
with XhoI. To reduce religation of potentially partially digested plasmid, the vector was treated
with Shrimp Alkaline Phosphatase (Promega # M9910) according to the manufacturer’s
recommendations. The prepared pUASTattB vector was then used for ligation with the cDNA
fragments. Transformed cells were plated onto LB agar plates with ampicillin as the selective
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antibiotic and incubated at 37°C overnight. Clones were picked and grown in LB with ampicillin
at 37°C overnight. DNA was purified from bacterial cultures using GenScript QuickCleanII
Plasmid Miniprep Kit (# L004320). Identification of positive bacterial transformants was
achieved by analytical digestion of extracted DNA with EcoRI and XhoI. Positive clones were
grown up in 50ml ampicillin containing LB medium overnight at 37°C with shaking and DNA
was then purified using Qiagen HiSpeed Plasmid Midi Kit (# 12643). The DNA was sent to
BestGene Inc for injection into fly embryos. From this point onwards, for the sake of simplicity,
I will refer to these lines as WTdLipin, ΔNLS dLipin and ΔPAPdLipin.
13. Site-directed mutagenesis and cloning of pTV2ΔPAPdLipin and pTargetΔNLSdLipin donor
constructs for ends-in-targeting gene replacement
Bac-Clone #RP98-9N11 (BACPAC Resources Center) served as a template to amplify
6kb of the dLipin gene. The clone was grown in LB with chloramphenicol as the selective
antibiotic. Phusion High-Fidelity DNA Polymerase (New England BioLabs #F-S30S) was used
to amplify the fragment (forward primer: lipinfwdnew; reverse primer: NLSREV; Table 4). The
6kb fragment was cloned into pBluescriptKSII via KpnI and NotI restriction sites. T4 DNA
Ligase (New England BioLabs # M0202S) was used to ligate vector DNA with the 6kb
fragment, colonies were picked and DNA extracted with GenScript QuickCleanII Plasmid
Miniprep Kit (# L004320). Presence of the 6kb dLipin insert was verified in an analytical
digestion with KpnI and NotI. Site-directed mutagenesis was then carried out with positive
clones using the Change-IT Multiple Mutation Site Directed Mutagenesis Kit by USB (# 78480).
To knock out the PAP activity (ΔPAP) of dLipin, D812 was converted into E (D812E, forward
primer: G-Cmutafwd; reverse primer: nonmutarev; Table 4). In order to eliminate the nuclear co-
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regulator function of dLipin, the Nuclear Localization Signal was deleted (ΔNLS) (NLS; AA
276-281; forward primer: NLSmutafwd; reverse primer: monmutarev; Table 4). For a more
detailed description please refer to Materials and Methods 12. Clones were screened for
successful mutagenesis/deletion by sequencing (primers: GCseqfwd and NLSseqfwd; Table 4).
An I-SceI site was inserted into these sequences using PCR (forward primer:
lipinfwdnew; reverse primer: GCISceIrevnew; Table 4). Thereby, 3kb of the mutated dLipin
gene were amplified via PCR and an I-SceI recognition sequence attached to the generated
fragment’s 3’end. The I-SceI sequence was added to the reverse primer. Additionally, a NotI
cutting site was introduced at the 5’ and of the PCR fragment, and a SexAI site at the very 3’
end. Using SexAI and NotI restriction sites in the plasmid containing the original mutated DNA,
3kb were cut out and replaced with the 3kb PCR that now contain the I-SceI site. The 3kb I-SceI
fragment and the plasmid containing the remainder 3kb of dLipin were ligated. The Ligation
reaction was transformed into methylation negative cells (dam-/dcm- Competent cells; New
England Biolabs # 29521) as SexA1 cuts only unmethylated DNA. Cells were plated on to LB
plates containing ampicillin as the selective antibiotic and incubated at 37°C overnight. Plasmid
DNA was extracted from colonies using the GenScript QuickCleanII Plasmid Miniprep Kit (#
L004320) and presence of the I-SceI site confirmed via sequencing (primer: ISceseqfwd; Table).
Using KpnI and NotI restriction sites, the entire 6kb fragment containing the D812E mutation
was cut out and ligated into the pTV2 plasmid that had been cut with the same restriction
enzymes to generate pTV2ΔPAPdLipin. The ΔNLSdLipin fragment was cut with KpnI and NotI
and ligated into the pTarget plasmid that had been digested with the same restriction enzymes to
create pTargetΔNLSdLipin. Analytical digest with KpnI and NotI was used to verify the presence
of the 6kb fragments in the final constructs. Positive clones were grown in 50ml ampicillin
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containing LB medium overnight at 37°C with shaking and DNA purified using Qiagen HiSpeed
Plasmid Midi Kit (# 12643). DNA for both constructs was sent off to BestGene Inc for injection
into fly embryos.
14. Genetic interaction experiments between dLipin and members of the TOR and Insulin
pathways
To test whether dLipin and Insulin/TOR signaling affect each other, genetic interaction
experiments were conducted. Therefore, dLipin was knocked down or overexpressed in concert
with members of the Insulin and TOR signaling pathways. Offspring with both genetic
modifications, should exhibit either an enhancement or rescue of the dLipin or Insulin/TOR
phenotype if there are any interactions. To this end, fly lines expressing dLipinRNAi or
dLipinWT6M or hypomorphic dLipin mutants were crossed with lines expressing RNAi against
genes involved in the TOR and insulin pathways gene, hypomorphic TOR and insulin pathway
mutants or TOR and insulin pathway overexpression lines.
The following is a list of genotypes created to study possible genetic interactions between dLipin
and genes of the TOR and insulin pathways.
Simplified genotype

Description

dLipinRNAi/InRcont.active;FB(r4)

Expression of constitutive active form of InR in
concert with dLipinRNAi using fat body-specific
driver.

cont.active

dLipinRNAi/InR

; DJ761

Weak ubiquitous expression of constitutively active
form of InR in concert with dLipinRNAi.

dLipinRNAi/PI3K21BHA; FB(r4)

Expression of dominant negative form of PI3K21B
in concert with dLipin knockdown using fat body-
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specific driver.
dLipinRNAi/PI3K21BHA; DJ761

Weak ubiquitous expression of constitutive active
form of InR in concert with dLipinRNAi.

PI3K21BHA; LipinWT6M/FB(r4)

Expression of dominant negative form of PI3K21B
in concert with WTdLipin using fat body specific
driver.

dLipinRNAi/FB(cg); PI3K92Edom.neg.

Expression of dominant negative form of PI3K92E
with concomitant dLipin knockdown using fat body
specific driver.

dLipinRNAi/FB(cg); PI3K92E

Expression of wild-type PI3K92E in concert with
dLipin knockdown using fat body specific driver.

dLipine00680/ dLipine00680; AKTmyr/

Expression of activated AKT in fat body in

FB(r4)

hypomorphic dLipin mutant background.

Df7095/ dLipine00680; AKTmyrlacZ/ FB(r4)

Expression of activated AKT in fat body in
transheterozygous dLipin mutant background.

Dp110CAAX; dLipinRNAi/ FB(cg)

Expression of constitutively active form of Dp110
in concert with dLipinRNAi using fatbody specific
driver.

dLipinRNAi/FB(cg); InRdom.neg.

Expression of dominant negative form of InR in
concert with dLipinRNAi using fat body specific
driver.

dLipine00680/ dLipine00680;Rheb/hsGal4

Expression of Rheb with fatbody specific driver in
hypomorphic dLipin mutant background.

dLipinRNAi/FB(cg); Rheb/InRdom.neg.

Simultaneous expression of Rheb, dLipinRNAi and
InRdom.neg. using fat body specific driver.

dLipinRNAi/FB(cg); TORRNAi

Simultaneous RNAi-mediated knockdown of TOR
and dLipin using fat body specific driver.

dLipinRNAi/FB(cg); raptorRNAi

Simultaneous RNAi-mediated knockdown of
raptor and dLipin using fat body specific driver.

dLipinRNAi/FB(cg); rictorRNAi
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and dLipin using fat body specific driver.
dLipinRNAi/FB(cg); Tsc1RNAi

Simultaneous RNAi-mediated knockdown of Tsc1
and dLipin using fat body specific driver.

dLipinRNAi/FB(cg); Tsc2RNAi

Simultaneous RNAi-mediated knockdown of Tsc2
and dLipin using fat body specific driver.

Table 5: List of genetic interaction experiments conducted to investigate the relationship
between dLipin and Insulin/TOR pathway.

To detect potential interaction between dLipin and genes of the TOR/insulin pathways,
offspring was examined for different parameters, depending on the genetic makeup of the
animals. The parameters included: effects on larval development and fat body morphology (fat
droplet size, cell size, cell shape).
15. Analyses of genetic interaction between dLipin and insulin receptor (InR)
To investigate larval viability in animals with concomitant dLipin and InRdom.neg.
expression, flies with the following genotype were generated: dLipinRNAi/FB(cg); InRdom.neg..
To this end the following cross was set up:
Parental cross: FB(cg)/FB(cg) X dLipinRNAi/CyOGFP; InRdom.neg./Tb,TM6B
! FB(cg)/CyOGFP; Tb,TM6B: Control animals; 25% genotype frequency expected.
FB(cg)/CyOGFP; InRdom.neg.: Experimental animals expressing InRdom.neg.; 25 % genotype
frequency expected.
FB(cg)/dLipinRNAi; Tb,TM6B: Experimental animals expressing dLipinRNAi; 25 %
genotype frequency expected.
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FB(cg)/dLipinRNAi; InRdom.neg.: Experimental animals expressing both transgenes; 25%
genotype frequency expected.
As a measure for larval lethality, I counted pupae formed for each genotype. As genotype
frequencies for each genotype were known, it was possible to directly compare the number of
pupae formed by control animals with any of the three experimental genotypes. I analyzed the
numbers using Chi-square statistical analyses.
16. Rescue of dLipin mutants by expression of human lipin transgenes
To investigate functional conservation between dLipin and the three human lipin paralogs
(lipin1, lipin2 and lipin3) transgenic fly lines were generated for expression of each of the
homologs in Drosophila (11).
Crosses were set up to analyze rescue effects for each of the three homologous genes. Flies of the
two following genotypes were analyzed:
Df7095/ dLipine00680; lipin1/2/3 / DJ761
Df7095/ dLipine00680; lipin1/2/3 / TubGAL4
Df7095/ dLipine00680; lipin1/2/3 / FBGAL4.
Animals transheterozygous for dLipin mutations and carrying both human lipin transgene
and driver were analyzed with regard to fat body development and larval lethality. To compare
larval lethality between different genotypes, I examined the number of pupae formed by animals
of the different genotypes. I set up individual crosses for each human lipin transgene. The
genotype frequency for resulting genotypes was known, thus I was able to compare the number
of pupae formed with the control genotype (Df7095/ dLipine00680; lipin1/2/3) to the number of
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pupae formed with experimental genotype (Df7095/ dLipine00680; lipin1/2/3 / Gal4)., Chi-Square
analyses were conducted to assess statistical significance.
Parental cross exemplified for lipin1:
Df7095/ CyOGFP; lipin1/lipin1 X dLipine00680/CyOGFP; Gal4/ Tb,TM6B
" Genotypes that were compared: Df7095/ dLipine00680; lipin1/ Gal4: experimental animals
Df7095/ dLipine00680; lipin1/Tb,TM6B: control animals
Genotype frequencies for both genotypes were 50% compared to each other. I compared
the number of pupae formed with control genotype to the number of pupae formed with
experimental genotype using Chi-Square analysis. The number of pupae formed with control
genotype was set to 100% and % for the number of pupae formed with experimental genotype
was calculated.
17. Rescue of dLipin mutants or animals with RNAi mediated dLipin knockdown by expression
of ΔPAPdLipin, ΔNLSdLipin and WTdLipin constructs
To determine the rescue effects of dLipin lacking either catalytic or transcriptional coregulator activity, ΔPAPdLipin, ΔNLSdLipin and WTdLipin transgenes were expressed in a
dLipin transheterozygous mutant background, or concomitant with dLipinRNAi. Animals of the
following genotypes were generated:
Df7095/ dLipine00680; ΔPAPdLipin, ΔNLSdLipin or WTdLipin / daGAL4
Df7095/ dLipine00680; ΔPAPdLipin, ΔNLSdLipin or WTdLipin / TubGAL4
Df7095/ dLipine00680; ΔPAPdLipin, ΔNLSdLipin or WTdLipin / FBGAL4
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dLipinRNAi / FBGal4; ΔPAPdLipin, ΔNLSdLipin or WTdLipin / tGPH.
These fly strains were observed with regard to fat body development, fat body
morphology, larval lethality and PIP3 localization. Animals of the genotypes
dLipinRNAi/FBGal4; ΔPAPdLipin/tGPH, dLipinRNAi/FBGal4; ΔNLSdLipin/tGPH and
dLipinRNAi/FBGal4; WTdLipin/tGPH were examined for PIP3 localization. Transheterozygous
dLipin mutants with concomitant expression of ΔPAPdLipin, ΔNLSdLipin or WTdLipin were
examined with regard to fat body morphology and larval lethality. I set up individual crosses for
each dLipin construct. To compare larval lethality between control (Df7095/ dLipine00680; Gal4)
and experimental genotypes (Df7095/dLipine00680; ΔPAPdLipin, ΔNLSdLipin or
WTdLipin/GAL4), I examined the number of pupae formed for the specific genotypes. The
genotype frequency for resulting genotypes was known thus, I was able to compare the number
of pupae formed with control genotype (Df7095/dLipine00680; ΔPAPdLipin, ΔNLSdLipin or
WTdLipin) to the number of pupae formed with experimental genotype (Df7095/dLipine00680;
ΔPAPdLipin, ΔNLSdLipin or WTdLipin/Gal4). To assess statistical significance, Chi-Square
analysis was conducted.
Parental cross exemplified for WTLipin:
Df7095/ CyOGFP; Gal4/Tb X

dLipine00680/CyOGFP; WTdLipin/WTdLipin

" Genotypes that were compared: Df7095/ dLipine00680; WTdLipin/Gal4: experimental animals
Df7095/ dLipine00680; WTdLipin/Tb: control animals
Genotype frequencies for both genotypes were 50% compared to each other. I compared
the number of pupae formed with control genotype to the number of pupae formed with
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experimental genotype using Chi-Square analysis. The number of pupae formed with control
genotype was set to 100% and % for the number of pupae formed with experimental genotype
was calculated.
18. Generation of mosaic animals for dLipinRNAi
The goal of this experiment was to generate larval fat body tissue with single cells that
lack dLipin activity in an otherwise wild type dLipin background. These mosaic animals were
generated using the flip-out technique (Blair, 2003). Animals were kept at 25 °C on standard
food. At this temperature basal expression of a heat-shock induced FLP (flippase) recombinase
led to the activation of the TubGAL4 driver in only a small number of cells. This is possible
because the FLP recombinase targets the FRT (flippase recognition target) sites flanking a CD2
cassette that was introduced to prohibit the expression of Gal4 from the driver promoter (Tubulin
α promoter). The CD2 cassette was subsequently removed via site-specific recombination by the
FLP recombinase, which allowed for the expression of Gal4 from the Tubulin promoter.
Presence of Gal4 then triggered dLipinRNAi expression in these cells. Mosaic cells were further
marked with UASGFP (Green fluorescent Protein). Hence, only very few cells expressed both
dLipinRNAi as well as the marker GFP.

	
  

58

FLP

Tubulin	
  promoter

FRT CD2 FRT Gal4

	
  

	
  

	
  

	
  

	
  

Gal4
Tubulin	
  promoter

Gal4

	
  

	
  

Gal4

Gal4
UAS
	
  

dLipinRNAi
	
  

Fig. 7: Depiction of the FLP-out process in mosaic cells. In single cells, expression of FLP
recombinase was triggered. FLP recombinase subsequently targets the FRT sites flanking a CD2
cassette and removes it. This allows expression of Gal4 form the Tubulin promoter. The
transcription factor Gal4 then binds to its target sequence UAS (upstream activating sequence)
and activates expression of dLipinRNAi. In addition to dLipinRNAi, Gal4 also triggers expression
of GFP.

Final cross:
hsflp/hsflp; UASGFP X dLipinRNAi; Tub-CD2-Gal4
=> Mosaic animals: hsflp; UASGFP/dLipinRNAi; Tub-CD2-Gal4
Fat body from mosaic animals was dissected in PBS pH7.4 (137mM NaCl, 2.7mM KCl,
10mM Na2HPO4, 1.8mM KH2PO4; pH adjusted with HCl) and fixed in 4% formaldehyde for 30
minutes. To verify successful dLipin knockdown the tissue was stained with anti-Lipin antibody.
Visualization of lipid droplets was achieved by staining with HCS LipidTOX Deep Red neutral
lipid stain (Invitrogen # H34477). After staining was completed the tissue was mounted in
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Slowfade Gold antifade reagent with DAPI (Invitrogen # P36931) and examined under a Carl
Zeiss AxioVision microscope.
19. Fat droplet staining
Fat droplets were stained with Bodipy 493/503 (Invitrogen # D2191) or HCS LipidTOX
Deep Red neutral lipid stain. Fat body was dissected in PBS, pH7.4 followed by fixation in 4%
formaldehyde for 30 minutes. The stains were diluted in PBS, pH 7.4. BODIPY was diluted to a
final concentration of 1 µg/ml, whereas HCS LipidTOX Deep Red was used at a 1:400 dilution.
Fixed tissue was stained for 30-60 minutes at room temperature. Tissue was protected from light
during this step to prohibit photo bleaching. After staining was completed, tissue was mounted in
Slowfade Gold antifade reagent with DAPI (Invitrogen # P36931). Images were taken using a
Carl Zeiss AxioVision microscope. Bodipy stained fat droplets were viewed with a GFP filter,
and HCS LipidTOX Deep Red stained fat droplets with a Cy5 filter. DNA was viewed using the
DAPI filter setting.
20. dLipin antibody staining
Tissue was dissected on ice in PBS, pH 7.4 and fixed in 4% formaldehyde for 30
minutes. After fixation, tissue was washed 4 times in PBST (PBS plus 0.2% Tween20) for 10
minutes and then blocked in PBST with 1% Normal Donkey serum (NDS) or Normal Goat
Serum (NGS), depending on the secondary antibody used. Blocking lasted for at least 2 hours at
room temperature accompanied by gentle shaking. Affinity purified anti-dLipin antibody was
added at 1:400 dilution in PBST with 1% NDS or NGS, and tissue was stained overnight at 4°C
with gentle shaking. Tissue was then washed four times in PBST for 10 minutes each and the
secondary antibody was added. Secondary antibodies used were Rhodamine conjugated donkey
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anti-rabbit IgG (Jackson ImmunoResearch #69532; Table 3) and Alexa Fluor 647 conjugated
goat anti-rabbit IgG (Life Technologies #A21244; Table 3), both used at a 1:1000 dilution (in
PBST with 1% NDS or NGS). The incubation period lasted 2 hours during which samples were
wrapped in aluminium foil to prohibit photo bleaching. Tissue was then washed 4 times in PBST
for 10 minutes each, and mounted in Slowfade Gold antifade reagent with DAPI (Invitrogen #
P36931). Images were captured with a Carl Zeiss AxioVision microscope.
21. Measurement of hemolymph sugar levels
The Glucose Assay Kit by Cayman Chemical Company (#10009582) was used to
measure the hemolymph sugar levels of feeding third instar larvae. Hemolymph of five
Df(2R)Exel7095/ dLipine00680 feeding third instar larvae and five heterozygous larvae was
collected. Triplicate samples were analyzed for each genotype (total n for each genotype: 15).
0.5µl of hemolymph were mixed with 19 µl PBS, pH7.4. After centrifugation at 13,000 x g for
10 min, 10µl of supernatant were added to 100 µl Assay Buffer (100mM PBS at pH 6.5). 0.05
units/ml trehalase (Sigma #T8778) were added to samples and standards and the tubes incubated
at 37°C overnight. 50 µl of samples and standards were then transferred to 500 µl Enzyme Mix
and incubated for 10 min at 37°C. 150 µl of the reactions were pipetted to a cuvette and
absorption measured at 514nm in a UV-spectrophotometer. A linear regression graph for
standards was created and glucose concentrations in samples calculated.
22. SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
A BioRAD Mini-PROTEAN® System was used for SDS Gel electrophoresis. First, the
components of the resolving gel were mixed in a flask and poured between the glass slides. The
resolving gel consisted of Acrylamide-bis (30%-0.8%), Lower Buffer (3M Tris Base, 0.8% SDS,
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pH 8.8 adjusted with concentrated HCl), 75% Sucrose, TEMED, 5% Ammoniumpersulfate and
distilled H2O. The pipetting scheme for the resolving gel depended on the desired thickness of
the gel.
The gel was covered with layering Buffer (1:8 dilution of Lower Buffer) and left to
polymerize. After completion of the polymerization process, the layering buffer was removed
with Whatman filter paper, and the stacking gel added. The stacking gel was made up of the
following components: Acrylamide-bis (30%-0.8%), Upper Buffer (0.5M Tris Base, 0.4% SDS,
pH 6.8 adjusted with concentrated HCl), 75% Sucrose, TEMED, 5% Ammoniumpersulfate and
distilled H2O. The comb was inserted quickly after addition of the resolving gel mix, and the gel
left to polymerize. Upon completion of this polymerization process, the comb was removed and
the gel inserted into the electrophoresis chamber. Gel Running Buffer (0.025 M Tris Base, 0.192
M Glycine, 1% SDS) was poured into the tank. The samples and Protein Marker (Prestained
Protein Marker, New England Biolabs # P7708S or PAGE RULER Prestained Plus, Thermo
Scientific # 26619) were loaded. Prior to loading, samples were dissolved in Sample Buffer (4%
SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromphenol blue, 0.125 M Tris HCl) and
heat denatured for 5 minutes at 95°C. After marker and samples were loaded, the gel was run at
250V until clear separation of the marker bands was achieved (~30min). The BioRad
PowerPac™ HC Power Supply served as the power source for the electrophoresis process.
23. Western Blot Analysis
Protein Transfer
The Mini Trans-Blotcell from BioRad was used for Western-Blotting. After completion
of gel electrophoresis, the gel was placed onto a PVDF membrane, which had been pre-wetted in
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100% methanol for 5minutes. Whatman filter paper sheets and a layer of fiber pads held the gel
and PVDF membrane together. It is important to prevent the formation of air bubbles between
the gel and the PVDF membrane when setting up this sandwich. This can be achieved by running
a pasteur pipette gently across the sandwich. The sandwich was placed into the buffer tank in a
gel holder cassette and the buffer tank was filled with transfer buffer (25 mM Tris, 192 mM
Glycine, 20% (v/v) methanol (pH 8.3)). After addition of a magnetic stirrer and the BioIce
Cooling unit, the cables were connected with the electrodes of the power source (BioRad
PowerPac™ HC Power Supply) and the proteins transferred onto the membrane at 100V for
65minutes. After the protein transfer was completed the membrane was soaked in 5% powdered
milk in TBST ( 50 mM Tris, 150mM NaCl, 0.05% Tween 20) for 1 hour. The membrane was
then washed in TBST for a short time, and 5ml 5% powdered milk in TBST was added. The
primary antibody was added to the TBST and the membrane incubated in the primary antibody at
4°C with light shaking overnight. Alternatively, the primary antibody was diluted in 5% Bovine
Serum Albumin in TBST. For dilution ratios of primary antibodies please refer to Table 3. Three
washing steps in TBST followed this incubation period, with every washing step lasting 10
minutes. 5ml TBST plus secondary antibody (dilution 1:2000, Table 3) was added to the
membrane and the membrane incubated for at least 2 hours at room temperature. Excess
antibody was washed away in TBS-T for 10 minutes. This washing step was repeated 3 times.
Detection
Proteins were detected in a colorimetric reaction using alkaline phosphatase conjugated
to the secondary antibody. After antibody treatment the membrane was prepared for detection by
soaking in TBS-MgCl2 (50mM Tris, 150mM NaCl, 5mM MgCl2) for 5minutes. During this
incubation step the substrate solution was prepared (15ml TBS-MgCl2, 0.10ml NBT (50mg/ml),
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0.05ml BCIP (50mg/ml); BCIP/NBT Color Development Substrate from Promega #S3771).	
  A
combination of NBT and BCIP was used, as combining the two substrates yields an intense,
black-purple precipitate that provides much greater sensitivity than either substrate alone. The
pretreated membrane was put into the substrate solution and developed until protein bands were
visible. To stop the colorimetric reaction, the membrane was transferred into 10% acetic acid.
24. Salivary gland chromosome staining
Before the staining procedure, Buffer A was freshly prepared (10X: 150mM Tris-HCl pH
7.4, 600mM KCl, 150mM NaCl, 5mM Spermidin, 1.5mM Spermin). Salivary glands of
wandering third instar larvae were dissected in physiological solution A (0.7% NaCl in distilled
H2O). These animals expressed hsGal4; dLipinWT6M. Wandering third instar larvae were
subjected to an hour-long heat shock at 37°C. . Dissection of larval salivary glands was
conducted immediately after heat shock, 2hs after heat shock and 24hs after heat shock.
Dissected glands were placed into solution B for 25 sec. for fixation (for 1ml: 10% of 37%
formaldehyde, 70% distilled H2O, 10% Triton X100, 10% Buffer A). After fixation, glands were
quickly rinsed in solution C (for 1ml: 10% of 37% formaldehyde, 40% distilled H2O, 50%
glacial acetic acid), and placed on a cover slip containing a drop of solution C for 3-4 minutes.
The coverslip with salivary glands was picked up with a microscopic slide and pressure was
applied by pressing down with a finger or the handle of the forceps. The slide was then turned
around and the coverslip/slide sandwich pressed tightly between two sheets of blotting paper.
The slide was flash frozen in liquid N2 and the coverslip removed with a razorblade. The area of
the chromosome squash was labeled with a pencil and the slide immersed into 100% ethanol for
at least 10 min. Slides were then washed in KP-Buffer (10X: 1.4M NaCl, 0.1M
Potassiumphosphate ph 7.4) twice for 10 min. Any residual KP-Buffer was removed by shaking
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the slide quickly and 20µl primary antibody solution added (dLipin: 1:200 to 1:2000). Slides
were incubated in moist chamber overnight at 4°C. The primary antibody and the cover slip were
removed by two washes in KP-Buffer, with each wash lasting 10 min. 40µl of secondary
antibody solution (Rhodamine conjugated anti-rabbit 1: 1000) was pipetted onto a coverslip and
the coverslip placed upon the slide. Incubation in the secondary antibody solution lasted for 2 hrs
at room temperature. The cover slip was removed by swirling it through KP-Buffer, and the slide
washed twice in KP-Buffer for 10 min. The slides were mounted in Slowfade Gold antifade
reagent with DAPI (Invitrogen # P36931), and images taken with a Carl Zeiss AxioVision
microscope.
25. Fat body chromosome staining
Fat body tissue of third instar larvae was dissected in physiological solution (0.7% NaCl
in distilled H2O), and the fat body tissue transferred to 6µl fixative solution (40% acetic acid.
30% lactic acid, 30% distilled H2O) that had been pipetted onto a coverslip. After 3-5 minutes a
slide was lowered onto the coverslip and pressure was applied by pressing down with a finger.
The slide was then turned around and the coverslip/slide sandwich pressed tightly between two
sheets of blotting paper. The slide was then immersed into liquid N2 and the coverslip removed
with a razorblade. The slide was immediately transferred into PBS at room temperature. This
was followed by an immersion into PBST (PBS plus 1% Triton X-100) for 20minutes at room
temperature. For blocking, slides were immersed into blocking solution (PBS plus 1% non fat
dry milk) and left there for a 30 minute incubation period. Slides were then treated with the
primary antibody (dLipin: 1:200 to: 2000), diluted in PBS, 1% BSA for 60 minutes at RT or
overnight at 4°C in humid chamber. Excess antibody was removed by washing 3 consecutive

	
  

65

times in PBS, 0.5% nonfat dry milk for 5 minutes. The secondary antibody (Rhodamine
conjugated anti-rabbit 1: 1000) was added diluted in PBS, 1% BSA and the slides incubated for
60 min at room temperature. Excess antibody was washed away in 3 washing steps, each lasting
5 min, in PBS at 4°C. Slides were mounted in Slowfade Gold antifade reagent with DAPI
(Invitrogen # P36931), and images taken with a Carl Zeiss AxioVision microscope.
26. Quantitative RT-PCR
To measure transcript levels of dp110 following dLipin knockdown, quantitative RTPCR was utilized. Fat body tissue from 100 w1118 larvae and 140 dLipinRNAi/FBcg larvae
(feeding stage) was collected and RNA extracted using TRIzol Reagent (Invitrogen #15596018). The extracted RNA was then treated with DNaseI (New England Biolabs #M0303S) to
remove traces of genomic DNA and further purified using Direct-zol RNA MiniPrep (Zymo
Research #R2050S). To determine changes in expression levels of dp110 following dLipin
knockdown dp110 transcripts were amplified using specific primers (Fruit Fly PI3k92E). rp49
(ribosomal protein 49) a housekeeping gene ubiquitously expressed in D. melanogaster was
selected as the normalizer gene or endogenous control. rp49 was amplified using the rp49fwd
and rp49rev primerset (Table 4). HotStart-IT SYBR Green One-Step qRT-PCR Master Mix Kit
(Affymetrix # 75770) was used for qPCR reactions. To determine the reaction efficiencies of
dp110 and rp49, a standard curve was generated for each gene by plotting the log of known
template concentrations against the Ct (threshold cycle) values for those concentrations. Relative
dp110 expression levels were quantified using the standard curve method (REAL-TIME PCR
from Theory to Practice, Invitrogen).
Fold difference: (EDp110)ΔCtDp110/(Erp49)ΔCtrp49
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E= efficiency from standard curve E=10(-1/slope)
ΔCtdp110= Ctdp110w1118 – Ctdp110dLipinRNAi
ΔCtrp49= Ctrp49w1118 – Ctrp49dLipinRNAi
RNA samples were analyzed in triplicates.
27. PIP2 and PIP3 visualization
Growth, Nutrition, and Inr/PI3K
Phosphatidylinositol
241

4,5-bisphosphate (PIP2) and Phosphatidylinositol (3,4,5)-

triphosphate (PIP3) can be visualized taking advantage of the fact that specific Pleckstrin homoly
domains (PH domain) show a specific binding affinity for either of these phospholipids. To
visualize PIP3, the PIP3 specific PH domain of general receptor for phosphoinositides-1 (GRP1)
was fused to green fluorescent protein (GFP), which generates a fusion protein called GPH.
Expression of the GPH construct was under control of the Tubulin promoter, hence the whole
construct is called tGPH (Britton et al., 2002).

Figure 2. tGPH, a PH-GFP Fusion Protein Used as an Indicator of PI3K Activity

Fig. 8: Schematic representation of the tGPH construct. Image modified from Britton et al.,

(A) Amino acid sequence alignment of the PH domains of Drosophila GRP1 (tGPH) and mouse GRP1 (mGRP1). Amino acids generally conserv
2002.
in PH domains are indicated by asterisks above the protein sequence. Two conserved amino acids that vary in the Drosophila gene
indicated by filled circles.
(B) Schematic representation of the tGPH fusion protein.
(C) GPH localization in S2 cells transiently transfected with the pMT-GPH gene. Left: cells starved for serum for 2 hr. Center: serum-starv
cells treated with 200 nM insulin for 5 min. Right: serum-starved cells treated with insulin for 10 min followed by the PI3K inhibitor wortman
at 100 nM.As the GPH protein exhibits a specific affinity for binding to PIP3, PIP3 present in the

cell will be labeled green upon GPH binding. PIP2 was tracked by a PIP2 specific PH reporter.
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reporter to generate the fusion protein PLCδPH-GFP (Gervais et al., 2008). Expression of the
PLCδPH-GFP construct was under control of a Tubulin promoter. PLCδPH-GFP binds
specifically to PIP2, thus PIP2 presence in the cell will be represented by green fluorescence.
As PIP2 and PIP3 are both generated at the plasma membrane, presence of these
phospholipids will be reflected in GFP signaling that concentrates at the plasma membrane. Fat
body tissue from third instar feeding larvae was dissected in PBS and the tissue fixed for 10
minutes in 4% formaldehyde. After fixation, tissue and cell staining was documented using a
Carl Zeiss AxioVision microscope.
28. dLipin localization following alterations of TOR/Insulin signaling
dLipin localization was analyzed after knockdown of TOR signaling in third instar
wandering larvae. Genotypes investigated were the following: FB(cg); TORRNAi and FB(cg);
raptorRNAi. Additionally, insulin pathway activity was reduced and any effects on dLipin
localization documented. The observed genotypes analyzed were: FB(cg); InRdom.neg. and FB(cg)
/ PI3K21BHA. Fat body tissue from larvae of these genotypes was stained with dLipin antibody
and samples mounted in Slowfade Gold antifade reagent with DAPI (Invitrogen # P36931). To
determine any change in dLipin localization, images were taken with a Carl Zeiss AxioVision
microscope.
29. Cell measurements
Cell area was measured using the AxioVision software (available on Carl Zeiss
AxioVision microscope) or ImageJ software (http://rsb.info.nih.gov/ij/download.html). To
determine the cell size of cells that did not show clear cell boundaries, the distance between
neighboring nuclei was measured. In cells where the nucleocytoplasmic ratio was analyzed,
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nuclear area was measured in addition to cell area, and the ratio between the two calculated. Data
was analyzed statistically using unpaired two-tailed Student’s t-Test.
30. Embryo collection and timing of larvae for dLipin/raptor genetic interaction studies
To ensure that larval development was as homogenous as possible, parental adult flies
were allowed to lay eggs on molasses plates for a period of 4 hours only. To prohibit the
deposition of retained eggs, flies were put on food for two hours beforehand so they could lay
any retained egg. The eggs laid within the 4 hour time period were transferred with a wet brush
onto standard fly food, and kept at 25°C. Larvae were allowed to develop for 5 or more days
before larval size and fat body development was compared. Larval and fat body tissue
morphology was examined using a Carl Zeiss Stereomicroscope and a Carl Zeiss AxioVision
microscope, respectively.
31. Ecdysone rescue experiments
Standard fly food containing 120µg/ml 20-Hydroxyecdysone (20 HE) was prepared. 20
HE was diluted in 100% ethanol and added to the food after it had cooled down to approximately
50°C. Ethanol was also added to the food of control flies, to ensure that there were no differences
between the 20 HE food and the normal food, except for the addition of 20 HE. Adult flies were
kept on food at 25°C and transferred daily onto new food. Number of pupae formed and
developmental timing of control and experimental offspring was compared and data were
analyzed with the Chi-Square test. The following cross was set up:
Parental cross: TubGal4/Tb X ΔNLSdLipin/ΔNLSdLipin either on food with or without 20-HE
! TubGal4; ΔNLSdLipin: Experimental animals 50% genotype frequency expected.
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Tb,TM6B; ΔNLSdLipin: Control animals 50% genotype frequency expected.
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III. Results
A. Linking dLipin and insulin pathway activity in D. melanogaster
Studies with mice and humans have established a strong connection between the
mammalian homologs of dLipin and insulin signaling. Mice with the fld (fatty liver dystrophy)
mutation display reduced glucose tolerance and decreased sensitivity to insulin stimulation (Reue
et al., 2000). The fld mutation was subsequently identified as a mutation within the lipin1 gene
(Peterfy et al., 2001). Similar findings were described for human adipose tissue, where low lipin1
transcript levels correlate with increased insulin resistance (Suviolahti et al., 2006). Furthermore,
insulin signaling influences subcellular localization and phosphorylation of Lipin1 in human
adipocyte cell lines (Harris et al., 2007). All these results were collected in either mice or
humans, both of which possess multiple lipin paralogs in their genomes, a fact that complicates
research in these organisms due to redundancy among the different lipin paralogs. Drosophila
melanogaster on the other hand has one lipin gene (dLipin) (Peterfy et al., 2001) making this
model organism a prime candidate to examine effects of Lipin on insulin signaling.
1. dLipin is necessary for cell growth
The fat body has emerged as the main tissue of dLipin activity in Drosophila (Ugrankar
et al., 2011). Diacylglycerol (DAG) produced by dLipin is the immediate precursor for
triacylglycerol (TAG) synthesis. The larval fat body functions as the storage organ for TAG and
is the major metabolic organ of the developing larvae. As TAG synthesis is dependent on proper
dLipin function, any effect of dLipin loss should be especially prominent within the tissue of
TAG production. It is for this reason, that I concentrated my work on the fat body.
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1.1. Cell-autonomous loss of dLipin activity in the fat body affects cell growth and fat content
One telltale sign of disrupted insulin signaling is a reduction in cell growth (Lehner,
1999; Johnston and Gallant, 2002). To test whether dLipin deficiency leads to a cell size defect,
mosaic animals were generated. These mosaic animals had single cells within the fat body that
exhibited diminished dLipin levels. By knocking down dLipin in single cells only, it is possible
to observe the cell-autonomous effects of dLipin loss. Knockdown of dLipin activity was
achieved by downregulation of dLipin mRNA via RNAi in single cells. A TubulinGal4 driver
was used to express a RNAi transgene in single cells, which resulted in a cell specific reduction
of dLipin mRNA and, consequently, dLipin protein.
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Fig. 9: dLipin is required cell-autonomously in the fat body for normal fat droplet
formation and cell growth. Fat body cells in mosaic animals that were deficient in dLipin
protein contained few fat droplets and were reduced in size. Fat droplets were stained with
LipidTOX Deep Red (LT) and dLipin protein was detected using an affinity-purified dLipin
antibody (dLipin). Note that although strongly reduced in some knockdown cells, residual dLipin
can still be detected in the cell nucleus. Depicted are cells of feeding third instar larvae. Scale
bar: 100µm.

A reduction of dLipin affected cell size in a cell-autonomous fashion (Fig. 9). Cells with
successful dLipin knockdown are outlined. Antibody staining indicated that dLipin protein was
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strongly reduced in these cells. The dLipin deficient cells were not only reduced in size, but also
exhibited reduced fat content. Thus, not only cell size, but also fat synthesis is controlled by
dLipin cell-autonomously.
1.2. Ubiquitous knockdown of dLipin results in cell size variability
Ugrankar et al. (2011) described a dLipin mutant phenotype that was characterized by a
wide variability of cell sizes in the fat body, including many hypertrophic cells. It was
hypothesized that this phenotype constituted a secondary compensatory effect caused by the
reduced total fat mass in these animals. I reproduced these data by knocking down dLipin
ubiquitously in third instar larvae using a strong TubulinGal4 driver and a dLipinRNAi construct.
Cells size following dLipin knockdown was highly variable, a phenotype mirroring the dLipin
mutant phenotype (Fig. 10).
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TubGal4> dLipinRNAi

	
  

control

	
  

Fig. 10: Systemic knockdown of dLipin results in cell size heterogeneity and cells with
reduced fat content. TubulinGal4>dLipinRNAi fat body cells displayed a change in cell
morphology, cell size and fat content. Cells were rounded, of very variable size and often
contained smaller fat droplets, or lacked fat droplets. This phenotype closely resembled the
dLipin mutant phenotype (Ugrankar et al., 2011). Fat droplets were stained with Bodipy (green)
and cell membranes with with CellMask Plasma stain (orange). Some very small cells, visualized
by plasma membrane staining, lacked fat droplets (arrow). Fat body cells from wild-type dLipin
control flies (w1118) were polygonal with normal fat content and fat droplets of normal size.
Depicted are fat body cells of feeding third instar larvae. Scale bar: 100µm.

Data concerning cell growth collected by mosaic analysis and ubiquitous dLipin
knockdown differed drastically. Cell-autonomous dLipin knockdown resulted in a cell growth
deficit, whereas systemic dLipin knockdown resulted in extreme cell size variability. This
discrepancy in cell growth defects emphasizes the importance of investigating not only system
wide but also cell-specific gene knockdown to grasp the full extent of effects caused by the gene
knockdown.
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1.3. Comparison of cell-autonomous and ubiquitous dLipin knockdown
To further analyze the cell growth defects observed after dLipin knockdown, I measured
the cell and nuclear area of fat body cells (Fig. 11). Whereas a strong statistical difference
between the size of control cells and cells with cell-autonomous expression of dLipinRNAi was
observed, no statistically significant difference was found between cell size of control cells and
cells after systemic dLipinRNAi expression. However, the standard deviation value for the
system-wide knockdown was extremely high, reflecting the extreme variability in cell size.
Conducting the F-test to compare the variance in fat body cell size from control animals to the
variance in fat body cell size from animals with systemic dLipin knockdown revealed a
significant difference between the variances of the two samples (p< 0.0001). Thus, systemic
knockdown of dLipin causes significant cell size variability, which indicates that cell growth was
altered upon systemic dLipin knockdown. Cell-autonomous loss of dLipin activity resulted in a
reduction of nuclear area. This points to a decrease in the number of endoreplication cycles,
which would suggest that cell-autonomous dLipin knockdown induces an overall growth
phenotype that affects cytoplasmic cell growth as well as genome replication. Following
systemic dLipin knockdown, nuclear area is not reduced, but increased. Hence, genome
replication does not seem to be negatively affected by systemic dLipin knockdown. Looking at
the nucleocytoplasmic ratio, I further characterized the nature of growth defects observed after
dLipin knockdown (Fig. 12).
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Fig. 11: Knockdown of dLipin affected cell and nuclear area. A) Systemic knockdown of
dLipin (TubGal4>dLipinRNAi) led to extreme variability of cell size, hence the big standard
deviation. In contrast, cell autonomous loss of dLipin resulted in cell size reduction. Cell area in
fat bodies was measured from feeding third instar larvae. As a control, cells from mosaic animals
without dLipinRNAi expression were measured. Cell area was measured using the Axioware
software package. Unpaired t –Test, ∗∗∗ p < 0.0001. B) The mosaic dLipin deficient fat body
cells displayed a reduction in nuclear area, which indicates that endoreplication was negatively
affected in these cells. After systemic knockdown of dLipin, fat body cells displayed larger
nuclei when compared to control cells. Nuclei of feeding third instar larvae were measured.
Nuclear area was determined using the Axioware software package. Unpaired t-Test, *** p <
0.0001; ** p = 0.0002. Error bars indicate standard deviation (SD).
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***

	
  

Fig. 12: Cytoplasmic growth was negatively affected in cells following knockdown of
dLipin. The nucleocytoplasmic ratio was elevated in cells with, either cell-autonomous or
systemic dLipin knockdown, indicating that cytoplasmic growth was affected, and affected to a
stronger extent than endoreplicative growth. Fat body cells of feeding third instar larvae were
measured. Unpaired t-Test, *** p < 0.0001. Error bars indicate SD.

Both cell-autonomous loss of dLipin activity as well as systemic reduction of dLipin
activity resulted in an increase in the nucleocytoplasmic ratio (Fig. 12). This implicates that
overall cytoplasmic cell growth was more severely affected by reduced dLipin expression than
genome replication. This effect was even more pronounced in fat body cells from animals with
systemic dLipin knockdown.
These data support the conclusion that dLipin is required for proper cell growth, as both
cell-autonomous as well as systemic dLipin knockdown lead to cell size defects. Cellautonomous dLipin loss caused a decrease in overall cell growth indicating that dLipin activity is
required in single cells for proper cell growth. It appears that systemic dLipin knockdown elicits
a secondary compensatory mechanism that compensates the reduced fat body mass after dLipin
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knockdown by cell overgrowth. A very similar phenotype was observed in transheterozygous
dLipin mutants (Ugrankar et al., 2011).
Having established a connection between dLipin and cell growth, it was of interest to see
whether insulin signaling was affected by dLipin activity.
2. dLipin activity is necessary to ensure proper insulin signaling pathway activity in the fat body
Figure 5 illustrates all the important steps involved in the signal transduction cascade of
the canonical insulin pathway. One critical step is the synthesis of PIP3 from PIP2, which is
catalyzed by PI3K at the plasma membrane. PIP3 recruits the pleckstrin homology domain (PH)
of AKT and PDK1 to the plasma membrane, thus allowing PDK1 to phosphorylate AKT. AKT
is then further phosphorylated by TORC2 and thereby gains full activation. Activated AKT
dissociates from the cell membrane and targets downstream effectors of the pathway. Thus, one
way to measure activity of the insulin pathway in the cell is by examining PIP3 levels at the cell
membrane.
2.1. PIP3 synthesis is dependent on dLipin
The laboratory of Bruce Edgar generated a transgene that encodes a pleckstrin homology
domain-green fluorescent protein fusion, PH-GFP (tGPH), which serves as an indicator for PIP3
synthesis (Britton et al., 2002). The PH domain of the fusion protein is recruited to the plasma
membrane upon PIP3 synthesis. Green fluorescence from the PH-GFP fusion protein thus
reflects PIP3 levels and spatial distribution in the cell. I compared PIP3 levels/localization in fat
body cells from animals with fat body-specific dLipin knockdown and control animals (Fig.
13A). It was also important to determine whether knockdown of dLipin in the fat body alone
would be enough to alter insulin pathway activity in other tissues, or whether the effect would be
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restricted to the fat body. Thus, I looked at PIP3 localization in the salivary glands of animals
with fat body-specific dLipin knockdown (Fig. 13B). Additionally I wanted to ensure that
potential differences in PIP3 levels/localization were not due to decreased availability of its
precursor PIP2. To this end, I used a transgene that encodes a PIP2 specific PH-GFP fusion
protein (ubi-PLC) (Gervais et al., 2008). This would, as in the case for PIP3, give me
information on PIP2 levels and distribution within the cell (Fig. 13C).
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Fig. 13: The second messenger PIP3, but not PIP2, was reduced at the cell membranes of
fat body cells that lack dLipin. (A) dLipin was knocked down in the fat body of animals
expressing the PIP3 reporter tGPH (green), and feeding third instar larvae were dissected
(FBGal4> dLipinRNAi). Membrane association of PH-GFP was strongly reduced in fat body
lacking dLipin, but not in fat body of control animals (FBGal4; tGPH). (B) In tissues not
targeted for dLipin knockdown (salivary glands), PIP3 showed normal association with the cell
membrane. (C) Fat body cells of animals that express the PIP2 reporter ubi-PLC showed no
change in the association of PH-GFP with the cell membrane (green) compared to control
animals (FBGal4; ubiPLC). Nuclei stained with DAPI. Scale bar: 100µm.

dLipin knockdown in the fat body had a clear negative effect on insulin pathway activity,
as demonstrated by the complete lack of PIP3 at the cell membrane (Fig. 13A). In control cells,
strong PIP3-GFP signals coincided with the cell membrane. This pattern was lost following
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dLipin knockdown. All PIP3 seemed to be lost from the cell membrane, which suggests a severe
disruption of the insulin pathway. There was no observable effect on PIP3 localization in tissues
outside of the fat body, as salivary gland cells exhibited unchanged membrane association of
PIP3. Therefore, the consequences of dLipin knockdown in the fat body seemed to be tissue
limited. The level and membrane association of PIP2 did not appear to be negatively affected in
the fat body indicating that it was indeed the conversion of PIP2 into PIP3 that was disturbed.
To further validate this result, I looked at PIP3 and PIP2 in dLipin transheterozygous mutants
(dLipine00680/Df(3R)Exel7095).

A)
	
   control

dLipine00680/ Df(3R)Exel7095

PIP3-specific PH-GFP

PIP3-specific PH-GFP

PIP2-specific PH-GFP

PIP2-specific PH-GFP

B)

Fig. 14: PIP3 association with the cell membrane was lost in dLipin mutants
(dLipine00680/Df(3R)Exel7095). A) PIP3 was no longer localized at the cell membrane in dLipin
mutants, which confirmed the results obtained by the dLipinRNAi experiment. B) PIP2 appeared
to be located at the cell membrane, indicating no change in PIP2 availability in these cells. PHGFP: green, nuclei stained with DAPI. Scale bar: 100µm.

I confirmed the earlier results with this second set of experiments. Membrane association
of PIP3 was no longer detectable, whereas PIP2 localization remained unchanged.
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The results from the PIP3/PIP2 visualization experiments clearly indicate that pathway
activity is disrupted after loss of dLipin, pointing to dLipin as a contributor to insulin pathway
activity in the fat body.
2.2. dLipin knockdown in the fat body does not result in cell growth defects
As mentioned earlier, diminished insulin signaling pathway activity often results in a
reduction of cell size. Cell size should therefore be negatively affected in the fat body cells after
fat body-specific dLipin knockdown (FBGal4>dLipinRNAi) as these cells clearly showed a loss
of PIP3 membrane association (Fig. 13).

	
  

Fig. 15: Knockdown of dLipin via RNAi in the fat body did not result in a growth defect.
Cellular area of fat body cells after dLipin knockdown (green: FBGal4>dLipinRNAi) was
measured and compared to control fat body cell area (red: fat body of animals carrying only the
Gal4 transgene; blue: fat body of animals carrying only the dLipinRNAi transgene). No
significant difference in cell area was detected for either genotype. Fat body cells were from
wandering third instar larvae. Error bars indicate SD.

The measurement of cell area showed no significant difference in cell size between the
fat body cells following fat body-specific dLipin knockdown (FBGal4>dLipinRNAi) and control
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cells. This was a surprising result considering the fact that PIP3 membrane association was lost
in these cells and therefore insulin pathway activity should have been strongly decreased.
In addition, development and size of larvae and pupae did not seem to be affected by fat
body-specific knockdown of dLipin.
To further elucidate the relationship between dLipin and the insulin signaling cascade I
concentrated on genetic interaction experiments among members of the canonical insulin
signaling cascade and dLipin.
3. dLipin genetically interacts with the insulin signaling pathway
To screen for potential interactions between dLipin and members of the insulin signaling cascade
I set up numerous crosses.
3.1. dLipin and insulin receptor act in concert in fat body development and cell growth
To assess possible genetic interactions between dLipin and genes of the insulin pathway,
I examined animals expressing dLipinRNAi and a dominant negative form of the insulin receptor
(InRDN). The single knockdown of dLipin resulted in fat body cells with small fat droplets, and
InRDN expression led to fat body cells of smaller size, but seemingly normal fat content.
Combining both transgenes in the fat body changed the morphology of the cells dramatically,
and reduced fat body mass. Fat body cells displayed a rounded morphology, with an increase in
cell size. This phenotype strongly resembled the dLipin mutant phenotype described in Ugrankar
et al. 2011, as well as the phenotype after TubulinGal4>dLipinRNAi systemic knockdown (Fig.
10).
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To visualize fat body mass in experimental and control larvae, I used the fat body marker
Dcg-GFP (Suh et al., 2007). Fat body tissue of animals carrying this marker exhibits green
fluorescence when irradiated with light of the appropriate wavelength. To characterize the cell
growth defect following loss of InR activity, I measured the cell area of cells expressing InRDN.
A)
FBGal4>InRDN

FBGal4>dLipinRNAi

FBGal4>dLipinRNAi;
InRDN

B)
FBGal4>dLipinRNAi

FBGal4>InRDN

FBGal4>dLipinRNAi; InRDN
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C)

***

Fig. 16: dLipin and insulin signaling act in concert in fat body development and cell
growth. (A) Feeding third instar larvae expressing a dLipinRNAi transgene and a transgene
encoding a dominant negative form of the insulin receptor (InRDN) exhibited a severe fat body
defect with increased cell size variability and small fat droplets; a phenotype that strongly
resembles the dLipin mutant phenotype. Fat droplets were visualized by Bodipy staining (green)
and nuclei with DAPI (blue). Scale bar: 100µm (B) Larvae carrying both transgenes had less fat
body mass compared to larvae expressing either one of the transgenes. Fat body tissue was
labelled with Dcg-GFP (green). C) Area of fat body cells was reduced in animals expressing
InRDN. Cells of wandering third instar larvae were measured and compared to cells of control
animals (red: animals carrying only the Gal4 transgene; blue: animals only carrying the InRDN
transgene). Unpaired t-Test, *** p < 0.0001. Error bars indicate SD.

I tried to rescue the defects in fat body development observed in animals with fat body
specific dLipin deficiency and InRDN expression by knocking down Dullard activity (FBGal4>
dLipinRNAi; DullardRNAi/InRDN). Dullard is a phosphatase that targets an insulin-sensitive
phosphorylation site within Lipin1 (Wu et al., 2011). If Dullard has the same function in
Drosophila, reducing Dullard in the cell would increase insulin pathway input on dLipin and
thus, possibly counteract the effect of InRDN expression on dLipin. However, RNAi knockdown

	
  

85

of Dullard in concert with dLipin knockdown and InRDN expression did not rescue phenotypes
and did not have an obvious phenotypic affect when carried out alone (data not shown).
Through genetic interaction experiments I was able to further weave dLipin within the
fabric of the insulin network. It became clear that both dLipin as well as the insulin receptor are
required for normal fat body development, and that loss of dLipin in a InRDN genetic
background led to a cell overgrowth phenotype resembling the transheterozygous dLipin mutant
phenotype (Ugrankar et al., 2011). This suggests that dLipin activity during adipogenesis and in
fat synthesis is dependent on the insulin pathway. 	
  
3.1.1. Reduced dLipin activity with simultaneous InRDN expression does not cause an
organismal growth defect
To further address the possibility of an interaction between dLipin and InRDN in cell
growth control, I tested animals with weak ubiquitous expression of both transgenes for effects
on organismal growth (daGal4>dLipinRNAi; InRDN). I was not able to detect any organismal
growth defect in these animals when compared to control animals. To score for growth defects, I
measured the size of pupae (data not shown).
3.1.2. Viability is reduced after dLipin knockdown with concomitant InRDN knockdown
While studying the effects of InRDN expression and dLipin knockdown on fat body
development and morphology, I noticed that the viability of animals carrying both transgenes
appeared to be reduced. To document this phenotype I counted pupae formed for lines carrying
either or both transgene/s and compared them to a control fly line. All four genotypes compared
emerged from one single cross. Thus, I could compare the number of pupae formed by animals
with experimental genotypes (FBGal4>dLipinRNAi; FBGal4>InRDN;
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FBGal4>dLipinRNAi;InRDN) to the number of pupae formed by animals with control genotype
(FBGal4). I set the number of pupae formed by animals with control genotype to 100%. I
compared each experimental genotype with the control phenotype using a Chi-Square test, as the
expected frequency for each genotype was known. A very significant rise in larval lethality after
knockdown of dLipin in an InRDN background was detected, whereas neither the control line nor
single transgene carrying lines displayed any difference in pupation capacity (Fig. 17). This
increased larval lethality was reflected by a decrease in the number of pupae formed, as most
animals perished during larval development.

***

Fig. 17: Viability is decreased following InRDN expression with simultaneous dLipin
knockdown. dLipinRNAi was expressed concomitant with InRDN (dominant negative form of
InR). Animals carrying both transgenes exhibited a decrease of viability, with very few
individuals reaching the pupal stage. Two tailed Chi-Square Test, *** P< 0.0001. No statistically
significant difference was found between either the single transgenes or between the single
transgenes and the control (only FBGal4 driver). Animals carrying the driver transgene only
were used as the control animals.

At this point, I had firmly established that a change in dLipin activity elicits changes in
insulin pathway activity, as PIP3 synthesis was reduced. It also became apparent that dLipin and
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the insulin pathway interact in fat body development. The defect in fat body development
appeared to be caused by a further decrease of dLipin activity upon InRDN expression, which
indicates that dLipin activity is dependent on input from the insulin pathway.
3.2. Interaction studies between dLipin and genes of the insulin pathway
In addition to the genetic interaction between dLipin and InR, I investigated possible
interactions between dLipin and numerous other genes of the insulin pathway
All these interaction studies failed to show phenotypes or caused lethality but should be
mentioned here for the sake of completeness.
dLipinRNAi/InRconst.active;FB(r4): Overexpression of a constitutively active form of Insulin
Receptor in the fat body with concomitant dLipin knockdown. No interaction detected, as
overexpression of InRconst.active alone did not lead to an insulin overactivation phenotype in the fat
body.
dLipinRNAi/InRcont.active; DJ761: Ubiquitous expression of a constitutively active form of Insulin
Receptor in concert with dLipin knockdown. No interaction detected, as overexpression of
InRconst.active did not lead to an insulin overactivation phenotype in the fat body.
dLipinRNAi/PI3K21BHA; FB(r4): Simultaneous knockdown of dLipin and PI3K21B activity in
the fat body. Neither flies of genotype dLipinRNAi; FB(r4) nor flies of genotype PI3K21BHA;
FB(r4) could be established due to lethality.
dLipinRNAi/PI3K21BHA; DJ761: Ubiquitous simultaneous knockdown of dLipin and PI3K21B
activity. Neither flies of genotype dLipinRNAi; DJ761 nor flies of genotype PI3K21BHA; DJ761
could be established due to lethality.
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PI3K21BHA; LipinWT6M/FB(r4): Overexpression of dLipin in fat body tissue with loss of
PI3K21B activity. No rescue of the loss-of-function phenotype observed in PI3K21BHA by
overexpression of dLipin.
dLipinRNAi/FB(cg); PI3K92Edom.neg.: Simultaneous dLipin knockdown and loss of PI3K92E
activity. No interaction detected, as PI3K92Edom.neg. animals not display an insulin signaling
knockdown phenotype.
dLipine00680/ dLipine00680; AKTmyr/ FB(r4): Expression of constitutively active AKT in dLipin
hypomorphic mutant. No interaction detected, as AKTmyr animals did not display an insulin
signaling overactivation phenotype.
dLipine00680/Df(3R)Exel7095; AKTmyrlacZ/FB(r4): Overexpression of AKT in dLipin
transheterozygous mutant. No interaction detected, as AKTmyrlacZ did not display an insulin
signaling overactivation phenotype.
To confirm that insulin pathway activity was indeed interrupted downstream of PIP3
synthesis, I examined AKT activity in fat body tissue upon dLipin knockdown.
4. dLipin knockdown reduces insulin pathway activity downstream of InR and PIP3
PIP3 at the cell membrane serves as an anchor for AKT. AKT migrates to the membrane
and is activated by phosphorylation of 2 amino acid residues. One phosphorylation is carried out
by PDK1 and the other by TORC2 at serine505 (S505). The AKT phosphorylation at S505
corresponds to AKT serine473 (S473) phosphorylation in mammals. Mammalian AKT S473
phosphorylation is required for full activation of AKT (Hemmings and Restuccia, 2012).
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To address possible changes in AKT activity upon reduced dLipin activity I examined
S505 phosphorylation levels of AKT. dLipin deficiency resulted in a reduction of PIP3 synthesis,
which suggests that the insulin pathway is interrupted. To test this, western blot analysis was
carried out with antibodies against panAKT and S473 phosphoAKT and fat body samples from
third instar larvae with fat body-specific dLipin knockdown (FBGal4>dLipinRNAi) (Fig. 18A).
The S473 phosphoAKT antibody is known to react with Drosophila S505 phosphoAKT. By
measuring levels of overall AKT (panAKT) as well as phosphoAKT levels, it is possible to
deduce whether not only AKT phosphorylation but also general AKT levels are modified within
the cell. To verify the results collected with tissue from animals expressing dLipinRNAi, I
repeated the western blot with fat body tissue from dLipin mutants (dLipine00680/Df(3R)Exel7095)
(Fig. 18B).
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Fig. 18: Insulin pathway activity is interrupted downstream of PIP3. A) Western Blots show
phospho

that levels of AKT
were greatly reduced in fat body tissue from feeding third instar larvae
expressing a dLipinRNAi transgene, while the overall AKT (panAKT) levels remained
unchanged. Fat bodies from w1118 animals were used as control tissue. B) PhosphoAKT levels
were also reduced in fat body tissue from dLipin mutant feeding third instar larvae (dLipine00680/
Df(3R)Exel7095). Fat body tissue from heterozygous (either dLipine00680 or Df(3R)Exel7095)
animals was used as control tissue. The lower band corresponds to the AKT protein. Actin
served as a loading control.

Western blot analysis shows that phosphoAKT levels in the fat body are reduced upon
dLipin knockdown (FBGal4>dLipinRNAi) and in dLipin mutants (dLipine00680/ Df(3R)Exel7095).
Overall AKT levels remained unchanged, indicating that TORC2 mediated phosphorylation is
inhibited. These data confirm that insulin pathway activity downstream of PIP3 is reduced in fat
body cells after a reduction of dLipin activity. The next question asked was whether dLipin acts
downstream or upstream of PI3K or whether it affects PI3K activity itself to interrupt the
signaling cascade. To this end I tested whether loss of dLipin is sufficient to counteract the
effects of PI3K overactivation.
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5. dLipin affects insulin pathway activity by either affecting PI3K or PTEN activity
Overexpression of Dp110, the catalytic subunit of PI3K, in the fat body induces strong
overgrowth of cells. This is due to an overactivation of the insulin pathway. If dLipin acts on, or
downstream of PI3K, loss of dLipin activity should reduce or reverse the cell overgrowth
observed after Dp110 overexpression.
5.1. dLipin knockdown counteracts Dp110 overactivation-induced cell overgrowth
I combined a transgene encoding a constitutively active form of Dp110 (Dp110CAAX)
and dLipinRNAi with a fat body-specific driver and examined possible cell growth effects (Fig.
19).	
  	
  The CAAX signal added to the C-terminus of Dp110 is a farnesylation signal that promotes
protein-membrane interaction, and thus directs Dp110 directly to the cell membrane where it
then generates PIP3. This increase in PIP3 synthesis induces cell growth.
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Fig. 19: dLipinRNAi knockdown can suppress the overgrowth phenotype observed after
Dp110 overactiviation. A) Fat body-specific expression of a constitutively active version of
Dp110 (catalytic subunit of PI3K), Dp110CAAX, resulted in overgrowth of fat body cells. When
Dp110CAAX expression was combined with dLipin knockdown, this growth effect was reversed,
with cells appearing normal in size. There was a variability of phenotypes observed after dLipin
knockdown. Some tissue samples displayed the typical dLipinRNAi phenotype with small fat
droplets, while other samples showed no difference in fat droplet morphology. Fat droplets were
stained with Bodipy (green) and nuclei visualized with DAPI (blue). Tissue was collected from
feeding third instar larvae. Scale bar: 100µm. B) Distance between neighboring nuclei was
measured as a means to determine cell size. The distance between nuclei in fat body tissue from
animals expressing Dp110CAAX was significantly larger when compared to fat body tissue from
animals expressing both, Dp110CAAX and dLipinRNAi. Unpaired t-Test, *** P< 0.0001. Error
bars indicate SD.

The cell overgrowth observed after Dp110CAAX expression in the fat body was reversed
after reduction of dLipin transcripts via RNAi. Depending on the extent of the RNAi-induced
knockdown of dLipin, two different manifestations of the phenotype existed. After strong dLipin
knockdown, cell overgrowth was reduced, and fat droplets were small in size. If RNAi-mediated
knockdown of dLipin was not as pronounced, cell overgrowth was reversed as well but fat
droplet size was unchanged. It is apparent from both phenotypes that the overgrowth induced by
Dp110CAAX expression was successfully repressed by dLipin knockdown.
Paradoxically, some animals with Dp110CAAX expression in the fat body showed
extreme hypotrophy of fat tissue (data not shown).
5.2. dLipin knockdown suppresses Dp110-induced activation of the insulin pathway
As Dp110CAAX expression leads to an overactivation of insulin pathway downstream of
PI3K, I investigated whether this overactivation can be reversed by loss of dLipin activity. I
looked at PIP3 localization in fat body cells from larvae that carry the Dp110CAAX transgene
and from larvae with both the Dp110CAAX and the dLipinRNAi transgene (Fig. 20).
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PIP3 specific tGPH

LipiTOX

FBGal4> Dp110CAAX

FBGal4> Dp110CAAX;dLipinRNAi

FBGal4> Dp110CAAX;dLipinRNAi
Fig. 20: Loss of dLipin is sufficient to downregulate insulin pathway activity in fat body
cells with constitutively active PI3K. The PIP3 reporter PH-GPH was membrane associated in
cells expressing Dp110CAAX. When dLipin was knocked down strongly in the fat body cells of
these animals (FBGal4> Dp110CAAX; dLipinRNAi) the membrane association was no longer
detectable (middle picture). In cases of weaker dLipin knockdown, PIP3 remained at the cell
membrane (bottom picture). To have another measure of the severity of the dLipin knockdown, I
stained fat droplets with LipiTOX (red). A strong dLipin knockdown corresponded to smaller fat
droplets. Feeding third instar larvae were dissected. Scale bar: 100µm.

PIP3 localization at the plasma membrane in animals with Dp110CAAX expression was
intact in cases of weak dLipin knockdown but lost in animals with stronger dLipin knockdown
(Fig. 20). This indicates, that a reduction in dLipin activity is sufficient to prohibit PIP3 synthesis
even in the presence of PI3K overactivation and it also suggests that dLipin affects PIP3
synthesis itself.
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In addition to the PIP3 experiment, I also performed a western blot analysis to examine
AKT phosphorylation levels.
5.2.1. Dp110-induced AKT phosphorylation is suppressed by a knockdown of dLipin activity
Overactivation of Dp110 should increase AKT phosphorylation, and RNAi-induced
knockdown of dLipin should suppress this. To test this hypothesis, I performed a western blot
analysis with fat body tissue from third instar feeding larvae expressing Dp110CAAX and
compared this sample with fat body tissue from animals with dLipin knockdown and
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Fig. 21: Reducing dLipin levels in Dp110 overactivation background reduces phosphoAKT
levels. Overactivation of Dp110 (FBGal4>Dp110CAAX) resulted in increased phosphoAKT
levels. When dLipinRNAi was introduced into this genetic background (FBGal4>Dp110CAAX;
dLipinRNAi), levels of phosphoAKT were greatly reduced, although more phosphoAKT was
present in these samples compared to dLipin knockdown alone (FBGal4>dLipinRNAi). Tissue
samples from animals expressing only the Gal4 transgene were used as control. Fat body tissue
was dissected from feeding third instar larvae. Actin served as a loading control.

Increased AKT phosphorylation after PI3K overactivation was reduced in animals with
concomitant dLipin knockdown. Loss of dLipin activity overrode the effect that PI3K activation
had on AKT phosphorylation.
This experiment showed that even in cells expressing a constitutively active PI3K it is
sufficient to knockdown dLipin in order to downregulate insulin pathway activity. Reduced
dLipin activity was able to override the PI3K input on the insulin pathway downstream of PI3K.
At this point of my work I was able to place dLipin as a contributor to insulin pathway
activity, most likely acting at the level of PIP3 synthesis.
5.3. Can reduced dLipin activity be compensated for by inducing expression of insulin signaling
effectors upstream or downstream of PI3K?
To determine whether dLipin deficiency can be compensated for by expression of insulin
signaling cascade members downstream of PI3K, I overexpressed a constitutively active form of
AKT in the fat body in concert with dLipinRNAi. However when performing the crosses I
observed that AKT overexpression itself did not cause a phenotype, even when strongly
expressed with TubulinGal4 (data not shown). I used two different AKT fly lines with the same
result. I also tried to rescue the PIP3 phenotype by expression of chico (the Drosophila homolog
of the insulin receptor substrate) in cells with dLipin knockdown, but expression of chico alone
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and in concert with dLipinRNAi appeared to have no effect. Also, expression of InR concomitant
with dLipinRNAi in the fat body did not elicit an obvious effect. I furthermore tried to determine
whether dLipin has a direct influence on PI3K activity by investigating PI3K transition to the
cell membrane. To this end, I used an antibody that recognizes human p110 protein and that was
predicted to cross react with Drosophila p110. Unfortunately this antibody did not show a
specific reaction with Drosophila p110.
In conclusion, I was not able to determine whether expression of insulin signaling
cascade effectors downstream or upstream of PI3K can compensate for a reduction of dLipin
activity. To obtain additional evidence that dLipin interferes with insulin sensitivity in the fat
body I asked whether the reduction of PI3K and AKT activity observed after a decrease of
dLipin expression caused an increase in circulating sugars.
6. Circulating blood sugar levels are elevated in dLipin mutant animals
A hallmark of diabetes is the development of insulin resistance, which results in an
increase in circulating blood sugar in the presence of insulin. With the major metabolic tissue of
the developing larvae displaying signs of insulin insensitivity (Fig. 13 and 14), it seemed
reasonable to assume, that a disruption of fat body insulin sensitivity alone might be sufficient to
raise hemolymph sugar levels.
I measured hemolymph sugar levels of feeding third instar larvae with a
transheterozygous dLipin mutant background (dLipine00680/Df(3R)Exel7095). The major
circulating sugar of Drosophila melanogaster is trehalose, a sugar that can be converted to
glucose by the enzyme trehalase. Hemolymph of feeding larvae was treated with trehalase and
total glucose levels measured (Fig. 22).
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Fig. 22: Titers of circulating sugars are elevated in animals lacking dLipin. Hemolymph
samples were obtained from feeding third-instar larvae heterozygous for dLipine00680 or
Df(3R)Exel7095 (control) or transheterozygous dLipine00680/ Df(3R)Exel7095. Trehalose was
enzymatically converted to glucose and total glucose measured. Unpaired t-Test, *** p < 0.01;
error bars indicate standard error of the mean.

Measuring the levels of sugar in the hemolymph of mutant dLipin larvae established that
a reduction of dLipin activity leads to insulin resistance, as hemolymph sugar levels were
significantly increased (Fig. 22).
In summary, these data show that dLipin is necessary for proper insulin sensitivity in the
fat body, and that insulin resistance induced by a lack of dLipin activity in the fat body results in
elevated hemolymph sugar levels.
The next question(s) addressed was how dLipin activity itself was affected by insulin
signaling.
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7. dLipin levels are regulated by insulin signaling
Studies in adipocyte cell lines suggest an influence of insulin signaling on Lipin1’s
subcellular localization (Harris et. al. 2007, Peterfy et. al. 2009). It was demonstrated that Lipin1
phosphorylation following activation of insulin signaling leads to an accumulation of Lipin1 in
the cytoplasm. To test whether this was also the case for dLipin, I investigated the localization of
dLipin in the fat body of wandering third instar larvae after knockdown of insulin signaling.
7.1. dLipin levels, but not dLipin localization, are affected by a reduction in insulin signaling
I either expressed a dominant negative form of the regulatory subunit of PI3K
(PI3K21BHA) or a dominant negative form of the insulin receptor (InRDN) exclusively in the fat
body to reduce insulin pathway activity. Animals expressing the InRDN transgene displayed
reduced fat body cell size, but were otherwise viable and appeared to develop normally. In
contrast, animals expressing PI3K21BHA not only showed reduced cell size, but also suffered
from larval lethality; and the few larvae that reached the pupal stage died during metamorphosis.
This is consistent with a moderate reduction of insulin pathway activity with InRDN expression
and a stronger reduction of insulin pathway activity with the expression of PI3K21BHA. To
determine how expression of the transgenes affected dLipin expression and distribution, fat body
was stained with dLipin antibodies (Fig. 23).
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Fig. 23: dLipin levels, but not localization, are altered after knockdown of insulin pathway
activity. A) A dominant negative form of the regulatory subunit of PI3K (PI3K21BHA) was
expressed in the fat body (FBGal4>PI3K21BHA). Fat body tissue from third instar wandering
larvae was dissected and stained with dLipin antibody (red). Nuclei were visualized with DAPI
(blue). The same exposure time was used for all images. B) A dominant negative form of insulin
receptor (InRDN) was expressed in the fat body, and the tissue stained with dLipin antibody
(red). Nuclei were visualized with DAPI (blue). The same exposure time was used for all images.
Scale bar: 100µm.

Fig. 23 shows that dLipin localization was not affected by a reduction of insulin pathway
activity. It does appear, however, that overall levels of dLipin were reduced in fat body tissue
from animals with a strong knockdown of insulin pathway activity (FBGal4>PI3K21BHA). This
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experiment was also conducted with animals expressing InRDN (FBGal4>InRDN). The fat body
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Fig. 24: dLipin levels are reduced upon strong downregulation of insulin pathway activity.
Western analysis with dLipin antibody confirmed that dLipin levels are lowered in fat body
tissue after strong knockdown of insulin signaling (FBGal4>PI3K21BHA). The weaker insulin
phenotype of FBGal4; InRDN did not cause a decrease in dLipin levels. Fat body tissue from
w1118 animals served as a control. Wandering third instar larvae were dissected. Actin served as a
loading control.

The immunostaining results were corroborated by western analysis. dLipin antibody was
used to detect dLipin in fat body tissue from animals expressing either PI3K21BHA or InRDN in
the fat body. A clear reduction of dLipin was detectable after expression of PI3K21BHA,
whereas expression of InRDN appeared to have no effect on the amount of dLipin. Thus, insulin
pathway activity can influence dLipin protein levels, but does not appear to have an obvious
effect on subcellular localization of the protein.
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7.2. dLipin levels are not affected in cells with an overactivation of the insulin pathway
I was previously able to show that downregulation of insulin pathway activity leads to a
decrease in dLipin levels in fat body cells. Thus, it is plausible that an activation of insulin
signaling may have the opposite effect, namely an increase in dLipin levels. I conducted a
western blot analysis to test whether expression of Dp110CAAX has an effect on dLipin levels
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(Fig. 25). Expression of Dp110CAAX overstimulates the insulin pathway.
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Fig. 25: PI3K overactivation has no effect on dLipin levels. Western blot analysis with fat
body tissue from control animals (only FBGal4 transgene), FBGal4>dLipinRNAi animals,
FBGal4>Dp110CAAX animals and FBGal4>Dp110CAAX; dLipinRNAi animals showed that
overactivation of PI3K had no effect on dLipin levels, and that dLipinRNAi knockdown is
effective in FBGal4> Dp110CAAX; dLipinRNAi animals. Actin served as a loading control.
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Western analysis revealed that overactivating the insulin pathway via Dp110CAAX
expression has no discernible effect on dLipin levels in fat body cells.
8. Summary of part A Results
I was able to establish that dLipin influences insulin pathway activity in the larval fat
body. Cell-autonomous loss of dLipin activity resulted in a growth defect. PIP3 synthesis by
PI3K and, thus, PI3K activity was disrupted in cells lacking dLipin. The TORC2 mediated
phosphorylation of AKT was consequently negatively affected in fat body from animals with fat
body-specific dLipin knockdown and in fat body from transheterozygous dLipin mutants, which
indicates that insulin pathway activity downstream of PI3K was indeed downregulated.
Furthermore, it appeared that dLipin and InR act in concert in fat body development.
Hemolymph sugar levels were significantly increased in dLipin mutants, consistent with the
conclusion that loss of dLipin causes insulin resistance in the fat body. dLipin activity itself was
also influenced by a disruption of insulin signaling resulting in a reduction in dLipin abundance.
Upregulation of the insulin pathway on the other hand, did not alter dLipin levels. With regard to
narrowing down the target of dLipin in the canonical insulin pathway, I was able to show that
dLipin activity influences insulin pathway activity at the PIP3 synthesis step.
I was then interested in pinpointing possible mechanisms by which dLipin is able to enact
its effect on the insulin cascade.
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B. To elucidate the mechanism that underlies insulin resistance caused by reduced dLipin
activity
An unphysiological reduction of adipose tissue is called lipodystrophy; it is a condition
known to result in insulin resistance (Huang-Doran et. al, 2010). Lipodystrophy in mice can be
caused by a mutation in the lipin1 gene (Reue et al., 2000). Therefore, one possible explanation
for how dLipin influences insulin sensitivity in the fat body is through its PAP activity. A loss of
dLipin activity results in a reduction of PAP activity in the cell, which leads to an increase in PA
and a reduction in DAG, and hence lowered TAG content. Therefore it is possible that either
elevated PA levels or lowered DAG/TAG levels negatively affect insulin sensitivity of the cell.
1. Knockdown of GPAT4 or AGPAT3 mirrors dLipin knockdown with regard to PIP3 synthesis
To test whether insulin resistance caused by the lack of dLipin is a result of the ensuing
lipodystrophy, I examined PIP3 synthesis in fat body tissue from animals with RNAi-induced
knockdown of fat synthesis enzymes, GPAT4, AGPAT3 and DGAT2. These enzymes are
essential for TAG production. RNAi-induced knockdown was limited to the fat body, and
feeding third instar larvae were dissected. I observed a reduction of fat droplet size after
knockdown of GPAT4, knockdown of AGPAT3, but not with DGAT2 knockdown (Fig. 26,
DGAT2 knockdown data is not shown). These phenotypes mirrored the fat body-specific effects
of dLipin knockdown. This result then led me to look at PIP3 synthesis in fat body cells from
animals expressing GPAT4RNAi and AGPAT3RNAi (Fig. 26). In concert with a decrease in fat
droplet size I observed a loss of PIP3 membrane association upon GPAT4 or AGPAT3
knockdown. This phenotype strongly resembled the phenotype upon dLipin knockdown.
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PIP3-specific tGPH

FBGal4> GPAT4RNAi

FBGal4> AGPAT3RNAi FBGal4> dLipinRNAi

control

LipiTOX

Fig. 26: Knockdown of TAG synthesis enzymes leads to loss of PIP3 membrane association.
PIP3 was membrane associated in cells expressing the FBGal4 driver only (control). In fat body
cells from animals with GPAT4 and AGPAT3 knockdown (FBGal4>GPAT4RNAi and
FBGal4>AGPAT3RNAi), PIP3 was no longer detectable at the membrane, and fat droplet size
was strongly reduced. This mirrored the dLipin RNAi phenotype (FBGal4>dLipinRNAi). PIP3
was detected by tGPH (green) and fat droplets by LipiTOX (red). Feeding third instar larvae
were dissected. Scale bar: 100µm.

Results from this experiment point to TAG synthesis or fat content as the parameter that
influences insulin responsiveness, as PIP3 synthesis was disrupted in fat body cells upon RNAiinduced knockdown of not only dLipin, but two other enzymes of the glycerol-3-phosphate
pathway.
2. PAP activity of dLipin is critical for insulin pathway activity
To examine whether indeed the PAP activity of dLipin and not its transcriptional coregulator activity is required for normal insulin sensitivity of fat body cells, I generated two
mutant forms of dLipin. In one form, the amino acid residue within the PAP motif at position
812 was altered from aspartate to glutamate (D812E) (ΔPAPdLipin). In the other form, the
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putative nuclear localization signal (ΔNLSdLipin) at position 276-281 was deleted. Thus,
ΔPAPdLipin should not exhibit PAP activity, and ΔNLSdLipin should not translocate to the
nucleus and hence should not be able to function as a transcriptional co-regulator. I conducted
co-expression experiments with these dLipin contructs and the dLipinRNAi transgene in the fat
body. If indeed the PAP activity of dLipin is responsible for modulating insulin pathway activity,
then expression of ΔPAPdLipin should not rescue the loss of PIP3 synthesis in animals with
RNAi-induced dLipin knockdown. On the other hand, if the co-regulator activity of dLipin is
responsible, then expression of ΔNLSdLipin should not rescue. As a positive control I expressed
a WTdLipin construct. Before I started the PIP3 rescue experiments, I had to establish the fact
that ΔNLSdLipin does not enter the nucleus and that ΔPAPdLipin exhibits no PAP activity.
2.1. Characterization of ΔNLSdLipin and ΔPAPdLipin

ΔNLSdLipin was expressed concomitantly with TORRNAi in the fat body, and subsequent
changes in subcellular localization examined. Knockdown of TOR activity in a wildtype genetic
background results in a translocation of dLipin from the cytoplasm into the nucleus (Fig. 27
upper right panel, Fig. 34). This important finding will be further documented in Part C.
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Fig. 27: ∆NLSdLipin does not enter the nucleus and prevents endogenous dLipin from
entering the nucleus. ∆NLSdLipin was expressed in the fat body concomitantly with TORRNAi.
Knocking down TOR leads to a translocation of dLipin (red) into the nucleus (arrows) as
confirmed by double-staining with DAPI (blue). When co-expressing TORRNAi and ∆NLSdLipin
this translocation was no longer observed, indicating that ∆NLSdLipin not only cannot enter the
nucleus, but also inhibits the endogenous dLipin from entering the nucleus. Scale bar: 100µm.
	
  

The results of this experiment confirmed that the ΔNLSdLipin was not able to translocate
to the nucleus. Furthermore, it caused a dominant negative phenotype by prohibiting endogenous
dLipin from entering the nucleus.
To verify that ΔNLSdLipin retains PAP activity, and that ΔPAPdLipin lost PAP activity,
I set up rescue experiments wherein I expressed WTdLipin, ΔNLSdLipin and ΔPAPdLipin in the
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fat body of tranheterozygous dLipin mutant animals (dLipine00680/ Df(3R)Exel7095) and looked
for improvements in fat body morphology.

dLipine00680/ Df(3R)Exel7095

dLipine00680/ Df(3R)Exel7095;
FBGal4> ∆NLSdLipin!

dLipine00680/ Df(3R)Exel7095;
FBGal4> ∆PAPdLipin!

dLipine00680/ Df(3R)Exel7095;
FBGal4> WTdLipin!

Fig. 28: Expression of mutant and wildtype dLipin constructs in dLipin mutant background
rescues defects in fat body morphology. WTdLipin, ΔNLSdLipin and ΔPAPdLipin were
expressed in transheterozygous dLipin mutant (dLipine00680/ Df(3R)Exel7095) animals.
Expression was limited to the fat body. Fat body defects visible in the dLipin mutant are rescued
by expression of WTdLipin, and ΔNLSdLipin but not ΔPAPdLipin. Fat droplet morphology is
visualized by Bodipy staining (green) and nuclei are stained with DAPI (blue). Scale bar:
100µm.

Expression of WTdLipin and ΔNLSdLipin rescued the fat body defects observed in dLipin
mutants. This indicates that, like WTdLipin, ΔNLSdLipin possesses normal PAP function. Fat
droplet size was increased and cell shape polygonal after expression of these two constructs.
ΔPAPdLipin on the other hand was not able to compensate for loss of PAP activity in dLipin
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mutants. The fat body defects observed in dLipin mutants were still present after expression of

ΔPAPdLipin. These data are consistenet with a lack of PAP activity in the ΔPAPdLipin
construct. .
2.1.1. Expression of any dLipin construct in the fat body alone does not rescue developmental
defects
While performing rescue experiments, I noted that expression of any of the dLipin
constructs in the fat body alone was not able to rescue lethality and developmental delay of
dLipin mutant animals. To examine rescue effects, I set up crosses and compared the formation
of pupae by transheterozygous dLipin mutants and transheterozygous dLipin mutants with
concomitant expression of either WTdlipin or ΔNLSdLipin or ΔPAPdLipin in the fat body. I set
up an individual rescue cross for each single dLipin construct (WTdlipin or ΔNLSdLipin or

ΔPAPdLipin). As both genotypes (control: Df/Rb; Gal4; experimental genotype: Df/Rb; Gal4/
WTdlipin or Df/Rb; Gal4/ ΔNLSdLipin or Df/Rb; Gal4/ ΔPAPdLipin) emerge from the same
cross, I knew the expected genotype frequency for each genotype. I compared the number of
pupae with control genotype (dLipin mutant: Df/Rb; WTdlipin or ΔNLSdLipin or ΔPAPdLipin) to
the number of pupae with experimental genotype (Df/Rb; Gal4/ WTdlipin or Df/Rb; Gal4/

ΔNLSdLipin or Df/Rb; Gal4/ ΔPAPdLipin). I was thus able to use pairwise Chi-square analyses
to score for significant differences between control and experimental genotype. dLipin
transheterozygous animals served as a control, thus I set the number of pupae formed by these
animals as 100%. For a more detailed explanation please refer to Materials and Methods section.
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Fig. 29: Expression of WTdLipin, Δ NLSdLipin and Δ PAPdLipin in the fat body of dLipin
mutant animals (dLipine00680/ Df(3R)Exel7095, Df/Rb) does not rescue larval lethality. To
screen for larval lethality, I scored pupation rates of dLipin mutant animals and dLipin mutant
animals expressing one of three dLipin constructs (dLipine00680/ Df(3R)Exel7095; FBGal4/
WTdLipin, dLipine00680/ Df(3R)Exel7095; FBGal4/ ΔNLSdLipin, dLipine00680/ Df(3R)Exel7095;
FBGal4/ ΔPAPdLipin ). Expression of the dLipin constructs was restricted to the fat body. No
rescue effects on survival were present for either dLipin construct, in fact, expression of
ΔPAPdLipin lowered pupation rates significantly. The transheterozygous dLipin mutant
genotype (dLipine00680/ Df(3R)Exel7095) is abbreviated to Df/Rb in the graph. Two tailed ChiSquare Test, *** p< 0.0001.

Expression of dLipin rescue constructs in the fat body of dLipin mutants alone did not
rescue larval lethality of dLipin mutants. No significant increase in the number of pupae formed
was observed for either dLipin construct. To the contrary, expression of ΔPAPdLipin seemed to
have a dominant negative effect, as pupation rates of these animals were even lower than those
of dLipin mutant control animals. Furthermore, the dominant-negative effect observed after

ΔPAPdLipin expression is a positive indicator that the transgene is indeed expressed. I also set
up a rescue experiment with the daGal4 driver, but no rescue effects were observed.
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2.1.2. Expression of ΔPAPdLipin results in a dominant negative phenotype
To further investigate the possibility that expression ΔPAPdLipin results in a dominant
negative effect, I expressed this construct with a strong ubiquitous driver, TubulinGal4
(TubGal4), in a dLipin mutant background and in a wild-type genetic background. No difference
in lethality was observed after ubiquitous ΔPAPdLipin expression in a wild-type genetic
background (data not shown), but ubiquitous expression of ΔPAPdLipin in a dLipin mutant
background significantly reduced viability (Fig. 30). Both genotypes resulted from the same
cross with known genotype frequencies, hence I was able to use Chi-Square analyses to score for
statistical significance.

***
	
  

Fig. 30: Ubiquitous expression of Δ PAPdLipin in dLipin mutant background causes
dominant negative effect. Expression of ΔPAPdLipin driven by TubulinGal4 in a dLipin mutant
genetic background (dLipine00680/ Df(3R)Exel7095; ΔPAPdLipin/TubGal4) resulted in reduced
viability. The number of larvae reaching the pupal stage was significantly reduced in animals
expressing ΔPAPdLipin, compared to dLipin mutants (dLipine00680/ Df(3R)Exel7095, Df/Rb). The
transheterozygous dLipin mutant genotype (dLipine00680/ Df(3R)Exel7095) is abbreviated as
Df/Rb in the graph. Two tailed Chi-Square Test, *** p= 0.0009.
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Expression of a dLipin construct with a mutation in the motif responsible for its PAP
activity resulted in a dominant negative phenotype with regard to viability only when expressed
in a dLipin mutant genetic background, but not when expressed in a wild-type genetic
background.
2.2.2. PIP3 synthesis depends on PAP activity
To determine whether the impact dLipin has on PI3K activity requires its transcriptional
co-regulator activity or its PAP activity and to further explore whether it is indeed fat synthesis
that is key to insulin sensitivity of the fat body, I set up crosses in which I expressed WTdLipin,

ΔNLSdLipin and ΔPAPdLipin in a background of fat body-specific dLipin knockdown (FBGal4>
dLipinRNAi; tGPH/WTdLipin; FBGal4>dLipinRNAi; tGPH/ΔNLSdLipin; FBGal4>dLipinRNAi;
tGPH/ΔPAPdLipin). To monitor PIP3 synthesis I expressed the PIP3 marker tGPH. I had already
shown that dLipin knockdown interferes with PIP3 synthesis (Fig. 13, Fig. 14). Expression of
WTdLipin in a dLipin knockdown background should rescue the loss of PIP3 from the cell
membrane. Expression of this construct therefore served as a positive control. ΔNLSdLipin and

ΔPAPdLipin expression may, or may not reconstitute PIP3 synthesis in animals with loss of
dLipin activity. Results of this experiment are depicted in Fig. 31.
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LipiTOX

PIP3 specific PH-GFP

FBGal4> dlipinRNAi; dLipinWT

FBGal4> dlipinRNAi; dLipin∆NLS

FBGal4> dlipinRNAi; dLipin∆PAP

Fig. 31: PAP activity of dLipin is required for PIP3 synthesis. Expression of both WTdLipin
and ΔNLSdLipin is sufficient to restore PIP3 synthesis after dLipin knockdown
(FBGal4>dLipinRNAi; WTdLipin and FBGal4>dLipinRNAi; ΔNLSdLipin). PIP3 was again
located at the cell membrane (arrows). In contrast, expression of ΔPAPdLipin could not rescue
the loss of PIP3 synthesis in animals with a loss of dLipin activity (FBGal4>dLipinRNAi;
ΔPAPdLipin). PIP3 was not located at the cell membrane. PIP3 was visualized by expression of
PIP3 marker tGPH (green). Furthermore, fat droplet size was increased in fat body tissue from
animals with WTdLipin and ΔNLSdLipin expression but not in animals with of ΔPAPdLipin
expression. Fat droplet morphology was visualized by LipiTOX staining (red). Nuclei were
stained with DAPI (blue). Scale Bar: 100 µm.
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The results show that PAP activity is required for PIP3 synthesis in the fat body.
Expression of WTdLipin and ΔNLSdLipin was able to reconstitute PIP3 synthesis in fat body
cells in concert with rescuing the reduction of fat droplet size. Expression of ΔPAPdLipin on the
other hand, could not reestablish PIP3 synthesis or increase the size of fat droplets. Therefore it
is likely that fat content and PIP3 synthesis are linked and that dLipin’s transcriptional coregulatory function is not responsible for the effects on the insulin pathway.
2.2.3. Expression of AtPAH1 in animals with fat body-specific dLipin knockdown
To validate the results described in the previous section, I attempted to rescue PIP3
synthesis by expressing one of the Arabidopsis thaliana lipin homologs, AtPAH1. The encoded
Arabidopsis Lipin protein does not seem to function as transcriptional co-regulators, only as
phosphatidate phosphatase enzymes as sequence alignments show that Arabidopsis Lipins lack a
co-regulator motif (Peterfy et al., 2001). Using the AtPAH1 lipin homolog one can thus
investigate whether PAP activity alone is enough to restore insulin sensitivity in dLipin deficient
animals.	
  Fat body-specific expression of AtPAH1 from a UAS construct did not rescue fat body
defects following dLipin knockdown (Fig. 32). This might have been due to either failed
construct expression or due to the fact that dLipin and AtPAH1 have diverged to a point where
functions are no longer conserved between the two encoded proteins. Further experimentation is
required to distinguish between these possibilities.
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AtPAH1
	
  

Fig. 32: The Arabidopsis thaliana homolog of dLipin cannot rescue the loss of PIP3
membrane association after dLipin knockdown. The Arabidopsis homolog of Lipin was
expressed to rescue the loss of PIP3 from the cell membrane. No rescue of the dLipinRNAi
phenotype was observed.	
  The	
  Arabidopsis homolog of Lipin was not able to rescue either the
reduced fat droplet size (red) or the loss of PIP3 from the cell membrane (green). Scale bar
100µm.

3. Dp110 transcript levels are reduced following dLipin knockdown
dLipin in its function as a transcriptional co-regulator could manipulate expression levels
of genes involved in the insulin signaling cascade, and thus influence insulin pathway activity.
Previously I had established that dLipin is able to attenuate Dp110 function in the fat body
(5.2.1.). I therefore investigated whether Dp110 expression levels were reduced in animals with
knockdown of dLipin in the fat body (FBGal4>dLipinRNAi). qRT-PCR was conducted and
transcript levels of Dp110 quantified (Fig. 33).
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Fig. 33: Levels of Dp110 RNA are reduced following dLipin knockdown. Levels of mRNA
encoding the PI3K subunit Dp110 were reduced 2-fold in fat body of larvae expressing a
dLipinRNAi transgene. Dp110 RNA was quantified by qRT-PCR; rp49 RNA served as the
normalizer. The difference between control (w1118) and knockdown animals was statistically
significant. RNA was extracted from fat body tissue. * p< 0.05.

Knockdown of dLipin in the fat body led to a moderate reduction of Dp110 transcript
levels, suggesting that dLipin participtes directly or indirectly in the transcriptional regulation of
the Dp110 gene.
4. Summary part B Results
I was able to establish a link between TAG synthesis and insulin pathway activity. Loss
of dLipin’s PAP activity was responsible for reduced PIP3 synthesis following dLipin
knockdown. Nuclear dLipin activity might play a contributory role, but did not appear to have a
major influence on insulin pathway activity.
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C. To elucidate the relationship between dLipin and TOR in D. melanogaster
One of the downstream targets of insulin signaling is the TOR kinase, more specifically
TOR Complex 1 (TORC1). Having shown that dLipin is an important contributor to insulin
pathway activity in the fat body of developing larvae, I proceeded to illuminate dLipin’s
potential interaction with the TOR signaling pathway.
In mammals, mTOR signaling is implicated in lipid biosynthesis (Laplante and Sabatini,
2009) and is responsible for Lipin1 phosphorylation (Huffman et al., 2002). So far, no interaction
studies have been conducted for dLipin and TOR interaction(s) in Drosophila melanogaster. As
was the case with insulin signaling, I focused my research on the major metabolic organ of the
developing larvae, the fat body.
1. dLipin levels and subcellular localization are dependent on TORC1 activity
In mammals Lipin1 was shown to be posttranslationally modified in a TOR-dependent
manner (Huffman et al., 2002). Numerous rapamycin-sensitive phosphorylation sites within
Lipin1 were identified. Rapamycin acts as a TOR antagonist. Posttranslational modifications of
Lipin1 in response to TOR signaling are connected to changes in Lipin1’s subcellular
localization (Peterson et al., 2011). Therefore, I investigated the spatial distribution of dLipin
after TOR knockdown (FBGal4>TORRNAi).
I looked at dLipin in fat body cells from third instar wandering larvae (Fig. 34). While
investigating subcellular localization, I noticed that overall dLipin levels appeared to be lowered
after TOR knockdown. To measure overall dLipin levels, I conducted a western analysis with fat
body tissue from animals expressing TORRNAi in the fat body (FBGal4>TORRNAi) probed with
dLipin antibodies (Fig. 34).
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Fig. 34: TOR knockdown results in diminished levels of dLipin and translocation of dLipin
into the nucleus in fat body tissue of third instar larvae. A) TORRNAi was expressed in the
fat body (FBGal4>TORRNAi) and dLipin detected using dLipin antibody (red). Cells were
counterstained with DAPI to visualize the nuclei. dLipin is noticeably more concentrated in the
nuclei compared to the cytoplasm. Furthermore, dLipin levels seemed to be decreased compared
to the control (w1118). Scale Bar 100µm. B) Reduction of dLipin levels was also observed when
western blot analysis was conducted with fat body tissue samples from control (w1118) and
experimental animals (FBGal4>TORRNAi). The blot was treated with dLipin antibody and Actin
was used as a loading control.

Subcellular localization and total dLipin levels are indeed influenced by TOR activity. A
reduction of TOR resulted in lowered dLipin levels and the residual dLipin translocated into the
nucleus, leaving little dLipin in the cytoplasm. It is interesting to note that although dLipin levels
were strongly reduced, fat droplet size appeared normal (data not shown). Cell size of fat body
cells after TOR knockdown was smaller compared to cells from control animals, a known effect
of TOR deficiency (Oldham et al., 2000).
A knockdown of TOR not only affects TORC1 but also TORC2, as TOR is an integral
member of both complexes. To determine whether the effects observed were due to a loss of
TORC1 or TORC2 activity, I studied the interaction of dLipin with raptor and rictor. Raptor is a
member of TORC1 only, and Rictor only associates with TORC2 (Loewith and Hall, 2011).
raptor and rictor were specifically downregulated using RNAi in the larval fat body, and fat
body cells examined for dLipin levels and localization. I did not observe any altered phenotype
after rictor knockdown. To determine if rictorRNAi was effective, I analyzed at S505
phosphoAKT levels in fat body cells expressing rictorRNAi and control cells. S505
phosphorylation is catalyzed by TORC2, which means that if rictor knockdown is efficient, AKT
phosphorylation should be lowered. I was not able to detect an effect on AKT phosphorylation
(data not shown). Thus, RNAi-mediated knockdown of rictor seemed to be inefficient. However,
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raptor knockdown was effective as fat body cell size of animals expressing raptorRNAi was
smaller. Next I examined the amount and distribution of dLipin protein in fat body tissue after
raptorRNAi expression (Fig. 35).
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Fig. 35: raptor knockdown results in diminished levels of dLipin and translocation of
dLipin into the nucleus of fat body cells of third instar larvae. A) raptorRNAi was expressed
in the fat body (FBGal4>raptorRNAi) and dLipin detected using dLipin antibody (red). Cells
were counterstained with DAPI to visualize the nuclei. dLipin was noticeably more concentrated
in the nuclei compared to the cytoplasm. Furthermore, dLipin levels seemed to be decreased
compared to control (w1118). Scale Bar 100µm. B) Reduction of dLipin levels was also observed
when western blot analysis was conducted with fat body tissue samples from control (w1118) and
experimental animals (FBGal4>raptorRNAi). The blot was incubated with dLipin antibody and
actin was used as a loading control.

Comparing Fig. 34 and Fig. 35, it is clear that the effects of raptor and TOR knockdown
were identical. It therefore appears that the phenotype observed after TOR knockdown is most
likely caused by a decrease in TORC1 activity. This experiment thus linked dLipin activity and
TORC1 signaling. Nuclear translocation of dLipin indicates an increased need for dLipin’s
nuclear function under conditions when TORC1 activity is low. In mammalian and yeast
systems, it has been shown that Lipin acts as a transcriptional co-regulator (Donkor et al., 2009;
Finck et al., 2006; Koh et al., 2008; Santos-Rosa et al., 2005). However, so far no nuclear
function has been demonstrated for dLipin.
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1.1. Binding of dLipin to polytene chomosomes
One way to determine whether dLipin is likely to affect transcriptional activity is by
looking at the binding of dLipin to chromosomes. Therefore, I stained chromosomes of fat body
and salivary gland cells with dLipin antibody. As salivary gland chromosomes go through more
cycles of endoreplications, they contain a higher DNA content and are bigger and easier to stain
than fat body chromosomes. Hence, I expressed dLipin in the salivary gland and tried to detect
target loci of dLipin binding. To express dLipin in the salivary gland, I used a ubiquitous heat
shock driver. I looked at chromosomes at different time points after heat shock induction to
analyze binding at different titers of dLipin protein (Fig. 36).
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dLipin

0 hs after heat shock

DAPI

2 hs after heat shock

DAPI

24 hs after heat shock

DAPI

hsGal4> dLipin
dLipin
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dLipin
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Fig. 36: Chromosome staining of salivary gland chromosomes does not reveal specific
binding loci for dLipin. dLipin expression was induced by heat shock (hsGal4>dLipin), and
salivary gland chromosomes were stained with dLipin antibody (purple). dLipin antibody
staining was conducted immediately after heat shock treatment, 2 hours after heat shock and 24
hours after heat shock. DNA was stained with DAPI. No binding sites for dLipin were detected.
Scale Bar 50µm.

I was not able to detect any specific signals on chromosomes for dLipin. Only
background staining of the dLipin antibody was detected. As dLipin did not appear to bind to
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salivary gland chromosomes, I proceeded with fat body chromosome staining. I prepared
chromosome squashes with wild-type fat body chromosomes, and with fat body chromosomes
from animals expressing TORRNAi (FBGal4>TORRNAi). I was not able to detect any specific
loci of dLipin binding for any of the genotypes (data not shown).
To further elucidate the relationship between dLipin and TORC1, I conducted genetic interaction
studies.
2. dLipin and raptor interact in larval development
I focused on raptor to test for a possible genetic interaction between TORC1 and dLipin.
Raptor functions as an integral part of TORC1. Thus raptor knockdown will diminish TORC1
activity. I concomitantly expressed dLipinRNAi and raptorRNAi with FBGal4, thereby achieving
a fat body-specific knockdown of both RNAi targets. I examined fat body morphology, PIP3
localization and larval development of both single and double-knockdown animals.
2.1. raptor and dLipin together regulate larval development
I noticed a strong decrease of larval size after dLipin and raptor double knockdown.
dLipin knockdown animals behaved and looked like wild-type animals. Animals with only
raptor knockdown showed a minor delay and slightly decreased larval size. Larvae pupariate 1-2
days later compared to dLipin knockdown animals. Raptor knockdown larvae develop into pupae
that die before adult flies can eclose. Thus, knockdown of raptor leads to a developmental delay.
This developmental delay was further enhanced in animals with combined dLipin and
raptor knockdown as they never entered the wandering stage and perished in the food between
8-12 days after egg deposition (AED) (Fig. 37). Larvae were translucent, which suggests that fat
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body tissue was underdeveloped. Figure 37 documents the developmentof larvae of the different
genotypes (Fig. 37).

FBGal4> dLipinRNAi; raptorRNAi

FBGal4> raptorRNAi

FBGal4> dLipinRNAi

Fig. 37: Fat body specific knockdown of dLipin and raptor together results in a
developmental delay and larval lethality. Animals expressing dLipinRNAi develop normally
(FBGal4>dlipinRNAi); animals with raptorRNAi are delayed by 1-2 days (FBGal4>
raptorRNAi). This delay is further enhanced in animals with concomitant dLipin knockdown
(FBGal4>dLipinRNAi; raptorRNAi). Animals displayed a slow growth rate, hence their
diminutive body size. They never entered the wandering stage and never formed pupae. Animals
were photographed 5 days AED.

Knockdown of dLipin in a raptor deficient background enhanced the developmental
delay observed after raptor knockdown. A possible explanation for this is that dLipin activity is
further reduced in animals with concomitant dLipin/raptor knockdown, leading to a severe fat
body underdevelopment. As dLipin knockdown also results in a down regulation of insulin
pathway activity, the developmental delay could alternatively be explained by reduced insulin
pathway activity in dLipin/raptor knockdown animals. Another possibility is that further reduced
TORC1 activity in animals with concomitant raptor and dLipin knockdown could have elicited
the enhancement in developmental delay.

	
  

127

2.2. dLipin and raptor interaction affects fat body morphology
raptor knockdown led to a cellular growth defect that resulted in smaller fat body cells.
Fat body cells continued to be smaller until pupariation, an indication that the smaller cell size
resulted from a true growth defect rather than developmental delay. Insulin pathway activity
following raptor knockdown appeared to be unaffected, as PIP3 membrane association was
conserved. When combined with dLipin knockdown, fat body cell size was further reduced and
PIP3 membrane association was no longer detectable (Fig. 38). The fat body seemed to be
substantially underdeveloped. The fact that PIP3 synthesis was not reconstituted in animals with
dLipin knockdown by concomitant raptor knockdown indicates that insulin resistance in animals
with dLipin knockdown is not caused by TORC1 overactivation, as is the case in type2 diabetes.
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PIP3-specific PH-GFP

LipiTOX

DAPI

FBGal4>dLipinRNAi

FBGal4>raptorRNAi

FBGal4>dLipinRNAi; raptorRNAi

Fig. 38: Simultaneous dLipin and raptor knockdown affects fat body development. Fat body
of larvae (5 days AED) was dissected and fat droplet morphology visualized by LipiTOX
staining (red). PIP3 localization was determined by expression of the PIP3 reporter tGPH
(green). DAPI was used to stain cell nuclei. The size of fat body cells from animals expressing
raptorRNAi (FBGal4>raptorRNAi) is reduced when compared to dLipin knockdown alone
(FBGal4>dLipinRNAi). This phenotype is strongly enhanced by concomitant loss of dLipin
(FBGal4>dLipinRNAi; raptorRNAi). PIP3 localization is not altered after raptor knockdown,
but dLipin knockdown as well as dLipin knockdown with concomitant raptor knockdown,
showed a loss of PIP3 membrane association. Scale Bars: 100 µm.
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To further document the decrease in cell size observed after dLipin knockdown with
concomitant raptor knockdown, I measured cell area, nuclear area and nucleocytoplasmic ratio
(Fig. 39).
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Fig. 39: Concomitant knockdown of dLipin and raptor in the fat body leads to diminished
cell area and increased nucleocytoplasmic ratio. A) Cell area was measured in animals with
dLipin knockdown (FBGal4>dLipinRNAi), animals with raptor knockdown
(FBGal4>raptorRNAi) and animals carrying both knockdown transgenes (FBGal4>dLipinRNAi;
raptorRNAi). Cell area of timed larvae was measured (5 days AED). Cell area after raptor
knockdown is significantly reduced compared to dLipin knockdown cell area. When dLipinRNAi
is introduced into raptorRNAi the growth deficit is significantly enhanced compared to
dLipinRNAi as well as to raptorRNAi knockdown. This significance between raptorRNAi cell
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size and dLipinRNAi/raptorRNAi cell size is indicated by the ***	
  above	
  the	
  bracket.	
  B) Nuclear
area measured in animals with dLipin knockdown (FBGal4> dLipinRNAi), animals with raptor
knockdown (FBGal4> raptorRNAi) and animals carrying both knockdown transgenes (FBGal4>
dLipinRNAi; raptorRNAi). Nuclear area of timed larvae was measured (5 days AED). Nuclear
area after raptor knockdown is significantly reduced compared to dLipin knockdown. This
reduction in nuclear size is only slightly more pronounced after combining both raptor and
dLipin knockdown, but no statistical difference was found. C) Nucleocytoplasmic ratio of timed
larvae (5 days AED) was measured. The ratio was significantly increased after knockdown of
dLipin in concert with raptor, whereas no significant difference could be found between the
single knockdowns. Error bars indicate standard deviation. Unpaired t –Test, ∗∗∗P < 0.0001.

Fat body cell size of larvae (5 days AED) was reduced in animals with raptor
knockdown; a phenotype further enhanced in animals with concomitant dLipin knockdown.
Nuclear area of larvae with raptor knockdown in the fat body was also significantly smaller
when compared to dLipin knockdown nuclei. Knocking down both dLipin and raptor did not
significantly decrease nuclear size any further, but had a strong effect on cytoplasmic growth.
This resulted in a strongly increased nucleocytoplasmic ratio of cells after concomitant dLipin
and raptor knockdown. raptor knockdown, which affected cytoplasmic growth and DNA
replication to the same extent, led to a proportional growth defect.
The data presented suggests that a concomitant reduction of dLipin and TORC1 activity
strongly reduces cytoplasmic growth of cells, but not DNA replication. This effect might be
caused by the reduced insulin pathway activity after dLipin knockdown in cells with concomitant
raptor knockdown.
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2.3. Interaction between raptor and dLipin is dependent on the PAP activity of dLipin, but not
the co-regulator activity
As mentioned before, dLipin has the ability to act in two different ways, as a PAP
enzyme and a co-regulator of transcription. To determine whether it was indeed the loss of
dLipin’s PAP activity or its co-regulator activity that resulted in enhanced developmental delay
and reduced cytoplasmic growth in animals with concomitant dLipin and raptor knockdown, I
co-expressed WTdLipin, ΔNLSdLipin or ΔPAPdLipin with dLipinRNAi and raptorRNAi in the fat
body and examined developmental delay and fat body cell size.
2.3.1. dLipin is no longer detectable in the nucleus after concomitant raptor/dLipin knockdown
As shown before (Fig. 35), dLipin migrates into the nucleus upon raptor knockdown.
Thus, a loss of nuclear activity of dLipin in dLipin/raptor double knockdown animals might
explain the enhanced phenotype. To test this, I first determined that indeed no dLipin is present
in nuclei of animals with simultaneous dLipin/raptor knockdown. Nuclear localization of dLipin
was greatly reduced in animals with concomitant reduction of dLipin and Raptor activity (Fig.
40).
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dLipin

FBGal4> raptorRNAi

FBGal4> dLipinRNAi: raptorRNAi
dLipin + DAPI

Fig. 40: dLipin is reduced in the nucleus after concomitant knockdown of dLipin and
raptor. dLipin was detected using dLipin antibody in fat body of feeding third instar larvae.
Larvae either expressed only raptorRNAi (FBGal4>raptorRNAi), or only raptorRNAi as well as
dLipinRNAi (FBGal4>dLipinRNAi; raptorRNAi) in the fat body. After raptor knockdown,
dLipin was concentrated in the nucleus. This nuclear concentration of dLipin was no longer
present in most cells after simultaneous knockdown of dLipin and raptor. dLipin appears red and
nuclei are stained with DAPI and appear blue. Scale Bar: 100µm.

2.3.2. PAP activity mediates the raptor/dLipin interaction in larval development
To test whether the deficit in nuclear activity of dLipin is responsible for the growth rate
defect observed after simultaneous dLipin/raptor knockdown or whether a reduction in PAP
activity causes the developmental delay, I tried to rescue larvae with dLipin/raptor knockdown
by individually expressing WTdLipin, ΔNLSdLipin and ΔPAPdLipin in the fat body of these
animals. I timed the larvae and looked at the morphology of whole larvae 5 days AED.
	
  

134

FBGal4> dLipinRNAi;
raptorRNAi

FBGal4> dLipinRNAi;
raptorRNAi/∆PAPdLipin

FBGal4> dLipinRNAi;
raptorRNAi/∆NLSdLipin

FBGal4> dLipinRNAi;
raptorRNAi/WTdLipin

Fig. 41: Developmental delay caused by simultaneous raptor/dLipin knockdown can be
rescued by expression of WTdLipin and Δ NLSdLipin, but not Δ PAPdLipin. Concomitant
knockdown of dLipin and raptor in the fat body resulted in a severe developmental delay. This
delay can be reversed by expression of WTdLipin and ΔNLSdLipin. Larval size was significantly
bigger when compared to dLipin/raptor double knockdown animals. Expression of dLipin
lacking PAP activity, ΔPAPdLipin, was not able to reverse the developmental delay. Larvae were
timed and pictures taken 5 days AED.

The enhanced developmental delay observed after simultaneous knockdown of dLipin
and raptor in the fat body was reversed after expression of WTdLipin and ΔNLSdLipin. Larval
size was significantly increased in these animals and animals underwent pupariation. However,
expression of ΔPAPdLipin did not rescue the enhanced developmental delay. Larval size was the
same as after the dLipin/raptor knockdown. This suggests that loss of PAP activity was
responsible for the severe developmental delay observed after dLipin/raptor double knockdown.
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2.3.3. PAP activity mediates the raptor/dLipin interaction with regard to fat body development
To verify that loss of PAP activity is responsible for the enhanced cell growth defect after
concomitant dLipin/raptor knockdown, I expressed WTdLipin, ΔNLSdLipin and ΔPAPdLipin in
raptor/dLipin double knockdown animals. Furthermore, distance between neighboring nuclei
was measured as an estimate for cell size. It was not possible to measure cellular area directly, as
cell boundaries were not visible in animals with FBGal4>dLipinRNAi; raptorRNAi and
FBGal4>dLipinRNAi; raptorRNAi/ΔPAPdLipin genotypes.
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Fig. 42: Fat body cell size of larvae with dLipin and raptor knockdown is rescued by
expression of WTdLipin and Δ NLSdLipin, but not Δ PAPdLipin. A) Expression of raptorRNAi
in the fat body resulted in a growth defect reflected by smaller cell size. dLipin knockdown in the
fat body did not cause growth defects. When combining dLipin and raptor knockdown in the fat
body, cell size was further decreased. Expression of WTdLipin and ΔNLSdLipin, but not
ΔPAPdLipin increased cell size significantly. Larvae were timed (5 days AED) and fat body
tissue stained with Bodipy (green) to visualize fat droplets, and DAPI (blue) to visualize cell
nuclei. Scale Bar: 100µm. B) When expressing WTdLipin or ΔNLSdLipin in dLipin/raptor
knockdown fat body cells, the reduction in cell size after double knockdown was no longer
present. Instead, cells were the same size as raptor knockdown cells. Expression of ΔPAPdLipin
did not rescue the growth defect. Error bars reflect SD. Unpaired t –Test, ∗∗∗ p< 0.0001.

Reduced size of fat body cells observed after raptor knockdown was enhanced by
concomitant dLipin knockdown. This was no longer the case when either WTdLipin or

ΔNLSdLipin were expressed in the knockdown animals. Thus, WTdLipin and ΔNLSdLipin were
capable of rescuing the enhancement. However, they were not able to compensate for the loss of
raptor activity, as cell size after WTdLipin and ΔNLSdLipin expression was not significantly
increased compared to cell size after raptor knockdown alone.
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The observation that expression of WTdLipin and ΔNLSdLipin, but not ΔPAPdLipin, can
abolish the enhancement of fat body defects strongly suggests that loss of PAP activity, but not
of the transcriptional co-regulator activity of dLipin caused a cytoplasmic growth defect in
animals with concomitant raptor knockdown.
3. Overactivation of TOR activity in the fat body
I pursued two approaches to determine whether elevated TOR activity can rescue
phenotypes observed after dLipin knockdown. First, I tried to activate TOR in the larval fat body
of animals with dLipin knockdown by simultaneously knocking down both Tsc1 and Tsc2. Both
Tsc1 and Tsc2 function as inhibitors of TORC1 activity. Thus, downregulation of Tsc1 and Tsc2
should activate TORC1 signaling. Unfortunately, I was not able to observe any effect of Tsc1
and Tsc2 knockdown alone on cell morphology. TORC1 overactivation should result in cell
overgrowth. Hence, efficient Tsc1 or Tsc2 knockdown should have resulted in cell overgrowth.
However, I was not able to detect any growth effects. Second, I tried to activate TOR by
overexpressing the TORC1 activator Rheb in animals of the genotype FBGal4/dLipinRNAi;
Rheb/InRdom.neg. Expression of Rheb alone did not lead to any discernible growth effect in fat
body tissue. Hence, expression of Rheb was not able to activate TORC1.
I was not able to achieve TORC1 activation either by knocking down its inhibitors or activating
its activators.
4. dLipin deficiency does not affect TORC1 activity
At this point I had established that a strong interaction exists between dLipin and TORC1
(Raptor). I was able to show that dLipin protein level and dLipin’s subcellular localization
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depend on TORC1 activity and that a reduction of dLipin’s PAP activity in a raptor-deficient
background strongly enhances developmental delay and cell growth defects.
The enhancement of the raptor phenotype could result from a further decrease of TORC1
activity following dLipin knockdown. To measure TORC1 activity, I assayed phosphorylation
levels of the TOR target 4EBP1 an inhibitor of translation (Hara et. al., 1997). 4EBP1
phosphorylation deactivates 4EBP1 and thereby promotes translational activity. 4EBP1
phosphorylation levels of fat body cells were examined after knockdown of dLipin and compared
to control sample. Antibodies for pan4EBP1 and phospho4EBP1 were used in this western blot.

control

FBGal4>
dLipinRNAi
pan4EBP1

17kDa

phospho4EBP1
17kDa

72kDa
55kDa

Tubulin

36kDa

Fig. 43: dLipin knockdown does not reduce 4EBP1 phosphorylation levels. Western blot
analysis was performed with fat body samples from feeding third instar larvae. The membranes
were probed either with antibodies for phospho4EBP1 or pan4EBP1. Samples from animals with
dLipin knockdown in the fat body (FBGal4>dLipinRNAi) were compared to samples from
control animals carrying only the Gal4 transgene (FBGal4). Tubulin was used as a loading
control.
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Western analysis revealed that dLipinRNAi expression did not reduce TORC1 activity.
4EBP phosphorylation levels in the fat body of experimental and control animals were similar.
raptor knockdown alone led to a complete loss of 4EBP1 phosphorylation (data not shown). This
made it impossible to look into a possible enhancement of the effect of reduced Raptor activity
on 4EBP1 phosphorylation by concomitant knockdown of dLipin.
Thus, the enhancement of cell growth defects and organismal developmental delay
observed after dLipin knockdown in raptor-deficient background may not be due to a further
decrease of TORC1 activity in these animals.
5. Summary of part C Results
I discovered a strong genetic interaction between dLipin and raptor during larval and fat
body development. This interaction appeared to influence fat body cell size and larval growth
and it required the PAP activity of dLipin. I furthermore showed that Raptor, and therefore
TORC1, regulates not only dLipin abundance, but also its subcellular localization. This indicates
that dLipin activity is regulated by TORC1 and therefore, is subject to control by nutrient
signaling.
D. Experiments not directly linked to insulin or TOR signaling
1. dLipin’s subcellular localization is not influenced by intracellular dLipin levels
When looking at dLipin distribution within fat body cells, I discovered that knockdown
of insulin pathway activity via expression of PI3K21BHA, and knockdown of TORC1 pathway
activity via expression of raptorRNAi each resulted in a reduction of dLipin levels. At the same
time, reducing TORC1 activity led to translocation of dLipin into the nucleus whereas reducing
insulin pathway activity did not affect dLipin localization. One possible explanation for this
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difference could be that intracellular dLipin levels influence its distribution. it could be that
dLipin only navigates into the nucleus after knockdown of TORC1 activity because dLipin levels
are lower in these cells than in cells with a reduction in PI3K21B activity.
To address this possibility, I determined the amount of dLipin protein in samples from fat
body of feeding third instar larvae expressing either PI3K21BHA (dominant negative form of
PI3K21B) or raptorRNAi by western blot analysis.

control

FBGal4>
PI3K21BHA

FBGal4>
raptorRNAi
dLipin

130kDa

95kDa

Actin

Fig. 44: dLipin levels are similar after knockdown of raptor and expression of PI3K21BHA.
To determine whether more dLipin is present after PI3K21BHA (FBGal4>PI3K21BHA)
expression compared to raptorRNAi (FBGal4>raptorRNAi) expression, I conducted a western
blot analysis with dLipin antibodies. Control sample was from w1118 animals. Fat body was from
wandering third instar larvae. Actin served as a loading control.

The western analysis showed that dLipin levels were comparably low after PI3K21BHA
expression and raptor knockdown. This indicates that differences in subcellular localization
following PI3K21BHA expression and raptor knockdown were not caused by differences in
intracellular dLipin levels.
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2. Generation of donor fly lines for ends-in-targeting gene replacement
In order to study the two different dLipin functions, PAP activity and transcriptional coregulator activity, I attempted to create fly lines in which the endogenous dLipin gene was
replaced by a dLipin gene with a mutation that either interferes with PAP activity or co-regulator
activity. In theory, this would allow us to determine the direct effects of loss of either dLipin
activity on metabolism and development. A fly strain carrying the dLipin gene with a mutation in
the PAP motif was successfully generated. This fly line proved to be homozygous lethal, which
showed that the PAP function of dLipin is essential for survival. Characterization of this fly line
was performd by Qiuyu Chen and is described elsewhere (Qiuyu Chen, Investigation of Nuclear
and Cytoplasmic Functions of the dLipin Protein of Drosophila Melanogaster, Masters Thesis,
2014).
The ends-in-targeting gene replacement method (Rong and Golic; 2000) was chosen to generate
flies with a replacement of endogenous dLipin with either ΔPAPdLipin or ΔNLSdLipin. This
method employs a two-step approach. First, a mutated copy of the targeted gene is introduced in
the genome, and second, part of the endogenous gene is replaced with the mutated copy, which
leaves only one (mutated) copy of the gene in the genome.
I participated in the mutagenesis experiment by creating transgenic donor fly lines that
carry both the endogenous dLipin gene and the donor construct with the mutant copy of dLipin.
dLipinΔPAP and dLipinΔNLS donor constructs were inserted into the genome by P-element
transformation. Each construct contained two flanking FRT sites, an I-CreI-recognition site as
well as an I-SceI recognition site. The fly lines carrying either of these constructs within their
genomes are called donor stocks.
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dLip
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FRT

Fig. 45: Depiction of donor constructs. FRT sites are flanking the construct. The mutated
dLipin gene carried either the NLS deletion or nucleotide change in the PAP motif. The I-SceI
site is located in the middle of the dLipin gene. The construct further contains the I-CreI
recognition site and the white marker gene.

After I had created the two donor stocks, I handed them over to fellow graduate student
Qiuyu Chen. She continued the mutagenesis experiment that was meant to provide dLipin
mutants for both of our projects. For the sake of completeness, I will shortly explain the steps she
took to obtain the mutants. First, the donor line was crossed with flies expressing FLP
recombinase and I-SceI endonuclease. This leads to the excision of the construct at the FRT sites
and induces a double strand break at the I-SceI site. The double strand break triggers
homologous recombination between the endogenous dLipin gene and the mutated version.
Homologous recombination results in a duplication of the dLipin gene, with the mutated and the
endogenous copy lying next to each other, separated by the white gene and I-CreI site. To
remove one copy of the dLipin gene, flies were crossed with flies expressing the I-CreI
recombinase. This resulted in another homologous recombination step that left only one copy of
the dLipin gene in the genome. Flies were then examined to see if they contain the mutated
dLipin gene or the wild-type dLipin gene by PCR. Qiuyu Chen was able to generate a fly line in
which dLipin carried the mutation in its PAP active site. She did not obtain a fly line in which the
endogenous dLipin was replaced by dLipin lacking its NLS.
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3. Ecdysone treatment rescues the dominant negative effect of ΔNLSdLipin expression on larval
development and lethality
While carrying out experiments with the ΔNLSdLipin construct, I observed that strong
ubiquitous overexpression of ΔNLSdLipin with the Tubulin driver (TubGal4>dLipinΔNLS)
resulted in developmental delay and larval lethality. As fat body morphology of these animals
looked normal (data not shown), developmental delay and larval lethality were likely caused by a
defect in another tissue. As already shown (Fig. 27), like dLipinΔPAP overexpression,
dLipinΔNLS overexpression had a dominant negative effect leading to the exclusion of
endogenous dLipin from the nucleus. A potential tissue in which a complete loss of dLipin’s
nuclear activity could cause developmental effects is the ring gland. Ugrankar et al. (2011)
showed that dLipin is abundantly present in ring gland tissue of third instar larvae. The
prothoracic gland, which is part of the ring gland, is the primary location of ecdysone synthesis
and release. Ecdysone is then converted into the steroid hormone 20-hydroxyecdysone (20HE) in
peripheral tissues. This steroid hormone controls developmental progression from embryogenesis
to adult development. 20-HE binds to the Ecdysone Receptor (EcR), which is a nuclear receptor
that regulates expression of ecdysone-responsive genes as part of a heterodimeric complex with
Ultraspiracle (Usp) (Yamanaka et al., 2013).
To test whether expression of ΔNLSdLipin affects ecdysone synthesis or release, I fed
larvae that ubiquitously expressed ΔNLSdLipin with food containing 20-HE. I let animals
develop on food with or without 20-HE and compared larval development and lethality. I
examined animals with expression of dLipinΔNLS (TubGal4>dLipinΔNLS) as well as animals
only carrying the dLipinΔNLS transgene but no driver (control). Both genotypes arose from the
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same cross. Therefore, I was able to directly compare the number of pupae formed and
developmental delay of these two genotypes.

A)

***
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B)

Fig. 46: 20-HE treatment can rescue larval lethality and developmental delay caused by a
dLipinΔ NLS overexpression. A) Feeding 20-HE to larvae expressing dLipinΔNLS driven by
TubGal4 strongly reduced the larval lethality normally observed in animals with dLipinΔNLS
overexpression. No statistically significant difference between numbers of pupae was found
when experimental animals (TubGal4>dLipinΔNLS) were compared to control animals (only
dLipinΔNLS, no driver transgene). Without 20-HE treatment significantly fewer experimental
animals reached the pupal stage compared to control animals. Two tailed Chi-Square Test, ***
p= 0.0001. B) Developmental delay of animals that overexpress dLipinΔNLS was rescued by
20HE treatment. The majority of larvae reached the pupal stage earlier when fed 20-HE. Newly
formed pupae/prepupae were counted and plotted as percent of total number of pupae formed.
Day 1 represents the day of first puparium formation.

20-HE treatment rescued the developmental delay and larval lethality observed after

ΔNLSdLipin overexpression. This points to a defect in either ecdysone synthesis or ecdysone
release in larvae with ΔNLSdLipin overexpression. To further confirm this result, I tried to rescue
developmental delay and larval lethality of transheterozygous dLipin mutants (dLipine00680/
Df(3R)Exel7095) (Ugrankar et. al., 2011) by feeding 20-HE to these animals. However, 20-HE
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treatment had no rescue effect on dLipine00680/Df(3R)Exel7095 mutants (data not shown). This
indicates that providing 20-HE alone cannot overcome the severe developmental delay in
transheterozygous dLipin mutant animals. The may be due to the severe underdevelopment of the
fat body that characterizes these animals, in contrast to animals that overexpress ΔNLSdLipin,
which have a fat body that appears normal.
4. Expression of human lipin homologs can rescue larval lethality of transheterozygous dLipin
mutants
dLipin has 3 homologous genes in Homo sapiens, lipin1, lipin2 and lipin3. The three
paralogs have diverged over time and display different spatial expression patterns (Donkor et al.,
2007). To test whether the three human lipin genes can compensate for loss of dLipin in
Drosophila, or whether one or more of these genes diverged to where they have lost this ability, I
expressed lipin1, lipin2 and lipin3 in transheterozygous dLipin mutants
(dLipine00680/Df(3R)Exel7095).
An important aspect of this experiment is the assessment to what degree results attained
in Drosophila can be translated to mammalian systems. If lipin1, lipin2 and lipin3 retained
known dLipin functions, it is more likely that they will affect fat metabolism and diabetes in a
way similar to dLipin, and results gathered in Drosophila can be extrapolated, at least to a certain
degree, to lipin function(s) in mammals.
As described in Ugrankar et al. (2011) many dLipin transheterozygous mutant animals
die during larval development, with only 23 % reaching the wandering stage, and only very few
of these successfully pupariate. Therefore, to assess the rescue effects of lipin1, lipin2 and lipin3
expression, I examined the number of pupae formed. Both control genotype
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(dLipine00680/Df(3R)Exel7095; either lipin transgene alone) and either experimental genotype
(dLipine00680/Df(3R)Exel7095; Gal4/lipin1, dLipine00680/Df(3R)Exel7095; Gal4/lipin2,
dLipine00680/Df(3R)Exel7095; Gal4/lipin3) arose from the same cross, which allowed me to
directly compare genotypes with regard to the number of pupae formed.

A)

***
***

***

	
  

	
  

148

B)

***
***

	
  

149

C)

	
  

Fig. 47: Rescue of transheterozygous dLipin mutants (dLipine00680/ Df(3R)Exel7095) by
expression of human dLipin homologs (lipin1, lipin2, lipin3). Using three different driver
lines, I examined the rescue potential of the human lipin genes. To score for rescue effects I
examined the number of pupae formed. A) Weak, nearly ubiquitous expression using the DJ761
driver results in a significant rescue effect for lipin2 and lipin3, and a clear trend for lipin1.
DJ761Gal4 is expressed in all larval tissues except CNS and imaginal discs (M. Lehmann
personal communication) B) Strong ubiquitous expression with TubGal4 of lipin1, lipin2 and
lipin3 significantly lowered the ability of dLipin mutants to pupariate. C) Fat body-specific
expression driven by FBGal4 of lipin1, lipin2 and lipin3 did not affect the number of pupae
formed. The transheterozygous dLipin mutant genotype (dLipine00680/ Df(3R)Exel7095) is
abbreviated to Df/Rb in the graph. Two tailed Chi-Square Test, ∗∗∗ p < 0.0001.

Nearly ubiquitous but weak expression of lipin2 and lipin3 significantly reduced lethality
of dLipin mutants. lipin1 expression also seemed to have an effect on the number if pupae
formed, but the difference to the control was not statistically significant.
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Strong ubiquitous expression of any of the human lipin paralogs seemed to further decrease
viability of dLipin mutants. Specific expression of human lipin paralogs in the fat body had no
rescue effect. On the contrary, similar to the strong ubiquitous expression data, these data
revealed that fat-body specific expression of the human lipin genes may have a negative effect as
well.
Weak ubiquitous expression of human lipin genes in dLipin mutant animals was able to
significantly increase the pupariation rate and improve fat body morphology. Hence, one can
infer that human lipin genes posses functions of dLipin with regard to fat body development.
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IV. Discussion
Mammalian dLipin homologs have long been implicated in mediating insulin sensitivity
(Reue et al., 2000; Ryu et al., 2009; Suviolathi et al., 2006) and insulin signaling itself has been
shown to influence Lipin1 activity (Harris et al., 2007, Huffman et al., 2002; Peterfy et al., 2010)
and lipin expression (Manmontri et al., 2008). It is known that TOR signaling has an effect on
Lipin1’s subcellular localization and posttranslational modification (Eaton et al., 2013; Huffman
et al., 2002; Peterson et al., 2011) and it has been demonstrated that TORC1 and Lipin1 interact
in the control of lipid metabolism (Peterson et al., 2011). dLipin, the Drosophila counterpart of
the mammalian Lipin proteins, has been shown to be a regulator of larval metabolism by
contributing to fat body development and fat synthesis (Ugrankar et al., 2011). Goal of my
research was to address the question of whether dLipin is, as its mammalian homologs, a
mediator of insulin sensitivity, and whether the association between Lipin and TORC1 is
evolutionarily conserved. An additional aim was to elucidate the link between Lipin’s dual
molecular functions, PAP activity and co-regulator activity, and the insulin and TORC1
pathways.
1. Background
Cell growth defects often result from a deregulation of insulin signaling or TORC1
signaling. Cells show overgrowth phenotypes under conditions with insulin pathway
overactivation, whereas down regulation of the insulin pathway leads to a decrease in cell size
(Britton et al., 2002).
It is widely assumed that growth defects brought about by changes in the insulin signaling
pathway are in part caused by subsequent modifications of TORC1 activity (Saucedo et al.,
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2003). To date, it has not been shown that this pathway exists as proposed in the fly under
physiological conditions (Dong and Pan, 2004; Oldham et al., 2000; Pallares-Cartes et al., 2012;
Schleich and Teleman, 2009). It is therefore not clear to what extent the TORC1 and insulin
signaling pathways act in concert or independently in cell growth and metabolic control in
Drosophila melanogaster.
2. dLipin and insulin pathway interact in fat body of D. melanogaster
To characterize the relationship between dLipin and the insulin pathway I conducted experiments
to investigate the effects of dLipin on insulin pathway activity. I also examined the effects of
insulin pathway signaling on dLipin activity.
2.1. dLipin is required for cell growth and TAG production cell-autonomously
Knocking down dLipin activity in a cell-autonomous fashion in the larval fat body
reduced cell size. This reduction in cell size was accompanied by a near absence of fat droplets
(Fig. 9). Nuclear area, although also significantly reduced compared to control cell nuclei, was
disproportionally big in relation to cell area (Fig. 12). The reduction in nuclear size strongly
suggests that cell growth was indeed interrupted, and the decreased amount of fat in cells
deprived of dLipin activity did not cause the reduction in cell size.
The increase in the nucleocytoplasmic ratio in fat body cells was also observed after
system-wide loss of dLipin activity (Fig. 12). This phenotype can be interpreted as an indication
of reduced cytoplasmic growth during endoreplication cycles. Cell growth and DNA replication
in endoreplicating tissues are tightly regulated in response to nutritional signals mediated
primarily by circulating growth factors (Britton and Edgar, 1998). The increase in the
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nucleocytoplasmic ratio could thus result from a deregulation of insulin/TOR activity in cells
with cell-autonomous dLipin knockdown.
Taken together, the decrease in nuclear area in concert with the reduction of cellular area
following cell-autonomous knockdown of dLipin strongly suggests that dLipin is required for
cell growth in a cell-autonomous fashion. Cells also displayed a severe reduction in fat droplet
accumulation. Thus, dLipin is also essential for proper fat synthesis cell-autonomously.
To determine whether cell growth is affected due to a change in the activity of the insulin
pathway upon dLipin knockdown, I looked at PIP3 localization in fat body tissue from animals
with fat body-specific knockdown of dLipin activity and dLipin transheterozygous mutants.
2.2. dLipin is required for fat body insulin sensitivity
PIP3 synthesis was disrupted in fat body cells upon knockdown of dLipin activity (Fig.
13 and 14). PIP3 is a second messenger generated by PI3K at the cell membrane under
conditions of active insulin signaling. The deficiency in PIP3 was not caused by scarcity of its
precursor PIP2, as PIP2 membrane levels appeared unaffected (Fig. 13 and 14). When dissecting
fat body tissue from dLipin mutants and dLipin knockdown animals, it was apparent that
membrane integrity was negatively affected. Cells tended to easily dissociate from each other
resulting in an increased fragility of the tissue. DAG synthesis is catalyzed by the activity of
Lipin proteins. DAG serves as a precursor for membrane phospholipids (Bishop and Bell, 1988).
Therefore, loss of dLipin activity may have mediated changes in cell membrane composition.
Furthermore, PAH1, a yeast homolog of dLipin, participates in the transcriptional control of
phospholipid synthesis (Santos-Rosa et al., 2005). Thus, changes in phospholipid content of the
cell membrane might have prohibited proper PIP3 synthesis at the cell membrane. However, as
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PIP2 membrane localization seemed to be unaffected it seems likely. It is more likely that the
absence of PIP3 from the plasma membrane after dLipin knockdown was caused by a defect in
its synthesis and not by alterations in membrane structure.
Another parameter required for insulin pathway activity is phosphorylation of AKT.
Under normal insulin signaling conditions, AKT is recruited to the cell membrane by PIP3 and
subsequently phosphorylated at two specific residues in order to attain full activity (Liao and
Hung, 2010). Measuring AKT phosphorylation in fat body from animals with fat body-specific
dLipin knockdown and dLipin transheterozygous mutants showed a clear reduction of AKT
phosphorylation (Fig. 18). I specifically examined phosphorylation at residue 505 (S505), which
is catalyzed by TORC2. The reduction of phosphorylation after loss of dLipin activity points to a
reduction in TORC2 and subsequently, AKT activity.
The reduction in PIP3 synthesis taken together with decreased phosphoAKT levels shows
that reduced dLipin activity leads to reduced insulin pathway activity in the fat body.
2.3. dLipin affects PI3K activity
I was able to place dLipin at the level of PIP3 synthesis in the insulin signaling cascade
by showing that a decrease in dLipin activity ameliorates the effects of PI3K over activation
(Fig. 19) and that dLipin is required for PI3K activity (Fig. 20, Fig. 21). I expressed
Dp110CAAX, a constitutively active Dp110, and observed a strong increase in cell size. When
dLipin activity was down regulated in fat body cells with Dp110 overactivation, the overgrowth
phenotype was reversed (Fig. 19). Furthermore, PIP3 synthesis (Fig. 20) and AKT
phosphorylation levels (Fig. 21) were strongly reduced in cells with concomitant Dp110AAX
expression and dLipin knockdown compared to cells with Dp110CAAX expression only. Because
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PIP3 synthesis is negatively affected, even in the presence of PI3K overactivation, it seems likely
that dLipin affects insulin pathway activity by either modulating PI3K or PTEN activity.
Another possible explanation for the loss of PI3K activity after dLipin knockdown is that
dLipin’s effect on AKT S505 phosphorylation is enough to blunt overexpression effects of PI3K.
As mentioned before, phosphorylation of AKT at residue 505 was reduced upon a decrease of
dLipin activity (Fig. 18). This phosphorylation step is catalyzed by TORC2. It has been shown
that reduction of AKT phosphorylation by TORC2 is sufficient to attenuate hyperactivation of
PI3K (Hietakangas and Cohen, 2007). However, this would not explain why PIP3 synthesis, and
thus PI3K activity itself, was reduced.
Taken together, these data strongly suggest that dLipin is necessary for insulin pathway
activity in the fat body at PI3K or PTEN level, and that loss of dLipin activity is sufficient to
weaken PI3K signaling.
Further experiments will have to be conducted in order to be able to pinpoint where
exactly dLipin influences the signaling cascade. Examining PTEN activity in cells with reduced
dLipin expression may elucidate which step in PIP3 synthesis is affected by diminished dLipin
activity.
It deserves to be noted that in addition to fat body hypertrophy, I observed animals with
severe hypotrophy of the fat body after Dp110CAAX expression. It would be interesting to
examine the expression levels of genes involved in fat synthesis, adipogenesis and lipolysis in
these animals using RNASeq to further investigate whether fat synthesis is inhibited or whether
lipolysis is increased.
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I was not able to conduct experiments in which dLipin knockdown or knockdown of the
insulin signaling pathway was combined with overactivation of TORC1. This would have been
helpful to better understand the crosstalk between TORC1 and insulin pathway in vivo. I was not
able to overactivate TORC1, neither by knocking down its repressors (Tsc1 and Tsc2) nor by
overexpression of an activator (Rheb). Future experiments should concentrate on finding
alternative ways to activate TORC1, possibly by feeding flies a diet high in amino acid content
or by overexpression of amino acid transporters. This would help to examine possible rescue
effects of TORC1 on insulin resistance caused by a lack of dLipin.
2.4. Disrupting dLipin activity in the fat body results in fat body insulin resistance but has no
apparent systemic effect
Transheterozygous dLipin mutants displayed a significant increase in circulating sugar
levels (Fig. 22), but no overall systemic growth defect. Two sugars circulate in Drosophila
hemolymph, glucose and trehalose, with trehalose being the major circulating sugar (Wyatt and
Kale, 1957). Trehalose is a disaccharide synthesized in the fat body. The rise in circulating
hemolymph sugars may indicate that glycogen breakdown in the fat body is increased in dLipin
mutant larvae. This rise in circulating sugar suggests that the fat body is insulin resistent. The
fact that transheterozygous dLipin mutants showed no defect in systemic growth implies that the
influence of dLipin on insulin pathway activity is largely or exclusively restricted to the fat body.
Disrupted insulin pathway activity in combination with normal growth was also present on the
cellular level, as fat body cells of animals with fat body-specific dLipin knockdown were not
reduced in size, although PIP3 synthesis was strongly reduced. This result implies that the
disruption in insulin pathway activity observed in fat body cells with fat body-specific dLipin
knockdown is not strong enough to induce obvious growth defects. Consistent with this
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interpretation was the finding that overall 4EBP1 abundance was not increased in animals with
fat body-specific dLipin knockdown (Fig. 43). 4EBP transcription is positively regulated by
FOXO and FOXO activity is elevated upon insulin resistance (Teleman et al., 2005). Thus, 4EBP
levels should have been elevated in cells after dLipin knockdown. Furthermore, data exists that
indicates that AKT activity, although possibly reduced, is not abolished under conditions of
reduced S505 phosphorylation. It was shown that under these conditions enough residual AKT
activity is present to ensure downstream insulin pathway activity. Hence, investigation of S505
phosphorylation alone might not be a reliable indicator for AKT activity or overall insulin
pathway activity (Hietakangas and Cohen, 2007).
These data all lead to the speculation that RNAi-induced knockdown of dLipin in fat
body cells might only result in a weak reduction of insulin pathway activity, and that residual
AKT activity was sufficient to trigger downstream signaling events. This suggests that the PIP3
reporter tGPH might not be a very sensitive measure of PIP3 levels. To further assess this
interpretation it would be informative to test FOXO activity in cells after dLipin knockdown, for
instance, by directly visualizing its nuclear translocation.
In addition, this result also points to a parallel pathway, that contributes to growth on a
cellular level, and which functions independently of insulin input and promotes cell growth even
in the presence of moderate or weak insulin resistance as caused by dLipin knockdown. Larvae
with dLipin knockdown in the fat body seem to feed normally and therefore consume nutrients
like amino acids. Amino acids activate the main nutrient-sensing pathway, the TORC1 pathway
(Li et al, 2010). One can speculate that TORC1 activity alone may be enough to promote cell
growth under conditions of weak or moderate insulin resistance in fat body cells. TORC1
signaling promotes translation and other cellular growth processes, and thus in turn promotes cell
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growth. It has been proposed that under physiological conditions TORC1 and insulin signaling
are not necessarily interconnected, but rather act in parallel pathways (Dong and Pan, 2004;
Oldham et al., 2000; Pallares-Cartes et al., 2012; Schleich and Teleman, 2009). Indeed, TORC1
activity was not reduced in animals with fat body specific dLipin knockdown, as 4EBP1
phosphorylation remained unchanged (Fig. 43). Thus, moderate or weak insulin resistance in
animals with fat body-specific dLipin knockdown might be compensated for on a cellular level
by TORC1 activity.
Thus, the absence of any growth defect in fat body cells with RNAi-mediated dLipin
knockdown may simply be due to the fact that this dLipin knockdown only elicits a very weak
reduction in insulin pathway activity.
As mentioned previously, unlike tissue-wide dLipin knockdown, cell-autonomous loss of
dLipin activity has a clear negative effect on cell growth. This seems to be caused by a more
severe loss of dLipin activity in these cells as compared to the fat body-specific knockdown of
dLipin. Cells after cell-autonomous loss of dLipin contained few, if any, fat droplets; an
indication that in these cells fat synthesis, and therefore dLipin activity was most severely
affected (Fig. 9). This is also reflected in cells seen in system-wide RNAi knockdown, as cells
that did not contain any fat droplets appeared to be the smallest cells (Fig. 10). A stronger
reduction of dLipin activity after cell-autonomous reduction of dLipin might thus be responsible
for a more pronounced loss of insulin pathway activity and consequently, a reduction in cell size.
Whether this reduction in cell size could also be caused by a subsequent downregulation of
TORC1 activity due to a stronger decrease of insulin activity is not clear at this point. If TORC1
activity remained unchanged, this could possibly indicate the existence of a threshold measure
for insulin pathway activity below which effects in cell growth become apparent.
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The fat body represents the major metabolic organ of the developing larvae.
Transheterozygous dLipin mutants displayed elevated circulating sugar levels, most likely
caused by insulin resistance in the fat body. It would be interesting to explore whether systemic
insulin signaling is subsequently modified to counteract the rise of hemolymph sugar levels in
animals with reduced insulin sensitivity of the fat body. In mammalian systems, insulin
resistance elicits increased insulin production in order to sensitize tissues for sugar uptake
(Cavaghan et al., 2000). dILPs (Drosophila insulin-like peptides) represent signaling peptides
secreted from the brain and other tissues, and act in neuroendocrine signaling and control
carbohydrate and lipid metabolism as well as growth and reproduction (Brogiolo et al., 2001;
Groenke et al., 2010; Colombani et al., 2012; Garelli et al., 2012). Although the exact
mechanism that controls dILP release is not completely understood, it is known that a humoral
signal originating from the fat body triggers dILP release from the neurosecretory cells in the
brain (Geminard et al., 2009). This signal is most likely fat body produced dIPL6, which
represses release of dILP2 and 5 from the brain (Bai et al., 2012). It has been previously
documented that insulin resistance in the fat body can be accompanied by an increase in brain
dILP expression, as seen for miR-278 mutant flies (Teleman et al., 2006). Thus, the possibility
exists that a reduction of dILP6 release from the fat body triggers dILP2 and dILP5 release from
the brain to increase dILP levels in response to insulin resistance in the fat body. This increase in
dILP hemolymph levels could represent a systemic response to insulin resistance in the fat body,
mirroring increased insulin production in individuals with type2 diabetes. Measuring expression
levels of Dilps in transheterozygous dLipin mutants and animals with fat body-specific dLipin
knockdown could help determine whether dILP production is influenced by reduced insulin
sensitivity of the fat body caused by decreased dLipin activity.

	
  

160

Overall, these data allow for the speculation that RNAi-induced fat body-specific dLipin
knockdown only elicits weak to moderate insulin resistance in the fat body. TORC1 activity in
these cells remains unchanged and allows for normal cell growth. In cells with severely
compromised dLipin activity on the other hand, insulin signaling pathway activity appears to be
strongly downregulated and, hence, cell growth is reduced.
2.5. Insulin pathway activity and dLipin activity are mutually dependent
Genetic interaction experiments between dLipin and the Insulin receptor (InR) revealed a
strong connection between dLipin and InR in the development of fat body tissue. Using a GFP
marker for fat body tissue, I observed that loss of InR activity concomitant with dLipin
knockdown results in a severe underdevelopment of the fat body in developing larvae (Fig. 16).
It is known that Lipin1 is required for proper adipogenesis (Kim et al., 2013; Phan et al., 2004;
Zhang et al., 2012). Zhang et al. (2012) showed that Lipin1 affects adipogenic gene expression
by influencing phosphatidic acid (PA) levels. Elevated levels of PA inhibit expression of
adipogenic genes, amongst them the key regulator peroxisome proliferator-activated receptor γ
(Pparγ). It is also known that Lipin1 physically interacts with PPARγ, and thereby regulates
PPARγ activity in adipogenic gene expression. This activity of Lipin1 is independent of its PAP
activity, and relies on Lipin1’s nuclear activity (Kim et al., 2013). Insulin signaling is also a
positive regulator of adipogenesis, as AKT activation alone can promote differentiation of 3T3L1 cells into adipocytes by inducing Pparγ expression (Kohn et al., 1996; Xu and Liao, 2004). If
the effects on adipogenesis in Drosophila are also mediated via PPARγ, or by a different
adipogenic factor cannot be answered at this point. So far, no fly homolog for PPARγ has been
identified (Hong et al., 2010).
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It is possible that a reduction of insulin pathway activity further lowered dLipin activity
in cells with dLipinRNAi and InRDN expression. Insulin pathway activity has been identified as a
regulator of Lipin1 activity. Insulin influences phosphorylation and subcellular localization of
Lipin1 (Harris et al., 2007; Peterfy et al., 2010). Reduction of InR activity in cells with dLipin
knockdown could thus further lower PAP activity, and consequently increase PA levels.
Increased PA levels might inhibit proper adipogenic gene expression. A disruption in
adipogenesis would result in a decrease of fat body cell number and subsequently a reduction of
larval fat body mass. This reduction of fat body mass concomitant with diminished TAG
synthesis during larval development could explain the severe underdevelopment of the fat body
in larvae with dLipinRNAi and InRDN expression. A loss of dLipin activity might also enhance
insulin resistance in developing larvae expressing InRDN by further lowering AKT activity, and
thus prohibiting adipocyte differentiation. This defect in adipogenic gene expression would also
result in reduced fat body cell mass.
It is most likely that a combination of reduced dLipin activity due to decreased insulin
pathway activity in concert with reduced insulin pathway activity due to decreased dLipin
activity led to the severe defects in adipogenesis. This would point to an interdependent
relationship between dLipin and insulin pathway activity during adipogenesis.
In addition to fat body mass, cell growth was altered in cells with concomitant expression
of dLipinRNAi and InRDN in the fat body. Expression of InRDN alone significantly reduces cell
area (Fig. 16), whereas dLipinRNAi expression has no effect on cell size (Fig. 15). When both
transgenes were combined, cell size increased, cell shape became rounded and cell adherence
decreased (Fig. 16). As this phenotype closely resembled the fat body phenotype of
transheterozygous dLipin mutants (Ugrankar et al., 2011), one can speculate that the concomitant
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dLipinRNAi and InRDN expression mimics the effect of a strong dLipin deficiency with regard to
cell growth. As in the dLipin mutant, significant loss of fat body mass is being compensated by a
secondary mechanism, which leads to the overgrowth of cells. The overgrowth is most likely
induced to achieve critical weight required for larval maturation (Ugrankar et al., 2011). The
strong reduction of fat body mass and TAG content may also be the cause of increased larval
lethality observed after concomitant dLipinRNAi and InRDN expression. It would be interesting
to address the question whether the overgrowth of fat body cells observed in dLipin mutants and
in larvae with concomitant dLipinRNAi/InRDN expression represents a phenotype that is specific
for dLipin, or is the result of a general reduction in fat body mass. Investigation of strong
mutants for other enzymes involved in glycerolipid synthesis (e.g. AGPAT3, GPAT4, DGAT2)
could shed light on this question.
I was able to show that strongly reduced insulin pathway activity in the fat body led to a
reduction in dLipin protein levels (Fig. 24). However, subcellular localization appeared to be
unaffected (Fig. 23). Insulin signaling positively regulates cytoplasmic retention of mammalian
Lipin1, either by phosphorylation or by mediating an interaction between Lipin1 and 14-3-3
proteins (Harris et al., 2007; Peterfy et al, 2010). Thus, a decrease in insulin pathway activity
should have caused a decrease in cytoplasmic dLipin localization and a translocation of dLipin to
the nucleus or perinuclear region (ER). To further elucidate the effects of insulin pathway
activity on dLipin activity, it would be interesting to measure PAP activity after insulin pathway
overactivation and insulin pathway knockdown. In addition, dLipin phosphorylation status upon
insulin pathway modifications should be investigated using native gel electrophoresis and mass
spectrometry. These experiments would help elucidate whether PAP activity itself is modulated
by insulin pathway activity and whether different stages of phosphorylation correlate with
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differential PAP activity of dLipin. It would also be worthwhile to elucidate whether dLipin’s
microsomal association is affected, using confocal microscopy. Furthermore, it would be
interesting to investigate whether AKT is the kinase responsible for insulin-mediated Lipin
phosphorylation.
Thus, it appears that dLipin protein levels are regulated by insulin pathway activity.
Subcellular distribution of dLipin on the other hand appears unaffected by insulin pathway
activity. Whether the phosphorylation status of dLipin is modified by insulin pathway activity
remains to be elucidated. It furthermore seems that dLipin activity during adipogenesis and in
TAG synthesis is dependent on insulin pathway activity. These data also suggest that dLipin may
regulate insulin pathway activity during adipogenesis.
2.6. dLipin’s PAP activity is required for normal insulin sensitivity of the fat body
Animals with a reduction in GPAT4 or AGPAT3 activity in the fat body displayed a
reduction in fat droplet size and PIP3 synthesis, mirroring the phenotype caused by dLipin
knockdown (Fig. 26). GPAT4 and AGPAT3 are enzymes of the canonical TAG synthesis
pathway and act directly upstream of dLipin, producing lysophosphatidic acid (LPA) and
phosphatidic acid (PA), respectively. The fact that a reduction in the activity of these
glycerolipid synthesis enzymes caused a reduction in PIP3 synthesis suggests that the process of
TAG synthesis itself represents a mechanism that controls insulin sensitivity in the fat body. This
hypothesis was further validated by experiments that showed that dLipin with intact nuclear
function, but no PAP activity, was capable of reconstituting insulin sensitivity in the fat body of
animals with dLipin knockdown (Fig. 31). The reconstitution of insulin sensitivity went hand in
hand with an increase in fat droplet size in the fat body. Insulin pathway activity and fat body

	
  

164

morphology in animals expressing dLipin lacking PAP activity concomitant with dLipin
knockdown remained disturbed (Fig. 31). Thus, it appears that dLipin can influence the insulin
pathway through its role as a PAP enzyme.
TAG synthesis intermediates have been implicated as second messengers affecting
insulin signaling. Elevated phosphatidic acid (PA) levels reduce activity of mTORC2 and
increase mTORC1 activity (Blaskovich et al., 2013; Zhang et al., 2012). Preliminary data links
PA to phospho kinase C (PKC) activation (Limatola et al., 1994; Stasek et al., 1993). PA levels
are increased upon a reduction in Lipin activity (Han et al., 2006). Increased Lysophosphatidic
acid (LPA) levels can lead to insulin resistance (Neschen et al., 2005; Rancoule et al., 2014).
LPA levels might be elevated following AGPAT3 knockdown, as LPA is the substrate of
AGPAT3. Elevated levels of diacylglycerol (DAG) result in insulin resistance through activation
of phospho kinase C (PKC) and a subsequent reduction of PI3K activity (Erion and Shulman,
2010). DAG accumulation would be expected after downregulation of DGAT activity. I was not
able to detect changes in PIP3 synthesis after DGAT knockdown. This was most likely due to the
fact that DGAT knockdown was not strong enough, as fat content of cells appeared nearly
normal. As of now, no involvement of G-3-P in insulin sensitivity has been detected, but as all
other lipid intermediates contribute to insulin sensitivity it appears plausible that the same might
be true for glycerol-3-phosphate.
Insulin resistance following GPAT4, AGPAT3 and dLipin knockdown in the fat body
could hence be due to an unphysiological accumulation of lipid intermediates, which in turn
negatively affects insulin sensitivity of the tissue. Consistent with the effect of AGPAT3
knockdown in Drosophila, insulin resistance has been observed after a reduction of AGPAT
activity in adipocyte cell culture (Subauste et al., 2012). PA levels should be elevated in cells
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with reduced dLipin activity, as PA is the substrate for dLipin. As previously mentioned, in
mammalian systems an elevation in PA levls is associated with increased TORC1 activity
(Blaskovich et al., 2013). I did not observe an increase in TORC1 activity in fat body cells, as
4EBP1 phosphorylation was not elevated (Fig. 43). This discrepancy might be due to the fact
that results stem from research done in 2 different systems, namely Drosophila and mouse, or
that the conditions under which results were obtained differed too much. Reduced TORC2
activity caused by PA accumulation cannot explain the reduction in PI3K activity observed in fat
body cells with reduced dLipin activity, as it would only affect AKT activity. Thus, it appears
that PKC activity is increased upon PA accumulation due to dLipin knockdown and
subsequently, PI3K activity diminished. This hypothesis should be tested further by conducting
genetic interaction experiments between dLipin and the different PKC isoforms.
Individuals with lipodystrophy display elevated levels of free fatty acids (Meiniger et al.,
2002). Therefore, it is possibile that a total reduction of TAG synthesis following GPAT, AGPAT
or dLipin knockdown elicits insulin resistance through an increase in free fatty acids. An increase
in free fatty acids has a negative impact on insulin sensitivity by inhibiting glucose uptake
(Boden, 2003). Furthermore, SREBP activity is controlled by Lipin1, suggesting that under
conditions of Lipin deficiency, SREBP activity, and therefore de-novo fatty acid synthesis, is
deregulated (Peterson et al., 2011). Increased insulin levels positively control SREBP1
expression even in the presence of insulin resistance (Shimomura et al., 2000). As dLipin
knockdown results in insulin resistance, a possible increase in dILP levels could further raise
SREBP activity, which would perpetuate the insulin resistant condition.
Another effect of insulin resistance is a rise in FOXO activity that goes hand in hand with
an upregulation of Fatty Acid Synthase (FAS) (Luong et al., 2006). It would be worthwhile to
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measure free fatty acid levels following dLipin, AGPAT and GPAT knockdown to test whether
fatty acid levels are indeed elevated. Also, SREBP and FAS mRNA or protein levels should be
investigated. In addition, the lipid profile of animals after a reduction of dLipin activity should
be analyzed via chromatography.
qRT-PCR measuring Dp110 transcript levels of fat body tissue from animals with fat
body-specific dLipin knockdown showed that upon reduced dLipin activity, PI3K activity
appears to be reduced as reflected in decreased Dp110 mRNA levels (Fig. 33). Whether this
moderate reduction in Dp110 mRNA is a direct effect of dLipin deficiency, or a secondary effect
of reduced insulin pathway activity caused by dLipin deficiency remains elusive at this point. As
insulin sensitivity of the fat body appeared to be mainly dependent on dLipin’s PAP activity and
not dLipin’s nuclear activity, the observed decrease of Dp110 transcript appears to have no
major impact on insulin sensitivity.
Overall, my data indicate that disrupted TAG synthesis is a cause for reduced fat body
insulin sensitivity. A reduction in dLipin-mediated PAP activity thereby affected either PI3K or
PTEN activity. Reduced insulin pathway activity upon dLipin knockdown manifested in cell
growth defects and increased hemolymph sugar levels. Furthermore, dLipin’s activity during
adipogenesis and in TAG synthesis appeared to be dependent on insulin pathway activity. Thus,
TAG biosynthesis and insulin pathway activity are closely interconnected, and dLipin appears to
be an important link between the two pathways. My data furthermore provides a novel insight
into how lipodystrophy induces insulin resistance in Drosophila. Previous data linked HIVrelated lipodystrophy in humans with a disruption of the insulin cascade downstream of AKT
activity (Haugaard et al., 2005). My data suggests that lipodystrophy-induced insulin resistance
might develop via different mechanisms in Drosophila and humans.
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3. Characterization of the relationship between dLipin and TOR signaling
To elucidate the relationship between dLipin and TOR signaling in D. melanogaster, I
evaluated the effects of TOR activity on dLipin function. Furthermore, I examined the combined
effects of TORC1 and dLipin knockdown on cell growth and larval development.
3.1. dLipin is a target of TORC1 signaling in the fat body
I established that TORC1 signaling acts as a regulator of dLipin activity in vivo. dLipin’s
subcellular localization as well as cellular abundance was clearly affected by a loss in TORC1
activity (Fig. 35). Following a knockdown of TORC1 activity via raptor knockdown, dLipin
migrated into the nucleus and overall dLipin levels were greatly reduced. The same nuclear
redistribution was observed for Lipin1 after loss of TORC1 activity (Peterson et al., 2011). Thus,
dLipin cytoplasmic retention is positively controlled by TORC1 and this interaction is
evolutionary conserved.
Several phosphorylation sites of Lipin1 in mammals are known to be rapamycinsensitive, which indicates that TOR activity is involved in phosphorylation at these sites (Harris
et al., 2007). Peterson et al. (2011) found that mTORC1 directly phosphorylates Lipin1 and
thereby positively regulates cytoplasmic retention of Lipin1 protein. Once located in the nucleus,
Lipin1 interferes with SREBP activity and thus prohibits lipid biosynthetic gene expression
(Peterson et al., 2011). Furthermore, Lipin1 has been identified as a transcriptional co-regulator
of beta-oxidation genes and also influences adipogenic gene expression (Chen et al., 2012; Kim
et al., 2013). To affect gene expression and SREBP activity, Lipin1 translocates to the nucleus.
Thus, TORC1 negatively controls these specific nuclear functions of Lipin1.
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In response to low TORC1 activity, dLipin showed nuclear translocation comparable to
Lipin1. This suggests that dLipin’s cellular localization and hence its function is controlled by
TORC1 activity and this furthermore implicates that dLipin’s role in lipid metabolism is
similarly dependent on TORC1 activity.
Upon nuclear entry, dLipin might like its mammalian counterpart participate in the
transcriptional control of beta-oxidation and adipogenesis genes and other genes involved in
starvation resistance. dLipin might also negatively affect SREBP activity, and thus lipogenesis
(Finck et al., 2006; Zhang et al., 2008; Peterson et al., 2011). RNASeq using fat body tissue from
animals with a reduction in TORC1 signaling in the presence or absence of a concomitant dLipin
knockdown could help identify targets genes of dLipin.
In addition to TOR, insulin signaling pathway activity appears to influence the
phosphorylation status of Lipin1 (Harris et al., 2007; Peterfy et al., 2010). Similar to TOR,
insulin appears to promote Lipin1’s cytoplasmic retention and opposes membrane association. It
also appears that insulin and TOR regulate Lipin1 phosphorylation in concert (Huffman et al.,
2002).
My data show that in contrast to reduced TORC1 activity, a reduction in PI3K activity
did not lead to the nuclear concentration of dLipin (Fig. 23). It therefore appears that the
posttranslational modifications of dLipin that are brought about by TOR, which promote
cytoplasmic retention of dLipin, are not insulin-dependent. In accordance with this finding are
results by Peterson et al. (2011) that show that nuclear translocation of Lipin1 cannot be reversed
by activation of the insulin pathway. Therefore, my data points to the possibility that multiple
phosphorylation states of dLipin exist, depending on TORC1 and/or insulin signaling pathway

	
  

169

activity. Some phosphorylation sites might thereby be controlled in concert by both pathways,
and others independently.
As intracellular dLipin levels could potentially influence subcellular dLipin localization, I
measured dLipin protein levels in cells with TORC1 knockdown and PI3K knockdown. I found
that dLipin levels were comparably low after both knockdowns. Thus, the translocation of dLipin
into the nucleus is not affected by intracellular levels of dLipin (Fig. 44) but rather appears to be
controlled by posttranslational modifications depending on TORC1 activity. I did not observe
dLipin binding to chromosomes (Fig. 36). This may be due to the fact that dLipin functions as a
transcriptional co-regulator and does not directly bind to DNA. During the experiment, the
physical interaction between dLipin and its regulatory interaction partners might have been
interrupted, which could have resulted in dLipin dissociating from the chromosome.
My data suggest that dLipin activity in lipid metabolism is regulated by TORC1
independently of the insulin pathway. Subcellular localization of dLipin is determined by
TORC1, as under conditions of reduced TORC1 signaling dLipin is found in the nucleus. This
indicates that under conditions of reduced nutrient signaling, the requirement for dLipin’s
nuclear function is increased, possibly in order to prohibit de-novo lipogenesis by SREBP and to
activate genes involved in beta-oxidation and starvation responses.
3.2. dLipin and TORC1 control larval growth in concert
Larval growth appeared to be negatively affected by concomitant reduction of dLipin and
TORC1 activity. Larval size 5 days after egg deposition was significantly reduced in animals
with concomitant dLipin and raptor knockdown compared to dLipin and raptor single
knockdowns (Fig. 37). Furthermore, larval development was terminally halted at the feeding
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third larval instar stage. raptor knockdown itself resulted in a moderate developmental delay and
a reduction of fat body cell size. As larvae with fat body-specific raptor knockdown did not
appear to be bigger in size despite a prolonged larval feeding phase, one can speculate that larval
growth rate during development was reduced. Fat body cell size reduction was not accompanied
by a reduction in PI3K activity, as PIP3 synthesis remained intact (Fig. 38). dLipin knockdown
did not result in a developmental delay or a reduction of cell size but, as mentioned before,
interfered with PIP3 synthesis and AKT S505 phosphorylation.
Rescue experiments with dLipin lacking either its co-regulator or PAP activity showed
that the enhanced reduced larval growth in dLipin/raptor knockdown larvae was caused by a
reduction of dLipin-mediated PAP activity (Fig. 41). raptor knockdown itself most likely does
not elicit a strong reduction in PAP activity, as fat droplet size remained unchanged in the
presence of a reduction in Raptor activity. dLipin was nearly absent from the cytoplasm and
concentrated in the nucleus following raptor knockdown, suggesting that only small amounts of
cytoplasmic dLipin are enough to provide cells with sufficient PAP activity.
A combination of reduced TORC1 signaling via raptor knockdown in concert with
decreased PIP3 synthesis via dLipin knockdown might be responsible for reduced larval growth
and increased larval lethality. Both TOR activity and insulin pathway activity influence larval
growth (Colombani et al., 2003; Gupta et al., 2013; Rulifson et al., 2002; Walkiewicz and Stern,
2009). As TORC1 activity does not appear to be affected by dLipin input, a further reduction of
TORC1 in animals with concomitant raptor/dLipin knockdown is likely not the cause of the
growth defect (Fig. 43). Thus, these data support a model in which growth is controlled, at least
in part, by the independent action of the TORC1 and insulin pathways.
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One possible explanation for this result is that TORC1 and insulin pathway signaling in
the fat body both influence a mechanism that integrates the overall energy status of the animal.
Geminard et al. (2009) found that the fat body relays the nutritional status of the animals to the
neurosecretory cell of the brain and thus the nutritional status of the fat body has a direct effect
on dILP release. Increased dILP release then triggers larval growth (Geminard et al., 2009).
raptor knockdown in the fat body alone slows down larval development, possibly due to reduced
larval growth rate, suggesting that nutritional signals from the fat body affect growth. Thus, in
larvae with reduced dLipin activity, and hence reduced insulin pathway activity and
concomittantly reduced TORC1 activity via raptor knockdown, nutritional signaling from the fat
body could have been significantly altered, decreasing larval growth even further.
Taken together, these data indicate that larval growth is regulated in concert by the
insulin pathway and TORC1 and that lack of dLipin can interfere with this interaction by
reducing PIP3 synthesis and thus decreasing insulin pathway activity.
3.3. dLipin and TORC1 control cytoplasmic growth
Nucleocytoplasmic ratio was increased in fat body cells from animals with concomitant
reduction in dLipin and TORC1 activity (Fig. 39). Likewise, severe loss of dLipin activity, either
cell-autonomously or system-wide, also affected this tight connection between DNA replication
and cytoplasmic growth (Fig. 12). As raptor knockdown alone did not result in an increase in the
nucleocytoplasmic ratio, the rise in nucleocytoplasmic ratio observed after concomitant dLipin
and raptor knockdown does not appear to result from an enhancement of the growth phenotype
caused by raptor knockdown. This is also consistent with the fact that I did not observe a
reduction in TORC1 activity after RNAi-mediated dLipin knockdown (Fig. 43). Hence, this

	
  

172

growth defect is most likely caused by a reduction in insulin pathway activity in concert with
reduced TORC1 activity in animals with concomitant dLipin/raptor knockdown as opposed to
further reduced TORC1 activity.
This increase in nucleocytoplasmic ratio may be due to a decoupling of endoreplicative
genome replication from cytoplasmic growth. The larval fat body is an endocreplicative tissue,
undergoing multiple rounds of G1/S phase transitions without cell division. Endoreplication uses
much of the same machinery as standard mitotic G1/S transition, and it is usually assumed that
genome replication and cytoplasmic growth are tightly coupled (Edgar and Orr-Weaver, 2001).
Endoreplication is a process closely controlled by nutritional and growth factor signals (Britton
and Edgar, 1998). A severe deficiency in dLipin, and thus insulin pathway activity, or a
reduction in TOR activity could result in changes in growth factor and nutrient signaling and
consequently influence cytoplasmic growth. The double fat body-specific dLipin and raptor
knockdown might mirror this defect, and likewise inhibit cytoplasmic growth.
Alternatively, autophagic activity may be increased in fat body cells upon strong cellautonomous dLipin knockdown and concomitant knockdown of dLipin and raptor. Autophagy is
a catabolic process in which cytoplasmic component are degraded in autolysosomes to provide
energy for the cell. Autophagy is usually triggered as a response to starvation (Codogno and
Meijer, 2005). A reduction in TORC1 activity is known to induce autophagy (Castets et al.,
2013), and recently Lipin1 has been identified as a contributor to autophagic flux in muscle
tissue (Zhang et al., 2014). Furthermore, insulin pathway activity controls autophagic activity,
with a reduction in insulin signaling resulting in increased autophagy (Codogno and Meijer,
2005). Autophagy can result in reduced cytoplasmic volume, as cells consume cytoplasmic
components to provide energy (Neufeld, 2012). It is possible that in cells with concomitant
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dLipin and raptor knockdown the decrease in TORC1 activity together with reduced insulin
pathway activity due to dLipin knockdown upregulates autophagy and, hence, decreases
cytoplasmic volume. Strong cell-autonomous knockdown of dLipin alone might also be enough
to increase autophagic activity in fat body cells.
Further experiments will need to be conducted to address the exact mechanism causing
the increased nucleocytoplasmic ratio upon severe dLipin knockdown and concomitant
dLipin/raptor knockdown. Investigating autophagic activity in animals with dLipin/raptor
knockdown and in animals with cell-autonomous dLipin knockdown may be a first step in
answering this question.
4. Expression of dLipin with a mutation in the PAP active site or deletion of NLS motif has a
dominant negative phenotype
Expression of dLipin lacking an intact PAP active site or NLS motif resulted in dominant
negative phenotypes (Fig. 27, Fig. 30). When ΔNLSdLipin was expressed in the fat body, it not
only did not enter the nucleus, but it also prevented endogenous dLipin from entering the nucleus
(Fig. 27). Expression of ΔPAPdLipin in dLipin transheterozygous mutants resulted in a decrease
of larval viability (Fig. 30). Lipin1, 2 and 3 proteins are known to form hetero- and homooligomers in adipocyte cell culture (Liu et al., 2010). dLipin might therefore form oligomers as
well. Dominant-negative effects seen after expression of both ΔNLSdLipin and ΔPAPdLipin
suggest that both functions of dLipin, PAP and co-regulator activity, require proper
oligomerization. GST-pulldown experiments would help elucidate whether dLipin proteins can
form oligomers in vitro, and co-immunoprecipitation experiments with animals expressing
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tagged dLipin and endogenous dLipin may elucidate whether dLipin proteins oligomerize in
vivo.
5. dLipin might regulate ecdysone release or synthesis in larval ring gland
Strong ubiquitous expression of ΔNLSdLipin resulted in larval lethality and
developmental delay; a phenotype that could be rescued by adding 20-HE to the fly food (Fig.
46). dLipin is abundantly expressed in the larval ring gland, the place of synthesis and release of
the 20-HE precursor ecdysone (Ugrankar et al., 2011). Fat body tissue from these animals was
well developed, which excludes fat body underdevelopment as a cause for the developmental
delay. Another possibility is that dLipin may be involved in ecdysone synthesis in the ring gland
itself, possibly through its role as a transcriptional co-regulator. 20-HE supplementation was not
sufficient to compensate for dLipin deficiency in transheterozygous dLipin mutants. This may be
because of the severe fat body underdevelopment in these animals that may prevent normal
developmental progression despite supplementation with 20-HE.
The fact that expression of WTdLipin in fat body of transheterozygous dLipin mutants
cannot rescue developmental delay and larval lethality corroborates the hypothesis that dLipin
function in tissues other than fat body is essential for larval survival and development.
Specifically knocking down dLipin in the ring gland should help elucidate the role of
dLipin in ecdysteroidogenesis. RNAseq experiments could be conducted to further investigate
the involvement of dLipin in ecdysteroidogenesis. This would help identify genes controlled by
dLipin in the ring gland, and clarify whether dLipin is indeed a critical regulator of ecdysone
synthesis and release.
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6. dLipin functions are conserved in Homo sapiens Lipin proteins
Rescue experiments with the human dLipin paralogs revealed that they possess at least
some dLipin function by partially compensating for loss of dLipin activity (Fig. 47). Lipin1 did
not show a significant rescue effect, but a clear trend was seen and it is likely, a larger sample
size would have resulted in statistical significance. It is interesting to note that stronger
expression of either of the Homo sapiens lipin homologs in fat body or ubiquitous expression
had a negative effect on the number of pupae formed. This indicates that strong expression of
Homo sapiens lipin genes induces lethality. The reason for this effect may be that human lipin
genes carry out some functions that dLipin does not have and that are detrimental to fly viability.
In summary, I was able shed light on the effects of lipodystrophy elicited by a lack of
dLipin activity on insulin pathway activity in the fly. I was also able to link insulin pathway
acitivity and dLipin activity during adipogenesis and TAG synthesis. Additionally I further
elucidated an interaction between TORC1 and dLipin in Drosophila melanogaster.
In larvae with reduced dLipin activity the insulin pathway was disrupted, as evidenced by
a lack of PIP3 synthesis and increased circulating sugar levels. Cell-autonomous reduction of
dLipin resulted in cell growth defects, likely caused by reduced insulin pathway activity in these
cells. Insulin resistance in the fat body of lipodystrophic larvae with dLipin knockdown was
possibly caused either by an unphysiological accumulation of lipid intermediates, an overall
reduction in cellular TAG stores or a combination of both. Additionally, dLipin activity during
adipogenesis and in TAG synthesis appeared to be controlled by the insulin pathway.
Furthermore, functions of the insulin pathway during adipogenesis appeared to be negatively
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affected by reduced dLipin activity. Thus, the functions of the insulin pathway and of dLipin in
lipid metabolism are in part mutually dependent.
dLipin localization and abundance was controlled by TORC1, and therefore nutrient
signaling. Reduced TORC1 activity promoted nuclear concentration of dLipin, which in turn
may affect lipid metabolism by facilitating dLipin-mediated expression of beta-oxidation genes
and by inducing dLipin-mediated SREBP inhibition. These data indicate that dLipin’s role in
lipid metabolism might be strongly dependent on TORC1 activity.
It further appeared that the insulin and TORC1 pathways are decoupled pathways in fat
body of developing larvae. I was also able to attribute a possible novel function in
ecdysteriodigenesis to dLipin and, thus help guide future dLipin research into a new and
interesting direction.
Taken together, my data revealed that TAG synthesis and the insulin and TOR signaling
pathways are tightly interconnected in the fat body of Drosophila and that dLipin may represent
an important link between anabolic lipid metabolism, catabolic lipid metabolism and insulin and
TOR pathway activity.
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V. Summary
I was able to further our understanding of underlying mechanisms that cause insulin
resistance in lipodystrophic individuals by investigating the relationship between dLipin, the
Drosophila homolog of mammalian Lipins, and insulin pathway activity. Lipin proteins are
known to act as PAP enzymes and a disruption of mammalian Lipin1 function results in
metabolic disturbances, including insulin resistance and lipodystrophy (Langner et al., 1991;
Reue et al., 2000). Ugrankar et al. (2011) previously established that a loss of dLipin activity
similarly results in lipodystrophy (Ugrankar et al., 2011). I was able to show that dLipin activity
is also crucial for fat body insulin sensitivity in Drosophila. Reduced dLipin activity in the fat
body interfered with PI3K-mediated PIP3 synthesis and reduced insulin pathway activity
downstream of PI3K. Genetic interaction experiments shed light on the epistatic relationship
between dLipin and the insulin pathway. These experiments revealed that dLipin affects insulin
pathway activity by modifying activity of either PI3K or PTEN. Levels of circulating sugars
were significantly elevated in transheterozygous dLipin mutants, an indication that a loss of
dLipin activity elicits insulin resistance. 	
  
Strong cell-autonomous knockdown of dLipin activity significantly reduced fat body cell
size. This is consistent with my findings that implicate dLipin in PI3K activity; as insulin
pathway activity is a major driving force of cell growth. Thus, dLipin might affect cell growth by
influencing insulin pathway activity. Additionally, fat synthesis was dependent on dLipin
activity in a cell-autonomous fashion.
Rescue experiment carried out with dLipin lacking PAP activity and dLipin lacking
nuclear activity demonstrated that PIP3 synthesis was dependent on dLipin-mediated PAP
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activity, and that loss of nuclear dLipin activity had no discernible effect on fat body insulin
sensitivity. This indicates that dLipin affects insulin pathway activity via its role as a PAP
enzyme, and not by regulating gene transcription as a putative transcriptional co-regulator.
In addition, dLipin activity itself appeared to be regulated by the insulin pathway.
Cellular abundance of dLipin was significantly reduced upon downregulation of insulin pathway
activity. Subcellular localization of dLipin, however, appeared to be unaffected. Furthermore,
insulin pathway activity appeared to regulate dLipin activity during adipogenesis and in TAG
synthesis. My data also implicate dLipin as a possible contributor to insulin pathway activity
during adipogenesis.
To further investigate the relationship between Lipin and TOR activity, I examined
dLipin’s subcellular localization upon reduction of TORC1 activity. Upon loss of TORC1
activity, dLipin translocates into the nucleus. Thus, cytoplasmic retention of dLipin is positively
regulated by TORC1 activity. The fact that dLipin translocates into the nucleus upon reduced
TORC1 activity suggests that TORC1 influences dLipin activity in lipid metabolism. Nuclear
Lipin1 is known to participate in the expression of beta-oxidation and adipogenesis genes and to
inhibit SREBP-mediated lipogenesis (Finck et al., 2006; Zhang et al., 2008; Peterson et al.,
2011). Consequently, dLipin’s role in lipid metabolism seems to depend on TORC1 activity.
Genetic interaction experiments between dLipin and TORC1 (raptor) revealed that
dLipin and TORC1 influence larval growth rate and cell growth in concert, but not through the
same pathway. It appeared that growth is controlled, at least in part, by the independent actions
of the TORC1 and insulin pathways and that dLipin can interfere with this interaction by
reducing insulin pathway activity.
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TORC1 activity itself, as measured by 4EBP1 phosphorylation, remained unchanged
upon dLipin knockdown suggesting that insulin resistance and growth defects in cells with
reduced dLipin activity are not caused by changes in TORC1 activity. This result furthermore
suggests that TORC1 signaling and the insulin pathway are parallel pathways in the larval fat
body.
Additionally, I was able to uncover a potential new function of dLipin in ecdysone
synthesis or release in the Drosophila ring gland. Strong ubiquitous expression of dLipin lacking
nuclear function resulted in developmental delay and larval lethality, a phenotype that was
rescued by 20-hydroxyecdysone supplementation.
Investigation of dLipin lacking PAP activity and dLipin lacking nuclear activity pointed
to the possibility that both functions of dLipin demand oligomerization, but further validation is
required. Finally, rescue experiments with mammalian lipin homologs revealed that mammalian
Lipins execute some of dLipin functions in vivo.
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